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Abstract
Background and Significance: Despite the many historical efforts by the U.S. to reduce lead
(Pb) in the environment, childhood Pb poisoning continues to be a public health issue today. Pb
has been identified as a child hazard because children are highly vulnerable to the effects even at
lower levels of exposure (blood lead levels (BLLs) < 10 µg/dL), and these effects can be
physical, cognitive, and behavioral. Current state and federal blood lead level screening
guidelines for identifying exposed children are based on assumptions that BLLs < 10 µg/dL will
remain stable or decline over time (with age); disregard the effects of lowest-range Pb exposure;
and disregard Pb levels in children older than approximately age 6. We have observed in past
clinical studies that in one U.S./Mexico border community, children in high-risk neighborhoods
experienced substantially higher proportions of elevated blood lead levels (CDC reference level
of ≥ 5 µg/dL) than the rest of the U.S., and a large proportion of children had detectable blood
lead levels. To test current policy assumptions regarding child blood lead level screening, this
study examined whether time and/or other possible factors over time, predicted child blood lead
levels in children with chronic low-level Pb absorption. Whether time was a significant
predictor was examined, and also whether age, sex, and living in families with incomes below
the U.S. poverty line, living in an older home, and living near industries predicted child blood
lead levels.
Aims and Objectives: Changes in current policy must be evidence-based. The over-arching
goal of this study was to test current assumptions that one blood lead level test is sufficient to
rule out child lead exposure, and that lead exposure and risk of lead exposure, reliably
diminishes as children age. The hypotheses also tested other possible factors that may influence
children’s BLLs, accounting for time. Specifically, this study determined: 1) the blood lead
vii

levels of children living in high-risk neighborhoods of El Paso County; 2) the numbers of
children with blood lead levels exceeding the current CDC reference level for “elevated” of 5
µg/dL; 3) whether blood lead levels change predictably with time, during a period of
approximately 18 months (across three time points); and 4) factors other than time that predicted
children’s low blood lead levels (< 10 µg/dL).
Hypotheses: H1): There will be significant differences in child BLLs across three time points;
H2): Time as a factor will predict changes in child BLLs across three time points (that exceed
within child variability of BLL); H3): Whether a child lived below the U.S. 2020 poverty
threshold will influence whether child BLLs change significantly over time; H4): Whether a
child lived in an older home (built before 1986) will influence whether child BLLs change
significantly over time; H5): Whether a child lived near industry will influence whether child
BLLs change significantly over time.
Methods: This was a prospective longitudinal study of child blood Pb levels in 206 children
ages 6 months to 16 years living in high-risk neighborhoods in El Paso County. The children
were a convenience sample, recruited through school events, community health fairs, and doorto-door invitations. Child BLLs were determined from finger-stick blood samples analyzed
using inductively coupled plasma mass spectrometry (ICP-MS) and were tested every 3 through
6 months approximately over 18 months. Children included were those tested for blood lead and
with BLLs from not detectable to 10 µg/dL. All data for this study were collected in the
community and data collection was stopped in March 2020 by COVID-19 shutdown orders. As
of March 2020, the base sample included 193 children with one (N = 193), two (N = 86), or three
(N = 29) BLL screenings. Family demographics, child medical history, and household
characteristics were collected from parents, and child blood lead levels were collected in
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children’s homes. Multiple imputation simulated missing data, yielding 193 children with three
time points. All individual growth curve (linear mixed) models were performed for datasets N =
29 and N = 193.
Results: Blood lead mean values for children were below the CDC reference value of elevated
blood lead levels ≥ 5.0 µg/dL at every test point. The proportion of children with elevated BLLs
however were 4.7%, 7.0%, and 3.4%, at Time 1, Time 2, and Time 3 respectively, which were
substantially higher than the expected national percentage of 2.5% for children ages 1 through 5
years across the three-time points. Individual growth curve (linear mixed models) showed that
child BLLs changed significantly within children, and that time was not a significant predictor of
BLL. Also, age and sex, living with a family income below the poverty line, and living in an
older home were not significant predictors of child BLL. The age by sex interaction and living
near an industry predicted child blood lead levels controlling for time as a repeated measure in
the N =193 multiple imputation dataset. Children living near an industry had higher blood lead
levels regardless of age and sex, with an average 0.22 µg/dL increase. Pre- and adolescent
females had higher blood lead levels than males of the same age.
Conclusion: Time is not a significant predictor of child BLLs, and policy regarding BLL child
screenings must be changed to require ongoing monitoring of child BLLs for children and
adolescents living in high-risk neighborhoods. Also, as suggested by previous literature, other
factors created special risk of lead exposure for children, including living below the poverty line,
and living in an older home. Very interestingly, the age and sex interaction was significant for
female pre-and adolescent children suggesting that puberty may play a critical role in lead
absorption in this age group. Living near an industry predicted a significant proportion of
variance in child blood lead levels but the estimate was not very precise (relatively broad
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confidence interval). This finding suggested that all children living near polluting industries
require ongoing BLL monitoring. The remaining unexplained variance in the model suggested
that other factors not explored in this study are contributing to variability in child blood lead
levels in these children with chronic low-level lead absorption.
Recommendations: Children in high-risk communities must be continually monitored. One
BLL test in early childhood is not sufficient to rule out chronic lead exposure in children.
Additional studies are needed to identify other possible sources of lead contamination, that may
exist in the soil, air and water. Comprehensive community education must be provided on an
ongoing basis in these high-risk neighborhoods, to help families identify lead sources typical
lead hazard sources by neighborhood; limit consumption of foods and use of products that may
cause lead exposure; increase nutrition; and safely renovate lead-paint sources in the home.
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1. Introduction
1.1 Childhood Lead Poisoning is Still a Public Health Issue
Despite the many historical efforts by the U.S. to reduce lead (Pb) in the environment,
childhood Pb poisoning continues to be a public health issue today. In the year 2012, the U.S.
Centers for Disease Control and Prevention (CDC) estimated that approximately 500,000 U.S.
children ages 1 through 5 years had "elevated" blood lead levels (BLLs) ≥ 5 µg/dL (Advisory
Committee on Childhood Lead Poisoning Prevention, 2012). While this estimate is already an
alarming figure calling for public health action, it underestimates the real number of children that
have "elevated" BLLs and who are at risk for adverse health effects of Pb exposure below this
level. The 2012 CDC child estimate for the designation of "elevated" was derived from data
collected through The National Health And Nutrition Examination Survey (NHANES) that
excluded populations who may be at highest risk of Pb exposure, such as under-represented
racial and ethnic minority groups, undocumented and documented migrants, refugees, people
living in poverty, and children who were adopted from outside the U.S. (Advisory Committee on
Childhood Lead Poisoning Prevention, 2012). Also, the estimate disregarded the adverse health
effects, later explained, that may occur below the "elevated" level, and in children that are
younger or older than the 1-5-year age range.
Data from NHANES has helped demonstrate a decrease in BLLs in the U.S. population
since environmental regulations were enacted in the 1970s. For example, geometric means of
BLLs of the U.S. population aged 1 through 74 years have decreased 93.6% since the mid-1970s.
While the geometric mean from 1976-1980 was 12.8 µg/dL, by 2015-2016 it had dropped to
0.82 µg/dL (Dignam, Kaufmann, LeStourgeon, & Brown 2019). While this estimate of
improvement might be partially correct, NHANES data may not be representative of the whole
1

U.S. population because the geometric means are calculated based on BLLs of participants who
complete the NHANES and as suggested above, NHANES data excludes some of the most
vulnerable in our nation. Also, NHANES data are used to provide an estimate of the prevalence
of elevated BLLs among children over time but cannot provide information or estimates at the
state or local level, incidence rates, and short-term trends (Centers for Disease Control and
Prevention [CDC], 2020).
There have been some attempts to use NHANES data in statistical models to predict state
and local child BLLs, but these have not been successful in predicting more than 30% of
exposures (Schultz, Morara, Buzton, & Weintraub, 2017). A recent study using NHANES data
for predictive modeling compared the prevalence of children ages 12 months to 5 years with
elevated BLLs ≥ 10.0 µg/dL between the years 1999-2010. This study revealed that
approximately 1.2 million cases of elevated BLLs occurred, but only 50% were reported to the
CDC (Roberts, Madrigal, Valle, King, & Kite, 2017). This study also demonstrated that the
highest numbers of children with elevated BLLs lived in the southern U.S.
In 2015, the city of Flint, Michigan declared a child Pb poisoning crisis when 4.9% of
children, almost double than the nation's average (2.5%), had "elevated" BLLs after the city's
water source was switched to one of higher acidity, and the city neglected to use a phosphatebased treatment that prevented leached Pb from getting in the water supply (Hanna-Attisha,
LaChance, Sandler, & Schnepp, 2016). While the crisis in Flint helped shed light again on the
importance of preventing childhood Pb poisoning, it still did not capture the problem nationwide.
A study by Reuters attempted to characterize the problem at this level by conducting a
nationwide spatial analysis of child BLLs at the neighborhood level. The study found that more
than 3,810 areas had child lead exposure rates at least double than those found in Flint, and that
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more than 1,300 of these areas had rates at least four times higher (Pell & Schneyer, 2016a).
Children living in neighborhoods with the highest water Pb levels experience higher percentage
of elevated BLLs and increase after the water source changed, from 4% to 6.6% (Hanna-Attisha
et al., 2016). The data were derived from states that had available zip code or census tract level
BLLs for the years 2004-2015. This investigative study helped to reveal the massive scope of
the problem nationwide. The gaps in data used in CDC estimates and the massive exposure
suggested the Reuters study, show that childhood Pb poisoning in the U.S. is a far bigger
problem than we currently estimate.
1.2 Children Are Most Vulnerable to the Effects of Pb Exposure
While Pb can be harmful in adults, children have biophysiological and behavioral
differences that greatly increase their likelihood of Pb exposure and adverse health effects. The
adverse health effects of Pb are magnified in children because children’s bodies do not have the
mature mechanisms to get rid of Pb fast enough from their bodies as compared to adults. This
allows for Pb to circulate in the blood longer and have more opportunities to accumulate and
disrupt developing organs. One important example is the developing brain. The brain protects
itself by blocking the entry of Pb with a layer of densely packed cells within the brain’s blood
circulatory system. In children, this barrier is not fully developed until after the age of about 36
months, allowing for Pb to easily reach the brain before this age (Sanders, Liu, Buchner, &
Tchounwou, 2009). Once Pb is in the brain, it is uncertain how much is accumulated, and for
how long Pb may disrupt brain functions. For these reasons, even the smallest dose of Pb in
children’s bodies may have long-lasting effects. (Biophysiological chemical mechanisms of Pb
in the body will be explained in later sections, see page 32.)
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Children’s playing, mouthing, and “hand-to-mouth” behaviors also increase their Pb
exposure. Children get exposed by playing outdoors, on floors, or near windowsills where
sources of Pb such as leaded dust, contaminated soil, and lead-based paint chips are more likely
to be found. When playing, children can inhale or ingest Pb particles by breathing suspended
contaminated dust or soil, and by placing unwashed hands into their mouths. At the same time,
children can be exposed to Pb particles more than adults because children have higher breathing
rates and tend to more frequently place their hands into their mouths (Agency for Toxic
Substances and Disease Registry [ATSDR], 2012; Gaultier, Peter, Penzel, Podszus, & von
Wichert, 1991). Also, children can get exposed by chewing on contaminated toys and items,
causing ingestion of Pb. This is especially seen in children while teething (Levin et al., 2008).
Children at special risk are those with pica, a condition in which the child tends to eat non-food
items such as soil and paint chips, which can be Pb contaminated (De la Burdé & Reames, 1973).
1.3 Methods for Determining Child Lead Exposure
Childhood Pb exposure is measured by analyzing Pb concentrations in children’s bodies.
Lead can be detected in many biological markers including hair, nails, urine, feces, saliva, whole
blood, and bone. The amount of Pb found in these biological markers describes how much of Pb
has been excreted, is circulating, or is sequestered in the body at the time of testing and may
provide an estimate of when the child was exposed. This information is important for health
professionals because it can be used to estimate a child’s exposure risk, can estimate current Pb
body burden, and thus, how much Pb was absorbed. Lead that is excreted from the body through
urine and feces reflects exposure within approximately 1 month. Urine and feces Pb however are
not a good metric for Pb body burden because concentrations are dependent on hydration,
circadian and diurnal rhythms (Blaurock-Busch, Friedle, Godfrey, & Schulte-Uebbing, 2010;
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Blaurock-Busch, Amin, & Rabah, 2011). Hair and nails reflect Pb exposure from 6 months to 1
year, but this type of Pb is said to be sequestered (Grashow et al., 2014; Rashed & Hossam,
2007). Lead that is sequestered is thought to be harmless in the body because it has not been
absorbed and instead is excreted, is not circulating, and thus does not contribute to Pb body
burden (National Research Council Committee on Measuring Lead in Critical Populations,
1993).
Bone concentrations are measured using x-ray fluorescence that analyzes deposits of Pb
in the different layers of the bone and reflects an accumulation of Pb exposure over time. Lead
in the bone can reflect exposure from 10-30 years and the procedure is a good metric for
determining Pb body burden (Payne, Egden, Behinaein, Chettle, McNeil, & Webber, 2010).
Most of these measurements have been done in adults, and the procedure seems promising to be
used in children but there are still issues with practicality because it requires children to remain
still as the instrument is sensitive to light movements and may not detect Pb in very young
children (Payne et al., 2010; Rosen et al., 1991; Roy, Gordon, Beumont, Chettle, & Webber,
1997; Somervaille et al., 1988). When Pb is in the bone it is harmless to other organs because Pb
is not circulating in the body, but it can still harm bone composition while stored.
Concentrations of Pb in saliva samples can reflect exposure within one month but is not a
good metric of Pb burden. Also, the method has not been tested enough to be used as a practice
because it is unreliable in children with lower levels of Pb exposure with BLLs < 5µg/dL
(Gardner, Geller, Hannigan, Sun, & Mangla, 2016). Future studies are needed to determine the
effectiveness of this method.
Whole blood Pb reflects on average an exposure of within 28 days but in children it may
reflect a longer term exposure (Manton, Angle, Stanek, Reese, & Kuehnemann, 2000). It also
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reflects how much of Pb is circulating in the body. Circulating Pb may be the most harmful type
because it can be absorbed by organs, especially in children where their organs are still
developing.
There are different methods for collecting samples and analyzing Pb in whole blood. A
sampling of whole blood can be done by finger-stick and collected in lead-free capillary microvial tubes treated with an anticoagulant, or by venous blood drawing collected in lead-free vials.
There are a few concerns regarding the collection of blood samples. The first concern is related
to sample contamination. Venous blood sampling is a preferred method over capillary sampling
because the risk of contaminating blood samples from Pb found on the skin surface is less from
the arm than from a finger. This can be very effectively protected against however by washing
the hands thoroughly and wiping the fingers with metal-removing wipes prior to the finger-stick
procedure.
The second concern is related to the training required to take blood samples because a
phlebotomist is required for venous sampling but collecting samples via finger stick requires
non-formal training.
The third concern is related to the instrumentation used to analyze samples. The type of
instrument used to analyze whole blood Pb levels is important in getting reliable and precise
results. Inductively Coupled Plasma Mass Spectrometry (ICP-MS) is the preferred method as it
requires far less blood sample and can provide highly precise results for lower BLLs (<5 µg/dL)
with greater precision compared to other instruments like Gas Furnace Atomic Absorption
Spectroscopy (GFAAS) or point-of-care devices (Jones et al., 2017; Murphy et al., 2009; Sobin,
Parisi, Schaub, & de la Riva, 2011; Trzcinka‐Ochocka, Brodzka, & Janasik, 2016). The unit for
Pb concentrations in whole blood is micrograms per deciliter (µg/dL). Currently, measuring Pb
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in whole blood by ICP-MS is the best way to estimate Pb in blood samples, and is the preferred
method for clinical practice (Barbosa, Tanus-Santos, Gerlach, & Parsons, 2005).
1.4 No Level of Blood Lead Level is Safe for Children
Setting a safe BLL for children is difficult because Pb can be harmful even at very low
levels of exposure. A safe BLL threshold should be based on the level at which no adverse
health effects are observed, but scientists up to now have not been able to find a safe BLL
threshold because even small amounts of Pb can accumulate over time in the body and disrupt
organ function. Some developmental animal and human studies have suggested that even at
levels as low as 2 µg/dL can have several damaging effects, including delayed growth, altered
behavior and cognition, and damage to organs (Bellinger, 2008a, 2008b; Bellinger, Stiles, &
Needleman, 1992; Binns, Campbell, & Brown, 2007; Canfield, Henderson, Cory-Slechta, Cox,
Jusko, & Lanphear, 2003; Flores-Montoya & Sobin, 2012; Flores-Montoya, Alvarez, & Sobin,
2015; Lanphear, Dietrich, Auinger, & Cox, 2000; Sobin, Montoya, Parisi, Schaub, Cervantes, &
Armijos, 2013; Sobin et al., 2015; Sobin, Flores-Montoya, & Alvarez, 2017).
What is also of concern is that children often do not show immediate symptoms at the
lower levels of exposure, but health effects are noticed when expectations for children’s
academic achievements are not met during school years or in adulthood. Early childhood Pb
exposure has been associated with attention-deficit/hyperactivity disorder (ADHD), lower IQ,
delayed puberty, developmental problems with their offspring, hypertension, renal effects,
reproductive problems, aggression and adult violent behavior (Agency for Toxic Substances and
Disease Registry [ATSDR] , 2017c; Barbosa et al., 2005; Bellinger, 2008a, 2008b; Landrigan,
Baloh, Barthel, Whitworth, Staehling, & Rosenblum, 1975; Landrigan et al., 1976; Needleman,
MacFarland, Ness, Fienberg, & Tobin, 2002; Nevin, 2000; Rossi, 2008; Wright et al., 2008).
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Later observed effects were from early childhood exposure estimated from blood levels >10
µg/dL. Studies are needed to find the later health effects of chronic exposure at lower levels (<
10 µg/dL) that occur among children at different ages. Based on what is known, the CDC, the
World Health Organization (WHO), and public health professionals have come to a consensus
and acknowledge that no BLL is safe for children.
Adverse health effects and symptoms in children vary greatly. At BLLs ≥ 45 µg/dL,
stomach cramps, nausea, vomiting, encephalopathy, seizures, coma, and even death can be
observed (ATSDR, 2017c). At BLLs ≥ 10 µg/dL, symptoms may include headaches, disrupted
sleep, and decreased language function (Yuan et al., 2006), intellectual abilities, academic
achievement, psychomotor function (Landrigan et al., 1975; Lanphear et al., 2005), decreased
high school attendance, decreased reaction times, decreased class rank, hand and eye
coordination deficits, and lowered vocabulary and grammatical reasoning scores (American
Academy of Pediatrics Committee on Environmental Health, 1993).
Lower levels of exposure (BLL <10 µg/dL) have been associated with lower IQ
(Bellinger, 2008a; Bellinger et al., 1992; Canfield et al., 2003; Lanphear et al., 2005), lower math
and reading scores (Evens et al., 2015; Lanphear et al., 2000) and deficits in cognitive functions
such as attention, language, and memory (Canfield et al., 2003; Lanphear et al., 2000; Sobin,
Parisi, Schaub, Gutierrez, & Ortega, 2011; Sobin et al., 2015). These effects suggest that even
low-level early Pb exposure in children can be dangerous.
While there is no BLL safe for children, determining which child gets clinical
management and/or prevention intervention is based on a reference level. In January 2012, the
U.S. Centers for Disease Control and Prevention (CDC) set a clinical reference level of 5 µg/dL
in whole blood to identify children with “elevated” BLLs higher than most children’s levels.
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This reference level was based on the estimated 97.5th percentile of BLLs from children ages 1 to
5 years, tested in the 2007-2010 NHANES (N = 1653) (CDC, 2013). However, this and any
value is arbitrary because health effects may occur at levels of Pb exposure well below 5 µg/dL.
It is also important to note that effects are not limited to children below the age of 6 years (CDC,
2017).
Another important consideration is that by setting this reference value based on the age
group ≤ 5 years, public health professionals and clinicians are assuming that it is at this age range
where child BLLs have adverse health effects. Yet, studies have repeatedly shown that Pb
exposure can also be detrimental for children above 5 years. For example, lower IQ scores were
found in children ages 5-7 years compared to children less than 5 years (Hornung, Lanphear, &
Dietrich, 2009). Instead, child BLLs reference values should represent the minimum BLL at
which adverse health effects would be expected across ages. To determine such a threshold,
scientists will have to study how BLLs change and what are the effects in children as they age.
Some scientists suggest that to determine such a threshold, prospective studies are needed
examining children with low to medium Pb exposure (BLLs ranging from 1 to 10 µg/dL)
(Spivey, 2007). Our study will aim to characterize BLL stability overtime in children with low
Pb absorption (BLLs <10 µg/dL), and initially will include “time” (age) as a main effect.
1.5 Inorganic Lead is Responsible for Childhood Lead Exposure
Lead was used and is still used in many products because it is a heavy metal that is
inexpensive, very soft, dense, easy to mold, and resistant to water corrosion. In the past 50
years, the U.S. has created regulations to reduce the use of Pb in many products and uses to
decrease adult and childhood Pb poisoning. Yet, once Pb is in the environment, it can stay there
for many years unless it is physically removed or properly encapsulated. This means that past Pb
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contamination can continue to be current sources for childhood Pb poisoning and may also
explain lower Pb levels of childhood exposure (Dignam et al., 2019).
Lead can exist in two types, organic and inorganic. Organic Pb (tetraethyl and
tetramethyl lead) is found in leaded gasoline and is highly toxic to the human body. Organic
types of Pb are less common in children’s environments today. Organic Pb was used in
automotive gasoline up to the year 1996 in the U.S., where the chemical form tetraethyl Pb
increased octane for engine performance (U.S. Environmental Protection Agency [EPA], 1996).
While leaded gasoline is no longer in vehicles used in the highways today, there can be historical
contamination in the soil near heavy trafficked areas and highways (Battelle Memorial Institute
& EPA, 1998). Emissions from industrial operations may also contain a mix of organic and
inorganic forms of Pb, but emissions of Pb tend to stay close to the source of emission,
depositing in the top surface of nearby soil or surfaces, and depositing in household dust. Also,
organic Pb can then undergo carbon degradation to form inorganic Pb.
Inorganic Pb, however, is the type that is commonly found in children’s environments.
Inorganic Pb can be found in children’s homes, schools, daycare, and playgrounds in lead-based
paint, soil, dust, plumbing, painted toys, furniture, toy jewelry, cosmetics, pottery, ceramics,
crystal, traditional remedies, imported canned foods, imported hard candies, food or liquid
containers, cigarette smoking (from second and third hand), and drinking water (Dignam et al.,
2019; EPA, 2013a, 2013d). Some of these sources are from legacy use of Pb in products such as
lead-based paint, and inorganic Pb is found in many more recent and new consumer products.
One source that continues to contribute to childhood Pb poisoning is lead-based paint.
Lead-based paint was used until the 1980s when the U.S. Consumer Product and Safety
Commission banned the use of paint containing more than 0.06% of Pb in residential structures
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in 1978 (Steinfeld & Novick, 1971). Environmental protection acts were passed in 1978 that
banned the use of lead-based paint however lead-based paint can still be found in older homes
built before approximately 1986 that have not been properly maintained and where the paint is
chipping, peeling, and/or chalking. Deteriorating lead-based paint can create Pb hazards for
children by contaminating household dust, or by producing paint chips that fall on the floor,
where they can be ingested or inhaled by young children. Lead-based paint found on friction
surfaces such as doors, doors frames, windows, floors, porches, stairways, and cabinets can
generate lead-contaminated dust and chips from opening, closing, and general wear (Dignam et
al., 2019; EPA, 2013a). Leaded paint has a sweet taste, and after discovering paint chips,
children may be enticed to continue eating them; and young children may also chew on these
painted surfaces. According to the U.S. Center for Disease Control and Prevention, “lead-based
paint and lead-contaminated dust are the most widespread and hazardous sources of Pb exposure
for young children in the U.S.” (CDC, 2020). It is estimated that approximately 24 million
housing units may have deteriorating lead-based paint and that about 4 million of these are
homes to young children. Lead-based paint continues to be a significant Pb exposure hazard for
children.
Another source of concern is public drinking water systems. Many systems used to and
may continue to leach Pb into the public water supply. Lead gets in public drinking water
systems through the corrosion of lead-contaminated plumbing and fixtures that were used before
1986 (EPA, 2016). Leaching of Pb from lead-contaminated plumbing and fixtures can happen
over time because of corrosion but can also be higher where water has high acidity or low
mineral content (EPA, 2016). In 1976, the U.S. Environmental Protection Agency (EPA) passed
the Safe Drinking Water Act which allowed the agency to set a 50 µg/dL limit of Pb in public
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drinking water systems (EPA, 2013b). The act was then followed by the Lead and Copper Rule
set in 1991 where corrosion control practices were implemented, like adding orthophosphate
treatment, and the Pb limit in large drinking water systems decrease to 15 µg/dL (EPA, 2015).
Most main lines from public water utilities are lead-free but the leaching can still happen in the
service lines between the home and the main lines. Leaching could also come from fixtures that
are labeled lead-free where Pb may have been used in the soldering. It is estimated that
approximately there are 6.1 million Pb service lines still in use today across America (Pell &
Schneyer, 2016b). In 2015, there was a national spotlight on Flint, Michigan for having Pb in
drinking water after switching to corrosive river water that leached Pb from old pipes. In 2016,
it was estimated that there were more than 5,000 U.S. water systems that violated the EPA Pb
limit, serving approximately 18 million people (Olson & Fedinick, 2016). Lead in water can
contribute to child BLLs up to 20% (Council on Environmental Health, 2016; Lanphear et al.,
2002; Spanier, Wilson, Ho, Hornung, & Lanphear, 2013).
Toys and consumer products can also continue to expose children to Pb. Lead can be
found in paint, especially bright colored paint, in metal or plastic components of toys and items
intended for children’s use. Toys made of plastic or metal can contaminate children’s hands with
dust that is generated from exposing toys to sunlight, washed with detergents that break down the
chemical bond between the Pb, and from handling the toys (CDC, 2020). Children get exposed
to Pb when they place contaminated items into their mouths or from getting their hands
contaminated with dust and then placing contaminated hands into the mouth. Since 1973, the
U.S. Consumer Product and Safety Commission (CPSC) has banned high amounts of Pb in these
products especially in products intended to be used by children. In 2008, Pb in paint or any
similar surface coatings on products intended for child use was set to 0.009% by weight or about
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90 ppm (parts per million) (U.S. Consumer Product Safety Commission [CPSC], 2016a). In
2011, children intended products must not contain more than 100 ppm of total Pb content in
accessible parts (CPSC, 2016b).
Lead in food and diet can come from the containers in which food is handled or stored.
Especially when acidic foods, hot meals, and microwave heating are used in these types of
containers. Lead leaches into the food and then children may ingest it. These containers can be
made of plastic, glass, ceramics, and glazed pottery. Especially, containers that have brightly
colored imprints or designs, and colored glass are highly suspicious for Pb. Imported cans used
to have Pb soldering to seal the cans, but in 1995 this practice was banned by the US Food and
Drug Administration (FDA) (U.S. Food and Drug Administration [FDA], 1995). Lead can also
be in food items like candies and spices. Imported candies, especially Mexican candy, may
contain Pb in the paint of the wrapper, or in the candy from using chili grown in contaminated
soil and not washed before the process (Tamayo y Ortiz et al., 2016; FDA, 2006a). In 2006, the
FDA set a limit of 0.1 parts per billion (ppb) in candy likely to be consumed by small children
(FDA, 2006a, 2006b). Spices from abroad can have Pb exceeding 2 ppm (n = 1486 samples and
31% exceeded 2 ppm) (Hore, Alex-Oni, Sedlar, & Nagin, 2019). Currently, there is no FDA
regulation for Pb in spices. Despite regulations that aim to limit Pb in children’s items and other
consumer products, these regulations are not enforced and many consumer products currently in
use can have Pb content exceeding the current limit. Toys, candies, spices, and other consumer
products may continue to be a source of childhood Pb poisoning.
Soil can be another source of Pb for children. Children, especially young children, can
place contaminated soil in their hands and then in their mouths. Lead is naturally occurring in
soil. Based on data from 4,857 sites during the years 2007-2010, the mean Pb concentration of
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topsoil (0-5 cm depth) in non-industrial areas and away from major highways in the U.S. is 25.8
± 185 ppm (Smith, Cannon, Woodruff, Solano, Kilburn, & Fey, 2013; EPA, 2016). Natural
concentrations of Pb in soil may not be a source of exposure to children. The risk of exposure
appears when the topsoil gets contaminated with Pb from industrial emissions, lead-based paint
chips from the exterior of homes deteriorating, and legacy contamination from leaded-gasoline.
The EPA has two Pb concentrations limits on the soil. For non-play areas, the Pb concentration
limit in the soil is 1,200 ppm, and for child play areas, it is 400 ppm. The Pb soil limit for child
play areas may still not protect children entirely. One problem is with how the average Pb
concentration of the child play area gets calculated. The average Pb concentration of an area
dilutes higher Pb concentrations that may be found in the area, making it seem that there is a
lower risk of exposure. This method can disregard highly contaminated soil usually found along
driplines of homes or in previous paint or chemical dumping areas. Another problem with the
current EPA Pb soil limit is that it was set when the CDC BLL of concern in children was 10
µg/dL. This means that the current EPA Pb soil may be too high, and a lower soil limit needs to
be set to represent exposure risk for the current CDC BLL of concern of 5 µg/dL.
While limiting Pb concentration in soil can help reduce childhood Pb exposure, the limit
disregards how much of Pb in soil can become available in children’s body when it is ingested.
How much Pb is available in soil after ingestion is referred to as “bioavailability,” a term that
will be explained in later sections. While soil can be a source of exposure to children, in other
words, some studies have demonstrated that it may account for up to 25% of the variability in
child BLLs (Bradham et al., 2017), soil concentrations alone are not enough to predict child
BLLs and can be predicted by the bioavailability of Pb in soil rather than the concentration
(ATSDR, 2017c; Bradham et al., 2017; Council on Environmental Health, 2016; Schilling &
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Bain, 1988) and by other environmental factors like climate, heat, and wind patterns, that
augment the dispersion of loose soil into the air (Laidlaw, Mielke, Filippelli, Johnson, &
Gonzales, 2005). Some researchers argue that soil may not be a significant source for children
since the exposure is sporadic, and children have to ingest enough of it to be exposed to Pb from
contaminated soil (Kimbrough & Krouskas, 2012; Laidlaw et al., 2005). Others suggest that the
issue is not how much, but rather, the bioavailability of whatever amount is consumed.
Lead contaminated dust in children’s household may be a stronger predictor for
childhood Pb poisoning. Household dust can contain Pb from deteriorating interior lead-based
paint, contaminated soil near the home, industrial emissions that settled inside the home,
especially in homes near industrial sites, and from occupational exposure of adults living in the
home, that bring Pb inside on clothes and shoes. Children, especially young children, may inhale
or ingest household dust because they are closer to the ground, and may place Pb contaminated
dust in their mouths. In 2001, the EPA set standards for Pb in dust of household floors and
windowsills, and just last year in 2019, the standards were lowered to comply with U.S.
Department of Housing and Urban Development (HUD) dust standards that were set in 2017.
The EPA and HUD standards for floors were lowered from 40 to 10 µg/ft2 and for windowsills
from 250 to 100 µg/ft2 (U.S. Department of Housinng and Urban Development [HUD], 2017;
EPA, 2019). Household dust is considered one of the most hazardous household Pb exposure
sources for children (Levin et al., 2008b; EPA, 2013c).
In summary, there are many sources of Pb in children’s environments, and there have
been many efforts in the U.S. by different federal agencies to limit Pb in various sources. Yet, it
must be noted that these regulations, except for Pb dust standards, were suggested when the
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action thresholds for child BLLs were higher (≥10 µg/dL). These standards do not provide
estimations of exposure that are aligned with the current CDC reference level of 5 µg/dL.
A more serious issue, however, concerns how child BLLs are used and interpreted for
understanding current child Pb exposure risk. As will be shown below, the many mechanisms
that take part in Pb absorption and distribution in the human body are highly variable. Because
inorganic Pb is more likely to be in children’s environments, the following sections will explain
the biological fate of inorganic Pb in children including Pb absorption, distribution, metabolism,
and excretion of Pb.
1.6 How Lead is Absorbed in the Body
There are two common routes by which inorganic Pb enters the human body. These are
through inhalation or ingestion. Inorganic Pb could also enter the bloodstream through a break
in the skin, but this type of exposure tends to be relatively rare. Once in the body, many factors
impact whether, how, and how much Pb is absorbed. One such factor is Pb particulate size. Not
surprisingly, smaller Pb particulates are more easily absorbed than larger Pb particulates.
Inhalation and ingestion of smaller Pb particulate size have been associated with higher blood Pb
levels with children being more sensitive to the effects than adults (Meng et al., 2014).
1.6.1 The Issue of Lead Bioavailability
Before more discussion of mechanisms that influence inhalation and ingestion of Pb, it is
important to consider the “bioavailability” of Pb in the human body. Lead bioavailability refers
to how much Pb is available for absorption in the body, and the rate at which it is absorbed
(Mushak, 1991). Concerning inhaled and ingested Pb, most of the bioavailability research has
been in mice and has examined the extraction of Pb in the lungs, or in how fast Pb moves
through simulated lungs fluid.
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One study assessed the bioavailability of directly inhaled Pb and partial Pb ingestion and
demonstrated that fluid composition in both lungs and GI tract, and the solid to liquid ratio
significantly affected Pb dissolution (p<0.05) (Kastury, Smith, Karna, Scheckel, & Juhasz,
2018). Another study was able to visualize the dynamics of Pb particles in the lung and GI tract
from dust exposure using single intratracheal Pb installation and its effects on BLL in mice over
a period of 24 hours. This study demonstrated that BLL increased between 0.25 and 4 hours of
inhalation, peaking at 8 hours and slowly declining during the remaining 24 hours. The
detection of Pb particles in the stomach and small intestine happened between hour 4 and hour 8
after dust exposure (Kastury et al., 2019). Another animal study analyzed how much inhaled Pb
stayed in the lungs and the stomach, and how these concentrations changed BLLs in mice.
Within 15 minutes of Pb exposure through inhalation, BLLs increased from 0 to 1. 62 µg/L.
When BLLs were between 32.7 and 63.3 µg/L, the concentration in the lungs, stomach, and
small intestine varied between 5.9 to 6.9 µg. Lead was not detected in the stomach until 2 hours
after Pb inhalation (Kastury et al., 2019). Also, in the same study, it was demonstrated that
BLLs increased at higher rates in the first 2 hours. While interesting, several gaps have been
noted in the bioavailability literature. Many studies do not have consistent methods for assessing
inhaled metals or simulating lung fluids. Particulate sizes are not identified and comparisons to
other studies concerning the extraction efficiency of simulated lung fluids are not made. Also,
the correlations between in vivo and in vitro studies to predict bioavailability (Kastury, Smith,
Juhasz, 2017) have not been reported. More studies are needed to examine how, under
conditions of constant exposure to Pb contaminated dust, the retention time of dust in lungs and
extraction variability affects bioavailability (Kastury et al., 2017, 2018). Accessing
bioavailability in children from inhalation and ingestion combined is important because children
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would most likely have a combination of Pb exposure through inhalation and ingestion, exposed
at a constant rate, and have higher retention of Pb in lungs and GI tract. Nonetheless, the
obvious complexity and variability of bioavailability in inhalation and ingestion exposure
pathways add another level of variability to children’s Pb exposure, and it is important to
consider when assessing children’s exposure with BLLs.
To summarize, similar to inhaled Pb, mechanisms involved in the absorption of ingested
Pb can vary broadly from child to child, from day to day, and according to feeding habits and
eating behaviors. The absorption of ingested Pb is influenced by the particulate size and
chemical form, the site in the GI tract where maximum absorption occurs, physiological and
molecular processes involved in Pb uptake that are influenced by individual differences, Pbnutrient interactions, how long Pb is in the stomach, and the maturity of the GI tract. Though not
yet well understood, how bioavailability of a Pb hazard source is an additional critical factor that
may alter how digestive proteins, pH of the gastric fluid in children vs. adults, and other ions
interact with different forms of Pb, thereby altering its bioavailability (Deshommes, Tardif,
Edwards, Sebastien, & Prevost, 2012). Together, these findings provide ample evidence for why
there is no simple linear relationship between Pb dose and Pb blood levels. The next section will
consider how these factors also suggest that children’s Pb blood levels are likely to fluctuate over
time (Merki, 1988; Mushak, 1991). In some studies, the bioavailability of inorganic Pb sources
in in-situ models were as high as 100%, ranging from 33% to 100% in soil (Oomen,
Rompelberg, Bruil, Dobbe, Pereboom, & Sips, 2003; Ruby, Davis, Kempton, Drexler, &
Bergstrom, 1992; von Lindern, Spalinger, Stifelman, Wichers Stanek, & Bartrem, 2016),
averaging 28% in dust (von Lindern et al., 2016), and ranging from 1.5% to 100 % in water
(Deshommes & Prevost, 2012). Unlike inhaled Pb, different chemical forms of the ingested Pb
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are absorbed at substantially higher rates in the GI tract. The most common chemical forms of
ingested Pb include sulfide, chloride, acetate, carbonate, chromate, monoxide, tetraoxide,
phosphate, and nitrate. These forms of Pb are found in the many sources for child exposure as
mentioned in the previous section which can be found contaminated soil, water, lead-based paint,
and consumer products (see page 12).
Pb sulfide is used in ceramics, ceramic glaze, and eye cosmetics like Surma and Kohl
from the Middle East, Asia, and Africa (National Center for Biotechnology Information, n.d.).
Pb chloride is used in white and bright pigments in inks for printing and personal care products
(PubChem, n.d.-a). Pb acetate is what is most commonly found in lead-based paint, and some
varnishes and it is used as a drier in conjunction with other forms of Pb for colors like Pb
carbonate (white), Pb monoxide (yellow), Pb chromate (yellow), and Pb tetroxide (red). Pb
acetate has a sweet taste which is why children may ingest paint chips (ATSDR, 2017b1;
PubChem, n.d.-f). Pb carbonate is also the form found in leaded water piping and fixtures
(Harrison & Laxen, 1980). Pb monoxide and tetraoxide can be also used in ceramics, pottery,
glazes, ointments, and storage batteries (PubChem, n.d.-b, n.d.-e). Pb phosphate is sometimes
used in plastics as a stabilizer (PubChem, n.d.-d). Pb nitrate can be found in some paints and
coatings (PubChem, n.d.-c).
Much of what we know about how Pb is absorbed through the gut, is from in-vitro
studies simulating the human intestinal fluid and animal studies. Once ingested, Pb can form
new species of Pb during the digestion process. The electrical charge associated with Pb
influences the diffusion rate in intestinal cells. Ionized forms of Pb can be absorbed more than
other forms because this form is free from other chemicals or complexes and can be easily
allowed into intestinal cells using ionic mechanisms for the transportation of essential cations
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like Ca2+, Mg2+, and Fe2+, and Na+(Jaishankar, Tseten, Anbalagan, Mathew, & Beeregowda,
2014). Yet, this form is less likely to occur and is usually found when Pb concentrations are
greater than 207 mg/L. Lead phosphate and Pb bile complexes are most likely to occur, and
while these forms may not be easily absorbed, these forms can change into ionized Pb or
eventually get transported into the intestinal cells, a process still not well understood (Oomen et
al., 2003).
Whether the chemical form of Pb is soluble can also determine how fast it is distributed
throughout the body. Gastric acid breaks down Pb into more soluble forms. There are water and
acid soluble forms of Pb, and water-soluble forms are absorbed faster than acid-soluble forms.
Water-soluble forms of Pb include chloride, phosphate, nitrate, acetate, carbonate, and chromate.
Of these, Pb acetate is the form that has the highest solubility and higher bioavailability (Ruby et
al., 1992). Acid soluble forms of Pb include sulfide, carbonate, chromate, oxide, and tetraoxide.
In one study, sulfide was less soluble than oxide and chloride in gastric fluids (Kelley, Brauning,
Schoof, & Ruby, 2002). As explained, the exact mechanisms in which Pb is absorbed in the gut
based on solubility still need to be discovered but perhaps since acid-soluble forms of Pb take
longer to be absorbed these types along with dose and duration in the stomach can prolong Pb
exposure in children and cause fluctuations in absorbed Pb reflected in BLLs. Children may
encounter more water-soluble forms of Pb in their environments like in lead-based paint, dust
and soil contaminated with lead-based paint, and they absorb these forms higher than adults. It is
important to remember bioavailability as the specific routes of exposure are considered. The
many determinants of Pb absorption are perhaps best explained by how the respiratory and the
digestive routes deal with Pb, and by how fast these systems make Pb available in the circulatory
bloodstream, and to other tissues and organs.
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1.6.2 Inhaled Lead
Lead concentrations, such as those found in household dust, are rapidly absorbed. The
pathway that Pb in dust takes in the respiratory system is relatively well understood. Fine
particulate Pb inhaled through the nose and mouth first passes through the windpipe and the left
and right bronchi which serve as filters. Both structures contain mucus-producing cells and tiny
hair-like projections called cilia to help trap and keep dust and other particles from reaching the
lungs. When dust or other particles are breathed in, the mucus and cilia trap the dust particles,
and move the mucus upward where it is either coughed up, sneezed, or swallowed (Bailey,
Ansoborlo, Guilmette, & Paquet, 2007; Government of Canada, 2020; U.S. National Library of
Medicine, & Bethesda, 2016). When dust is not trapped by the mucous of the windpipe and
bronchi, the dust can find its way to the lungs where it is directly absorbed in the small air sacs
of the lung called alveoli. The alveoli have a thin barrier of cells between air and blood
capillaries that allow the exchange of oxygen and carbon monoxide, and other gases in the blood
(Bailey et al., 2007; National Heart, Lung, and Blood Institute, 2019).
When Pb dust particles end up in the alveoli, macrophages (activated immune system
cells) engulf the dust particles and attempt to move them up to the windpipe where they can be
coughed, sneezed, or swallowed. During this process, Pb dust particles, depending on their size,
shape, and how they are distributed in the lungs (determined by a combination of air direction
and force) (James et al., 1994), can either exit the lungs completely, or are deposited in the
respiratory system. Particles that are greater than 5.0 µM are deposited mainly in the nose and
throat (the nasopharyngeal region); particles that are between 2.0 and 5.0 µM can penetrate the
trachea and bronchioles (the tracheobronchial region). Small particles <2.5 µM and very small
particles less than <1.0 µM can penetrate deep into the alveoli and if not cleared up can stay in
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there from months to years (Bailey et al., 2007; James et al., 1994), and some soluble gases and
ultrafine particles < 100 nm can quickly enter the bloodstream (Heyder, 2004; National Institutes
of Health, 2018; Nemmar et al., 2002; Okeson, Riley, Fernandez, & Wendt, 2003).
Once in the body, the mechanism by which Pb enters the bloodstream from the lungs is
not well understood, especially in children. It has been suggested that it is diffused in the small
airways and alveoli accessing the bloodstream directly, and/or filtered through the lungs, organs,
and then into the bloodstream (El-Sherbiny, El-Baz, & Yacoub, 2015). Studies have shown that
about 30-50% of inhaled Pb is retained in the lungs (Chamberlain, 1983) and 95% of inhaled Pb
found past the windpipe is mostly absorbed (Hursh, Schraub, Sattler, & Hofmann, 1969;
Morrow, Beiter, Amato, & Gibb, 1980; Rabinowitz, Wetherill, & Kopple, 1977; Wells, Venn, &
Heard, 1975). In one study that used 2.5 µm particles of two chemical Pb forms (Lead chloride
(PbCl2) and Lead hydroxide (PB(OH)2)) in rats demonstrates that 23-26% of inhaled Pb was
deposited in the lungs (Geiser & Kreyling, 2010). It is important to note that the duration of
respiration of Pb-contaminated dust can increase absorption through the respiratory system, and
that absorption of Pb can occur in a matter of hours after inhalation (Kastury et al., 2019). In one
study with adult participants, half of the amount of inhaled submicron particles of Pb oxide and
Pb nitrate happened mostly in the first 9 hours of exposure. This study also demonstrated that
35% of inhaled Pb was deposited in the lung, and 50% of the Pb was detected in the red blood
cells having a half-life in the blood of 16 days (Chamberlain, Heard, Little, Newtown, Wells, &
Wiffen, 1978).
In combination with particulate size, another factor that can place children at higher risk
of exposure is respiratory rate, that is, how fast one breathes in and out air from the lungs.
Children have higher respiratory rates and retain more dust in the lungs, especially in the
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tracheobronchial and alveolar regions, as compared to adults (Asgharian, Ménache, & Miller,
2004; Xu & Yu, 1986). Physiological differences, mechanisms of absorption in the lung, and the
tendency of children to play close to the ground, all contribute to a substantially higher risk of Pb
absorption through inhalation as compared to adults. It is estimated that children’s rate of
deposition of Pb particles is 1.6 to 2.7 times greater than of adults (WHO, 1995).
Some studies have suggested that the chemical form and concentration of inhaled Pb has
little effect on how much is absorbed through the respiratory system (Morrow, Beiter, Amato, &
Gibb, 1980). As described above, Pb deposition and absorption rates in the respiratory system
are complex. Lead deposition and absorption involves multiple factors including Pb particulate
size, length, and frequency of exposure, respiratory rate, and wherein the respiratory system the
Pb particulates are deposited, all of which can vary broadly. Also, children have higher
absorption efficiency of inhaled Pb than adults, and in combination with their exposure through
ingested Pb, places children at a greater risk of Pb exposure, and approaching the exposure risk
of adults in industrial settings with occupational exposure (National Environment Protection
Council, 2014).
1.6.3 Ingested Lead
As compared to inhaled Pb, ingested Pb goes through a much slower absorption process.
Even more so than for inhaled Pb, complex chemical, biological and bio-physicochemical factors
influence the absorption of ingested Pb and have the potential for broad fluctuation. One factor
that influences Pb absorption through the gastric system is the chemical form of Pb. In turn, the
chemical form of the Pb influences the “bioavailability” ingested Pb.
One common source of ingested Pb is from lead-contaminated food and drinks. Adults
and children vary broadly concerning how much food- or drink-borne Pb is absorbed. For
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adults, it has been estimated that 10 to 15% of Pb in contaminated food and/or drink is absorbed
(Harrison, Carr, Sutton, Humphreys, & Rundo, 1969; Hursh & Suomela, 1968; Rabinowitz et al.,
1974; M. B. Rabinowitz, Kopple, & Wetherill, 1980) among children, the percentages are much
higher, and have been estimated at 40% to 50%. Bioavailability from dietary led can range from
60 to 100 % (Flanagan, Chamberlain, & Valberg, 1982; Heard & Chamberlain, 1982; James,
Hilburn, & Blair, 1985). Also, children absorb more of water-soluble Pb compared to adults
with 40-50% than 3-10% accompanied by a meal (Heard & Chamberlain, 1982; James et al.,
1985; Rabinowitz et al., 1980; Watson et al., 1986). In a recent study, Pb was detected in infant
formula and baby food samples. In baby food, 1% of the 471 foods tested exceeded FDA Pb
guidelines, and 26% exceeded California state Prop 65 limits. In the 91 infant formula tested, 0
exceeded FDA Pb guidelines in 31 oz, but 22% exceeded California state Prop 65 limits
(Gardener, Bowen, & Callan, 2019).
Unlike adults, children, especially those below 5 years of age, can also ingest Pb from
non-food items because of their frequent “hand-to-mouth activity” and pica (see page 12 above).
These behaviors expose them to Pb in household dust, soil, and chips of Pb-based paint
(Hauptman, Bruccoleri, & Woolf, 2017). It has been estimated that children as compared to
adults ingest at least 100 mg more Pb than most adults. A child age 1 to 6 years may ingest 100
mg of Pb daily from soil and household dust, and this amount is higher in children that engage in
pica, where they can ingest as much as 10 g of Pb daily (WHO, 2010). As suggested above, the
bioavailability of ingested Pb plays a critical role in absorption. The chemical forms of Pb that
exist in non-nutritive substances, such as soil and paint chips, are far more bioaccessible than the
forms of Pb commonly found in foods. For this reason, the Pb that children ingest tends to be far
more dangerous and more readily absorbed than Pb ingested by adults through food items.
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Thus, while the chemical form, amount, and concentration of Pb are important factors in
determining how much Pb is absorbed in the body through ingestion, the bioavailability of Pb is
also critical to consider. Most of our understanding of how Pb might be absorbed in the stomach
is based on the results from animal studies. Several biological factors impact Pb absorption in
the gastrointestinal tract (GI tract). These include the site of Pb deposits; whether the stomach is
empty or full when the Pb is ingested; physiological and molecular processes that influence Pb
uptake and transport to the blood circulatory system from the stomach; how long Pb is in the
stomach; and the maturity of the GI tract (mostly determined by the person’s age).
Ingested Pb goes straight into the stomach. Unlike inhaled Pb, there are no known
physiological mechanisms that can potentially trap and limit Pb intake in the digestive system.
When Pb reaches the stomach, interaction with stomach acids transforms the Pb molecules into
more soluble forms. In the small intestine, Pb uptake occurs mostly in the upper and first
sections of the intestine (duodenum) via passive diffusion and active transportation (Mushak,
1991). In the third section of the intestine (ileum), small circular sacs called micelles capture Pb
available in the space of the intestines, and the micelles are absorbed by the walls of the
intestine. This process is called pinocytosis (Teichmann & Stremmel, 1990). Lead can also go
through the tight spaces between the enterocytes, specialized cells found in the lining of the
stomach, small intestines, and colon (Kiela & Ghishan, 2016; Mushak, 1991). Lead can also be
engulfed by immune system cells and/or by the budding of small vesicles (pinocytosis) from the
cell membrane of enterocytes (Williams & Beck, 1969). All of these mechanisms deliver Pb into
the liver and then circulatory system. At the same time, the uptake of Pb by enterocytes does not
always mean more Pb will be delivered to the blood. Most ingested Pb (approximately 70-90%)
is excreted in urine or feces; some can be retained in the cells for varying periods.
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Age and maturity of the GI tract impact Pb absorption and excretion. Children as
compared to adults absorb and retain substantially more ingested Pb. As mentioned above, some
studies have shown that children (ages 2 weeks to 8 years) absorbed 40 to 50% of ingested Pb,
while adults absorbed only 10 to 20% (Alexander, Clayton, & Delves, 1974; Ziegler, Edwards,
Jensen, Mahaffey, & Fomon, 1978). Stomach contents at the time of ingestion are also critical.
In an empty stomach, absorption can be as high as 100% in children, as compared to 60 to 80%
in adults (ATSDR, 2010; Heard & Chamberlain, 1982; Rabinowitz et al., 1980).
Several reasons have been suggested to explain why children absorb more ingested Pb
than adults. Depending on the age of the child, the amounts of protein and acid needed to digest
Pb may not be present or produced (Christie, 1981; Deren, 1971; Mushak, 1991). Similar to the
mechanism involved in the Ca binding protein, and the competition of Ca and Pb in this route of
absorption, the presence of proteins or having a high protein diet appears to reduce the
absorption and toxicity of Pb because Pb competes with amino acids derived from proteins that
use the same protein-carrier molecules. Children can absorb food proteins more easily than
adults, so when Pb is present, the absorption of Pb is faster and higher than adults (Mushak,
1991; Walker, 1985). Thus, for many reasons, children have higher uptake and retention of
ingested Pb, and lower ability to excrete ingested Pb.
Behavioral factors also directly impact Pb absorption in children. For example, the time
of meals and dietary nutrients can block or enhance Pb absorption in the GI tract. The absorption
of Pb is substantially greater when the stomach is empty. For this reason, exposure from tap
water and other beverages can be higher since people tend to drink more when the stomach is
empty than when the stomach is full. One study administered Pb acetate diluted in water in
twenty-three male adults with a meal and without a meal. Those who did not have a meal
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absorbed approximately 63% while those who had a meal retained 4% of ingested Pb after 12
hours of ingestion (James et al., 1985). The percentage was similar percentage Pb was ingested
on an empty stomach, and when a meal was eaten seven hours after Pb ingestion on an empty
stomach. On the other hand, when Pb was ingested with a meal, the Pb retention dropped
dramatically, to approximately 5%. This relationship is sometimes referred to in the literature as
“Pb-nutrient interaction.” Other studies of adults have confirmed that the presence of food in the
GI tract suppresses Pb absorption, especially water-soluble Pb. In contrast, while fasting,
approximately 57% of water-soluble Pb can be absorbed (Blake, Barbezat, & Mann, 1983; Blake
& Mann, 1983; Heard & Chamberlain, 1982; James et al., 1985). One study of children ages 3
to 5 years observed lower BLLs in children who ate breakfast as compared to children who went
without breakfast, after controlling for nutritional variables (Liu, et al., 2011). These interactions
can be synergistic, additive, or antagonistic. In other words, Pb in combination with another ion,
vitamin, or/and heavy metal can facilitate, or block absorption of Pb in the GI tract.
One important Pb-nutrient interaction is with calcium (Ca). Some epidemiological
studies and independent studies have demonstrated that there is a significant inverse association
between dietary Ca and blood Pb levels (Blake & Mann, 1983; Elias, Hashim, Marjan, Abdullah,
& Hashim, 2007; Heard & Chamberlain, 1982; Mahaffey, Gartside, & Gluek, 1986; Schell,
Denham, Stark, Ravenscroft, Parsons, & Schutle, 2004; Ziegler et al., 1978). The relationship
has been explained by the competitive uptake of Pb on a Ca carrier protein that transports Pb into
cells (Barton, Conrad, Harrison, & Nuby, 1978). In other words, if Pb concentration is higher
than Ca, the protein that is dedicated to allowing Ca into the cells take in Pb instead, because as a
calcium mimic, Pb can activate the same uptake proteins activated by Ca (for calcium
absorption). Thus, the chances of Pb absorption might be reduced by ensuring that one meets the
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recommended daily dietary intake of Ca (Bronner, Pansu, & Stein,1986; Gross & Kumar, 1990;
Hu, Wu, Cheng, Sparrow, Weiss, & Kelsey, 2001; Ziegler et al., 1978). In young children, the
efficiency of absorbing Ca is higher than adults (Heath, Soole, McLaughlin, McEwan, &
Edwards, 2003; Schedl, 1982).
Another well-studied Pb-nutrient relationship is with iron (Fe). Similar to Ca, iron
deficiencies are associated with higher blood Pb levels (Mahaffey & Annest, 1986; Marcus &
Schwartz, 1987). This relationship could be explained by studies done in animals (Bannon,
Abdounader, Lees, & Bressler, 2003; Barton et al., 1978; Morrison & Quarterman, 1987). Pb
competes with Fe absorption in the intestines. More Pb is absorbed when a child is Fe deficient
and Pb takes the place of Fe in the receptors or binding proteins found in the intestines. While
Pb absorption may be exaggerated with nutritional deficiencies, Pb does not interfere with Ca
and Fe absorption, and having more Ca and Fe than what the body needs will not reduce Pb
absorption. The body regulates how much of these nutrients are absorbed based on need. There
are also gene variants involved in Fe metabolism that have been associated with higher BLLs in
children, these include hemochromatosis and transferrin genes (Hopkins et al., 2008).
Lead exposure in humans is mainly from inhalation and ingestion. Exposure through the
skin is rare and it is dependent on the chemical form of Pb. Organic Pb can penetrate more
easily through the skin than inorganic Pb. Organic Pb is rarely used now, but up until the early
1990s, organic Pb was used in leaded gasoline. Inorganic Pb, the most common chemical form
found in the environment, and the form implicated in most human exposures, is not likely to be
absorbed in the skin. One study applied Pb acetate directly to the skin of adult volunteers and
found that the average absorption rate was 0.06% (Moore, Meredith, Watson, Summer, Taylor,
& Goldberg, 1980). In another study, Pb in nitrate salt solution was applied directly on the skin
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of an adult male. This study found that applying Pb directly to skin did not increase Pb levels in
blood or urine, and only in the sweat from the applied area (Lilley, Florence, & Stauber, 1988).
Thus, exposure to Pb from the environment is mostly from inorganic chemical forms of Pb and
through inhalation and ingestion. Nonetheless, as described above, Pb particle size, inorganic Pb
chemical form, the maturity of the respiratory system and GI tract, and diet are well-known
fluctuating factors that impact blood Pb levels and Pb body burden.
1.7 The Biological Fate of Lead in the Body
Once Pb enters the circulatory blood system there are additional factors that determine
the path of Pb throughout the body and the extent of toxic effects on different body organs and
systems. Generally speaking, absorbed Pb first enters the circulatory blood system and is carried
quickly via the blood and plasma to soft tissue organs (liver, kidneys, lungs, brain, spleen,
muscles, and heart), exchanged, filtered and/or trapped to different degrees depending on the
organ, and ultimately, stored in mineralized tissues (i.e., bone and teeth). The amount of Pb that
reaches the target tissue is depended on the distribution of the substance throughout the body, the
metabolism of Pb, and the rate of excretion. As mentioned before, the solubility of Pb is an
important factor but it is more important how Pb in the blood interacts with the components of
the blood because it would determine the fate of Pb in the body.
The distribution of absorbed Pb in the body occurs over a matter of minutes
(Chamberlain et al., 1978; deSilva, 1981; National Research Council, 1993). Most of the
absorbed Pb will be excreted through urine and feces (about 70-90%), and very small amounts
through hair, nails, sweat, breast milk, and seminal fluid (Leggett, 1993; O’Flaherty, 1998). Pb
is mostly eliminated from the body through the kidneys (ATSDR, 2017a). The rest of Pb that is
distributed and retained in the body is referred to as total Pb body burden and is exchanged
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(transported back and forth between tissues and the blood system) primarily in the blood, soft
tissue, and mineralizing tissues. Exchange can mean the transportation of molecules across
different components of a structure, cell, or organ, and it is the constant need to reach an
equilibrium of the concentration of toxicants in the space between the organs and blood. Lead
and other toxic substances tend to concentrate on the liver and kidneys because of their higher
perfusion of blood as compared to other tissues. The constant need to reach equilibrium in the
space between the blood and tissues determines whether Pb is going to be transported into the
bloodstream or get stored in tissues. At the same time, Pb can have greater affinity in other
tissues, like bone, and be stored over a long period. Total Pb body burden is dependent on the
frequency of Pb exposure, concentration, distribution, metabolism, and ability to eliminate Pb
from the body through urine or feces.
In blood, it is estimated that 99% of absorbed Pb is taken up into red blood cells. The
remaining 1% or less ends up in plasma (ATSDR, 2017a; deSilva, 1981; Everson & Patterson,
1980). This fraction of concentration is based on chronic Pb exposure and is believed to be
constant across a wide range of exposure levels. It has been noted that when BLLs reach 50
µg/dL (deSilva, 1981; Manton & Cook, 1984) slightly more Pb may appear in plasma. The
proportion of Pb concentration in red blood cells and plasma is referred to as the “steady-state
condition” (ATSDR, 2017a; Cavalleri, Minoia, Pozzoli, & Baruffini, 1978; deSilva, 1981;
Everson & Patterson, 1980; Manton & Cook, 1984), and it is under this state the Pb is removed
from the blood. The half-life of Pb in the blood is an important metric that estimates the moment
that a chemical in a biological system – in this case, Pb – decays to half of its original
concentration (O’Flaherty, Hammond, & Lerner, 1982). The magnitude of external exposure,
the amount of absorbed Pb (Pb body burden), the age of the individual, and the method of
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measuring Pb half-life, all impact the half-life of absorbed Pb. Earlier studies found that Pb in
the blood of adults has a half-life of about 28-35 days, but on average is 28 days (Leggett, 1993;
O’Flaherty, 1998; Rabinowitz et al., 1976). This half-life is for the first or short-term exposure.
Chronic exposure can extend the half-life of Pb to many months, and maybe years, but research
on chronic Pb exposure and its effects on blood level concentrations is very limited. The Pb
half-life in children’s blood is still to be determined and is expected to vary greatly depending on
the deficiency of dietary minerals such as Ca and Fe; how often the child exposures occur when
the child has an empty stomach; and whether exposures are chronic or sporadic.
There are two studies that attempt to measure Pb half-life in the blood of children, but the
findings are inconsistent. In one study, Pb half-life in blood was calculated using an equation
that estimates Pb from bone to blood concentrations. Data were from 50 exposed children, ages
1 to 8 years, with BLLs >25 µg/dL, who underwent weekly chelation treatment for three weeks.
The half-life of Pb was lower for younger children (ages 1-3 years, n=17) with a value of 6.9 ±
4.0 days compared to older children (ages >3 years, n=33) with a value of 19.3 ± 14.1 days
(Specht, Weisskopf, & Nie, 2019). The researchers concluded that children have a faster
turnover of Pb than adults but disregarded the effect of chelation treatments. The relevance of
these findings for children with lower BLLs and no chelation treatment is not known. The
second study retrospectively analyzed the time it took for children (N = 996, ages >6 years) with
BLLs ≥ 10 µg/dL to come to levels below 10 µg/dL. On average, it took approximately 382
days for a child’s BLL to decline to levels below 10 µg/dL, and it took longer for children with
higher BLLs, black children, males, and children living in rural areas (Dignam, Lojo, Meyer,
Norman, Sayre, & Flanders, 2008). While both studies reveal how BLLs may change over time,
the half-life of Pb in the blood among children with BLLs < 10 µg/dL is currently unknown.
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The way in which Pb enters in and out of the bloodstream is through the capillaries of the
circulatory system, the smallest form of anatomy in the vascular system of the body. There are
10 billion capillaries in the body, composed of a single layer of flat endothelial cells, having a
diameter of 4-8 µm, and are the principal site for the exchange of toxic substances between the
blood and the surrounding tissues. Diffusion along with carrier-mediated transportation
facilitates the distribution of toxins between organs and the circulatory blood system (Pittman,
2011). One limiting factor in transporting toxic substances from the capillaries is the particle
size, but larger toxic molecules may still be transported via pinocytosis and can remain for a
longer period of time in the blood because this process of transportation is relatively slow.
The first target organ of Pb is dependent on the exposure pathway. If inhaled, the first
target is the respiratory system. From the lungs, Pb is carried to the heart. The heart is
responsible for receiving low-oxygenated blood from the circulatory system from the right
atrium and sending it into the right ventricle where blood is pumped through the pulmonary
artery into the vascular network in the lungs and the pulmonary capillaries. The pulmonary
capillaries are intertwined in the alveoli of the lungs where oxygen, carbon dioxide, and other
airborne toxic substances are exchanged with the circulatory system and inhaled air. The
oxygenated blood then returns to the left ventricle and then into the left atrium and to the rest of
the circulatory system.
Once Pb is in the circulatory system, several mechanisms facilitate and oppose the
distribution of Pb into tissues. Simple diffusion and carrier proteins for calcium facilitate the
transfer of Pb into soft tissues. At the same time, there is one mechanism that opposes
distribution which involves plasma proteins such as albumin, transferrin, globulin, and
lipoproteins. These proteins bind to one portion of a Pb molecule, leaving an equal portion
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unbound. The unbound Pb passes through endothelial cells of the capillaries into the
extravascular space (space between the wall of the capillary and the tissue cell membrane, filled
with fluid). The bound Pb separates from the plasma proteins to maintain concentration
equilibrium between the amount of unbound Pb in the extravascular space with the amount of
unbound Pb in the blood. Pb that enters extravascular space may then be stored in tissue,
provoking adverse effects depending on the function and sensitivity to Pb exposure of the organ.
In children, this mechanism may not be matured enough to prevent further Pb absorption in
tissues.
The liver and kidneys have a higher affinity for Pb absorption and store more Pb than
other tissues in the body. While all of the mechanisms that create higher affinity for Pb in these
organs is not known, it is well established that these organs are responsible for the detoxification
and excretion of any toxic substances that enter the body (Andjelkovic et al., 2019). The liver is
the largest organ in the body, located on the left side and anterior side of the abdominal cavity
next to the stomach, and is the major storage site for water-insoluble toxins such as heavy metals.
The liver is composed of two lobes and divided into many functional units called lobules. The
lobules are cords of liver cells that frame the central vein in the liver and are responsible for the
exchange of oxygen and nutrients of blood, and bile supply in the liver. The liver receives blood
from two main sources. One source is from the GI tract through the hepatic portal vein. This
source of blood is nutrient-rich and oxygen-poor. The second major source of blood for the liver
is from the hepatic artery which is collected from kidneys, spleen, and lower extremities. This
source of blood is nutrient-poor and oxygen-rich. As both sources of blood enter the liver, the
blood is then mixed in the hepatic sinusoids, which are spaces between liver cells located near
the lobular cords of where the hepatic portal vein and artery passes. Once blood is mixed in the
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liver, the blood in the sinusoids drains toward the center of the lobule, and into the central vein
where it exits the liver through the hepatic veins (Lehman-McKeeman, 2010).
The mechanisms by which Pb is absorbed and retained in the liver are similar to other
tissues, where different mechanisms act at the same time. One mechanism is determined by the
solubility of toxic substances. Toxins that are lipophilic (fat-loving and fat-soluble) will be more
easily absorbed than water-soluble substances, which are retained in the liver for longer periods
of time. Only organic forms of Pb are lipophilic, absorbed quickly, and metabolized in the liver.
Inorganic forms, the most common form of Pb absorbed by children are not metabolized in the
liver but can be stored in the liver (ATSDR, 2017a). The second mechanism which facilitates
absorption in the liver is through intracellular proteins using active transportation, which
facilitate the concentration of toxins in the liver.
One intracellular protein critical to Pb absorption is metallothionein. This protein has a
high affinity (up to 99%) for many metals including Pb, Fe (iron), Cd (cadmium), Cu (copper),
and Hg (mercury). There are high concentrations of metallothionein in hepatocytes, and when
metals are bound to the protein, they do not pass easily through the cell membrane of
hepatocytes and instead concentrate in the liver (Gonick, 2011). Metallothioneins have
demonstrated to effectively bound to Pb and reduced the toxicity of Pb on cells (Huang et al.,
2009; Liu, Kershaw, & Klaassen, 1991).
The other way in which Pb may enter the hepatocytes is through the fenestrate, a layer of
endothelial cells with scattered small and large pores lining the liver sinusoids. The fenestrate
allows for larger molecules found in the blood to pass the endothelial lining and be absorbed by
the hepatocytes. All three of these mechanisms may explain how Pb is absorbed and
concentrated more in the liver as compared to other surrounding tissues (Braet & Wisse, 2002).
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Also, it is uncertain how these mechanisms function in children, where most of the time these
mechanisms are not matured enough and allow for more of Pb to be circulating in the blood.
The kidneys can also absorb and retain more Pb than other tissues. The main functions of
the kidneys are to remove metabolic waste from the body through urine and to maintain kidney
homeostasis. The kidneys are two bean-shaped organs located on the posterior wall of the
abdominal cavity. Each kidney has two physical parts, the outer layer called the cortex, and the
inner layer called the medulla. The medulla contains cone-shaped structures called renal
pyramids where urine passes from the tips of the pyramids to a large funnel-like structure called
the renal pelvis. The renal pelvis narrows into forming the ureter and connects the kidneys and
the urinary bladder. Pb absorption, concentration, and excretion through urine happen in the
nephrons. The nephron is the functional unit of the kidneys. Parts of the nephrons are located in
the renal cortex and medulla, and each nephron is composed of four structures that have unique
roles in filtering toxins from the circulatory blood. The first structure is the renal corpuscle
which is composed of Bowman’s capsule, and the ball-shaped arrangement of blood capillaries
called the glomerulus. This is the site for which blood enters and where substances carried in the
blood are filtered out of the body through the walls of the Bowman’s capsule (LehmanMcKeeman, 2010).
The kidneys receive approximately 25% of the total cardiac output at a perfusion rate of
1.2-1.3 liters of blood per minute. The walls of the Bowman’s capsule allow for small
molecules, such as Pb, to pass through. Larger molecules such as proteins are not allowed
because they are too big in size to cross the capillaries. Also, sometimes proteins have a
negative charge associated with them which repels them from the negatively charged cell
membrane of the capillaries. Once toxins enter the kidneys, they may be reabsorbed through
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active or passive transport mechanisms along the various sections of the nephron (Goyer, 1989;
Lehman-McKeeman, 2010; Lentini, Zanoli, Granata, Signorelli, Castellino, & Dell'Aquilla,
2017).
The next structure in the nephron is the proximal convoluted tubule. This site represents
the first opportunity of the nephron to reabsorb water, and needed ions, amino acids, glucose
molecules, and Pb. Water is absorbed through osmosis mechanism, while the rest of the
molecules are absorbed using active transportation, in the case of Pb to specific lead-binding
proteins, to the peritubular capillaries. The third structure of the nephron is the Loop of Henle.
This is the site for the second opportunity to absorb water and molecules, with active transport
being more predominately in the ascending limb of the structure. The fourth structure of the
nephron is the distal convoluted tubule, where it is the third opportunity to reabsorb water and
molecules, but passive transportation is more predominately in this structure. All the reabsorbed
water and molecules are carried in the peritubular capillary network which are tiny blood vessels
that allow for the reabsorption and secretion of blood and the inner lumen of nephron. The
capillaries eventually lead to the efferent arteriole and into the bloodstream. The rest that is not
reabsorbed exits the nephron as urine through collecting tubes, renal pelvis, urinary tract,
bladder, and excreted in the urine. The mechanism in which Pb may be reabsorbed perhaps is
through the same mechanism unbound metals like Cd and Hg are reabsorbed by active
transportation by the cells found in the proximal convoluted tubule where it then binds to
metallothionein and is retained in the cell wall (Fowler & DuVal, 1991). Also, Pb may be
absorbed by the epithelial cells that line the proximal convoluted tubule from engulfing
degrading red blood cells, a process called erythrophagocytosis and it is carried out by
macrophages (Kwon et al., 2015). This can explain why concentrations of Pb collect in kidneys
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which may cause adverse health effects. There are approximately 1.3 million nephrons in each
kidney. It is uncertain how much Pb the kidneys can retain, but, for example, Cd, another heavy
metal, can be stored at 10 times greater quantity in the kidneys than the liver, and can remain for
10 or more years.
Lead can also be stored in fat. While the concentration found in fat may be lower than in
other types of tissue initially, concentration equals the concentration found in the blood. Lead
found in fat can be released into the bloodstream when fat reserves are mobilized because of fat
being metabolized, such as in periods of fasting, starvation, and exercise (Mikalsen, BjørkeMonsen, Flaten, Whist, & Aaseth, 2019; Riedt, Buckley, Brolin, Ambia-Sobhan, Rhoads, &
Shapses, 2009). Sometimes a person may be exposed to Pb under starvation condition after the
initial exposure.
About half of Pb that the body absorbs is stored in bone/mineralized tissues and accounts
for approximately 94% of the total body Pb burden in adults, and about 74% in children (Barry,
1975). This means that mineralized tissues act as a storage unit for the body, but the storage is
relatively temporary because stored Pb from bone tissues can be released into the blood system.
Depending on the type and duration of exposure, anywhere from 40-70% of Pb in the blood may
come from bone stores (Smith, Osterloh, & Flegal, 1996).
Lead accumulation in bones happens in trabecular bone during childhood, and in cortical
and trabecular bone in adulthood (ATSDR, 2010). There are two components found in cortical
and trabecular bone that determine Pb concentrations in blood. The inert component is closer to
the center of the bone and stores Pb for decades. The labile component is located more towards
the outer layers of the bone and can easily exchange Pb from bone to blood (ATSDR, 2019;
Stojsavljević et al., 2019). Lead stored in the inert component can mobilize to the labile
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component with time or in situations where the body demands Ca from the bone (explained
below). Lead can be stored in all bone types, including teeth, cortical bone, such as midfemur,
and trabecular bone, such as temporal bone, and pelvis.
Bone is composed of cells called osteocytes, and an extracellular matrix arranged in
sheets called lamellae. The lamellae are composed of a mineral complex called hydroxyapatite
made mostly of calcium and phosphate ions. Hydroxyapatite is a calcium reserve for the body
and breaks or builds up according to the concentration of Ca found in the blood. For example,
when Ca blood levels are low, the hydroxyapatite is broken down, and Ca is released from the
bone into the bloodstream. When Ca levels are high in the blood, Ca is absorbed into the
hydroxyapatite of the bone. Lead mimics calcium in size and electrical charge, and during this
process of exchanging Ca between blood and bone, Pb can bind to hydroxyapatite and be stored
in bone (Dowd, Rosen, Mints, & Gundberg, 2001; Pounds, Long, & Rosen, 1991; Saisa-ard,
Somphon, Dungkaew, & Haller, 2014). It is estimated that approximately 90% of the total body
burden of Pb is in bone, and it can remain in the bone between 10 to 30 years. Unlike in other
organs, and tissues, Pb storage in the bone may or may not have adverse effects, but the rereleasing of Pb from bone into the bloodstream can affect other tissues and organs. There are
events in which the body demands more calcium and will tap into the hydroxyapatite. These
events include pregnancy, lactation, menopause, physiological stress, chronic disease,
hyperthyroidism, kidney disease, broken bones, osteoporosis, advanced age, and calcium
deficiency.
The Pb excretion rates by adults and children are different because children have
underdeveloped physiological pathways to flush out Pb fast enough like adults, and the harm to
organs may be greater because children’s organs are still developing. The difference in how Pb
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is absorbed and mobilized as compared to adults, places children at a higher risk of Pb exposure
and adverse health effects. In addition to the physiological differences, especially younger
children (ages ≤5 years) may be exposed to higher and more frequent Pb exposure because of
three behaviors, playing close to the ground, having “hand-to-mouth” activity, and
eating/drinking more of possible contaminated food or water (ATSDR, 2010).
Soft tissues usually retain less Pb because it is constantly being filtered out from the
organ. The concentration in soft tissues is usually below 0.5 ppm (Barry, 1975, 1981; Gross,
Pfitzer, Yeager, & Kehoe, 1975) and concentrations can be higher in kidneys and aorta because
Pb accumulates overtime in these tissues as a person ages (Barry, 1975; Gross et al., 1975). The
estimated concentration of Pb in soft tissues is derived from cross-sectional studies, up to now,
there is still uncertain how much Pb is retained in tissues after chronic exposure and aging.
Typically, the whole brain from an adult with no history of occupational exposure has Pb
concentrations less than 0.2 ppm (Barry, 1975). In individuals with high levels of exposure and
at lethal dosages, Pb brain concentrations can be above 1 ppm (National Research Council,
1993; Okazaki, Aronson, DiMaio, & Olvera, 1963). Pb can concentrate in different regions of
the brain, with highest being in the hippocampus, the area responsible for short- and long-term,
and spatial memory, and frontal lobe, the area responsible for problem-solving, emotional
expression, social and sexual behavior, and motor function (Grandjean & Landrigan, 2014;
National Research Council, 1993; Okazaki et al., 1963). Few studies analyze Pb concentrations
of differences in children and adults. One study by Barry in 1975, demonstrates lower Pb
concentrations in infants than in older children, and then in a later study, he found that older
children had no difference compared to adult women (Barry, 1975; Barry, 1981).
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Lead enters the brain by crossing the Blood-brain barrier (BBB), a thin layer of cells
associated with brain capillaries that protect the brain from toxins. The BBB has three
characteristics that restrict toxins in reaching the brain, these include being composed of closely
packed endothelial cells of the capillaries, having specialized cells from the immune system only
found in the brain called astrocytes, and having low protein content in the interstitial fluid.
Capillary endothelial cells in other organs are typically loosely joined and have pores located
between cells. In the BBB, the capillary endothelial cells are more closely arranged to each
other, and few, almost no pore are located between cells. The mechanisms in which Pb may
cross the BBB are similar to mechanisms in other tissues. If Pb is lipid-soluble, it will diffuse
through the phospholipid cell membrane and into the fluid surrounding the brain. If Pb is watersoluble, it will be transported across the BBB by carrier-mediated mechanisms. Astrocytes
surround the capillaries of the brain and are responsible for supporting the BBB, providing
nutrients to neurons, repairing nervous tissue, and facilitating neurotransmission. The cell
membrane of astrocytes has a high lipid content repelling and slowing down the movement of
water-soluble molecules through the BBB. The interstitial fluid is the liquid found between the
external wall of the capillary and the cell membrane of the surrounding tissue because the one
found in the BBB has low protein content it reduces the amounts of protein-bound toxins to
reach the brain (Lehman-McKeeman, 2010; Lidsky & Schneider, 2003).
Lead crosses the BBB by mimicking calcium and using calcium-dependent protein kinase
(PKC), a group of enzymes activated by Ca, to carry out functions in the central nervous system.
As described above, the BBB is very good at protecting the brain, but at higher levels of Pb
exposure, Pb can disrupt PKC’s role in regulating calcium into the brain by turning on and off
calcium-ATPase pumps. Once Pb enters the endothelial cells, it may also disrupt BBB
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cohesiveness. Also, Pb may disrupt the ability of astrocytes to maintain BBB integrity, creating
another way for Pb to enter the brain (Bressler & Goldstein, 1991; Lidsky & Schneider, 2003). It
is uncertain how much Pb is absorbed into the brain of a child, particularly at lower levels of
exposure, and whether there are mechanisms that mobilize Pb to exit the brain and re-enter the
bloodstream perhaps contributing to changes in child BLLs over time.
1.8 Lead and Red Blood Cells
Lead can be in each of the different components of blood, including red blood cells
(RBCs), plasma, and serum. It has been shown however that most absorbed Pb is bound in
RBCs, accounting for approximately 99% of Pb in whole blood (deSilva, 1981). Most of what
we know about how Pb enters and behaves in RBCs is from older studies with Pb2+ exposure.
While there are four oxidation stages of Pb, Pb2+ is the most common form in the environment
and human bodies. Any other oxidation stages of Pb are not stable under natural conditions, and
should transform into Pb2+. Lead can enter and exit RBCs through passive and active
transportation using mechanisms calcium (Ca2+) and potassium (K+), and when there are changes
in the permeability of the cell wall (Fukumoto, Karai, & Horiguchi, 1983; Simons, 1986, 1984).
Lead transportation can also be facilitated when interacting with ions present at the surface of the
cell. For example, in passive transportation, the uptake of Pb2+ can be stimulated by anion
exchange of bicarbonate (HCO3-), a weak acid, and a byproduct of human metabolism carried in
the blood to the lungs and exhaled as carbon dioxide (Simons, 1986). In active transportation,
Pb2+ can enter the cell through store-operated Ca2+ channels and Ca2+-ATPase when intracellular
stores of Ca2+ decrease (Zalups & Koropatnick, 2010). Pb uptake may also be triggered when
there is a reduction in sodium-potassium ATPase activity (NA/K ATPase), forcing K+ out of the
cell and allowing Pb to enter using Ca2+ intracellular transporters (Hasan, Hernberg, Metsälä, &
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Vihko, 1967; Riordan & Passow, 1971; Vincent, 1958). Also, Pb2+ can act as Ca2+ structurally
and functionally allowing it to enter RBCs with ease and at a higher rate because it has a smaller
ionic radius than Ca2+. Uptake of Pb2+ into the cell can be ten times more than Ca2+ (Zalups &
Koropatnick, 2010).
Once inside the RBC, most of the Pb2+ binds with proteins responsible for transporting
oxygen in the blood. It is estimated that the binding ratio of Pb: free Pb2+ in the cytosol is
6000:1 (Simons, 1986). For many years it was thought that Pb2+ mainly bounded with
hemoglobin, an iron protein responsible for carrying oxygen in the blood but was later found that
Pb2+ instead binds to delta-aminolaevulinic acid dehydratase enzyme (ALAD), a zinc (Zn2+)
protein responsible for heme synthesis. Mechanisms for which Pb binds to ALAD are derived
from a literature review on lead-binding proteins by Gonick (Gonick, 2011). According to
Gonick, Pb binds to the three-cysteine site of ALAD replacing Zn2+ and interrupting the
catalyzation of two delta-aminolaevulinic acid molecules into one molecule of porphobilinogen,
the second step in heme synthesis (Boudene, Despaux-Pages, Comoy, & Bohoun, 1984; Gonick,
2011). This interruption happens because Pb2+ because it has a higher binding affinity than Zn2+,
approximately 500 times greater (Gonick, 2011; Sahai & Schoonen, 2018). There are three
isoforms of ALAD in which Pb can bind to, ALAD-1, ALAD 1-2, and ALAD 2-2, and of these
ALAD 2 genes has the highest affinity and stability (Gonick, 2011; Kim, Lee, Lee, Hwangbo,
Ahn, & Lee, 2004; Pérez-Bravo et al., 2004; Franco, Edward, Moffett, Abadin, Sexton, &
Fowler., 2007; Wetmur, Lehnert, & Desnick, 1991). Individuals with ALAD 2 have
demonstrated to have higher BLLs compared to individuals with ALAD-1, and ALAD 1-2.
Initially, it was thought that individuals with ALAD 2 were more susceptible to Pb effects, but
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because Pb binds more securely, Pb is sequestered and not distributed to other organs or bone
(Gonick, 2011; Kelada, Shelton, Kaufmann, & Khoury, 2001).
Also, Pb2+ can disrupt cell shape and cell signaling properties that induce cell death. One
study demonstrated that Pb2+ treated RBCs increased intracellular Ca2+ and activate the efflux of
intracellular K+ causing cell wall deformity. The normal biconcave shape of RBC is changed
into a spiked echinocyte or acanthocyte (Kempe et al., 2005) exposing phosphatidylserine (PS), a
cell wall signaling phospholipid for cell death (Ahyayauch et al., 2018; He, Poblenz, Medrano, &
Fox, 2000). This process is called phospholipid scramblase, and it is the same mechanism used
when the cell indicates that it is damaged. This allows for macrophages, which have receptors
for PS, to recognize and engulf damaged RBCs. Through this mechanism, too much Pb2+ in the
blood can decrease RBCs and lead to anemia (Kempe et al., 2005). Even at low concentrations
of Pb2+, this mechanism can be triggered along with the production of ceramide, a long-chain
flip-flop inducing lipid found in the surface, which also causes PS exposure and eventually to
hemolysis (Ahyayauch et al., 2018).
Lead can affect RBC cell function in conjunction with genetic conditions at BLLs below
35 µg/dL. Glucose-6-phosphate dehydrogenase (G-6-PD) occurs mainly in males and it is a
defect in the enzyme responsible for converting sugar into energy for the cell to use and protects
the cell from reactive oxygen species build-up, byproducts of normal cellular functions. The
defect in this enzyme causes RBCs to break down prematurely faster than what the body can
replace RBCs. This condition is referred to as hemolytic anemia. Red cell 2,3diphosphogycerate (2,3-DPG), is a chemical responsible for binding to deoxyhemoglobin which
frees up oxygen to have it delivered to tissues. The chemical 2,3-DPG is increased when oxygen
levels are low for example in conditions like anemia, hypoxia, reticulocytosis, and
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hyperphosphatemia. Also, inhibition of hemoglobin production by Pb2+ through ALAD binding
may result in anemia.
1.9 Child Lead Exposure in El Paso, Texas
The Discussion section includes a historical overview of contamination in El Paso Texas
including the identification of child lead exposure from the now-removed ASARCO smelter.
Since ASARCO’s closure in 1999, many studies of ongoing child Pb exposure have been
published.
For example, the Texas Department of Health reviewed data from Texas Childhood Lead
Surveillance Program for El Paso County for the years 1997 through 1999 for the county of El
Paso to address the resident’s concerns about child lead poisoning. The report compared
proportions of children with elevated BLLs in six zip codes that are nearby the smelter with the
rest of the county. There was a higher percentage of children with elevated BLLs (> 10 µg/dL)
living in the six selected Zip codes compared to the rest of the county with 4.8% (133/2795) vs.
1.7% (385/22397). The percentage of children in the selected zip codes was twice as high
compared to the 2.4% of children tested in Texas for the same 3-year period (Villanacci et al.,
2001).
In 2007, one study analyzed BLLs of children living in zip codes identified by local and
state agencies as “high-risk” to Pb exposure and in the south wind path of the decommissioned
smelter site. A total of 222 children ranging in age from 4.1 to 12.5 years, 106 females and 116
males, were initially screened for BLLs. A blood sample was collected by the finger-stick
method and analyzed by the LeadCare II point-of-care device; a diagnostic tool used in clinical
practice. The study showed that a little more than half had undetectable BLLs, 128/222 (57.7%),
while 35/222 (15.8%) children had BLLs between 3.3 and 3.9 µg/dL, and 59/222 (26.6%) had
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BLLs ≥ 4.0 µg/dL. At this time the CDC recommended BLL for clinical action was 10 µg/dL.
The highest BLL detected was 15.8 µg/dL. From those initially screened, two groups were
formed, with 59 children exposed (BLLs ≥ 4.0 µg/dL) and 57 age- and sex-matched controls
with undetectable BLLs, totaling 116 children. These children were tested two more times to
make up three-time points within 3 months. Average BLLs for the 3-months were calculated.
The 3-month BLL average for the exposed group was 4.9 g/dL and for children in the unexposed
group was 2.8 µg/dL. The 3-month BLL average of both groups differed significantly, assuring
that the group assignment based on initial blood level screening achieved meaningful group
differentiation (mean diff = 2.04 µg/dL, df =114, t =5.47, p <0.001) (Sobin, Gutierrez, & Alterio,
2009). These findings suggest that BLLs at lower levels remain steady for children within 3
months at lower levels of exposure.
Yet, these BLLs were analyzed by The LeadCare device which later was determined to
be unreliable for lower level Pb exposure as compared to ICP-MS, with a negative bias of 0.457
µg/dL and an average variability of 1.0 µg/dL (Sobin, Parisi, Schaub, & de la Riva, 2011a). In
this study, BLLs were measured in 196 children ages 5.2-12.8 years (91 males, 105 females, and
mean age = 8.25) were tested using The LeadCare device and ICP-MS. Of these, 24 children
hand BLLs lower than the reported lower limit of detection of The LeadCare Device (1.4 µg/dL)
and were excluded from the comparability analysis with ICP-MS. The mean BLLs measure by
The LeadCare Device was 2.165 µg/dL, while by ICP-MS was 2.703 µg/dL.
Another study conducted in 2009 looked at genetic polymorphisms for Pb burden in El
Paso children ages 5.1 to 12.9 years, analyzing BLLs using ICP-MS. A total of 306 children
were tested, with 271/306 (88.5%) having BLLs ≤ 3.9 µg/dL, and 35/306 (11.6%) having BLLs
≥ 4.0 µg/dL, with highest BLL of 12.94 µg/dL (Sobin et al., 2011b). The CDC recommended
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BLL for action at that time was still 10 µg/dL and was lowered in 2012 to 5 µg/dL. While the
two studies were not epidemiological, they demonstrated that children living in neighborhoods
with historical contamination were still being exposed to Pb.
Another study compared child BLLs in urban and rural children ages 5-12 years living in
the border region of El Paso. The study analyzed 222 children aged 5-12 years, 111 from the
urban neighborhoods closer to the old smelter site previously tested by Sobin in 2007 and 2009,
and 111 from local rural townships, previously studied by Del Rio for As and other heavy metals
in children and water sources (Del Rio, 2015). Children were matched by age, sex,
race/ethnicity, and family income. Results showed that children living in an urban setting had
significantly higher BLLs than children who lived in the rural township (F(2, 220) = 125, p <
.001). Only location predicted child BLL with R2=0.36 (Alvarez, Del Rio, Mayorga,
Dominguez, Flores-Montoya, & Sobin, 2018). These findings also demonstrated that there was
still a Pb problem in the central area of El Paso.
There are many publications that show sex differences in child BLLs, with males
generally having slightly higher BLLs than females (this was observed in all of our laboratory’s
previously published studies reporting data from children in downtown El Paso Texas). The
reason for these sex differences is not completely understood but is generally attributed to higher
red blood cell count in males. For this reason, most studies of child lead exposure include sex as
a control factor in models examining the contribution to child BLL of possible lead hazard
sources.
Follow up soil tests have also demonstrated that contamination has remained persistent in
the neighborhoods closest to the smelter site. Additional studies conducted in 2001 by the Texas
Department of State and Health Services confirmed elevated concentrations of Pb and As in soil
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on UTEP campus, and surrounding neighborhoods. Soil samples from 0 to 1-inch and 0 to 6inch in depth were taken in different areas on UTEP campus, Arroyo Park, and from four
elementary school playgrounds (Alamo, Roosevelt, Mesita, and Vilas) and one high school (El
Paso High). At UTEP, the Pb concentration in 0 to 1-inch was the highest, with values ranging
between 3.0 to 1,400 ppm, with a mean concentration of 237 ppm. Three areas on campus had
average concentrations exceeding 500 ppm: Leech Grove (727 ppm, n = 8), Memorial Triangle
(664 ppm, n =12), and Jack C. Vowel Hall (658 ppm, n =7) (THHS & ATSDR, 2001b). For the
Arroyo park, the mean Pb concentration in 0 to 1-inch samples was 74 ppm, with values ranging
between 5 to 480 ppm. The mean concentration in 0 to 6-inch samples was 27 ppm, with values
ranging between 5 to 280 ppm (THHS & ATSDR, 2001a).
For the nearby schools, the average Pb concentration in 0 to 1-inch samples ranged
between 21 to 137 ppm, with values ranging between the below detection limit of 3.0 to 1,500
ppm. The highest value was found in El Paso High school (n = 74), with an average mean of
71.3 ppm. The average Pb concentration in 0 to 6-inch samples ranged between 31 and 313
ppm, with values ranging between below the detection limit of 3.0 to 1,800 ppm. The highest
value was from Alamo Elementary school (n = 6), with an average mean of 312.7 ppm (THHS &
ATSDR, 2001b). It is uncertain how the soil samples were analyzed for all sites, and what
dictated the number of samples taken at each site, but averaging Pb concentrations masked high
Pb concentrations found at UTEP, Arroyo park, and schools. Another study supports finding
elevated Pb and other heavy metals concentrations in the soil of public areas closest to the
smelter site. This study analyzed 492 soil superficial samples from 2001-2006 using pXRF and
found Pb concentrations between 10.8 to 420.9 ppm (Elkekli, 2013).
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More current research has demonstrated that Pb contamination from the smelter persists
in neighborhoods near the decommissioned smelter. In 2017, soil from 40 residences and 15
public parks found near the old smelter site were analyzed for Pb concentration using pXRF and
compared to the current EPA action threshold for child play areas of 400 ppm. A total of 364
soil readings were taken with 242 home readings and 122 parks. Only one park had at least one
reading > 400 ppm of Pb, while seven parks had at least one reading exceeding 200 ppm. In
residential yards, about one-third of the homes (12/40) had at least one reading > 400 pm, while
more than half (24/40) had at least one reading exceeding 200 ppm (Del Rio et al., 2019). A
2019 study found heavy metals, including Pb, in attic dust from homes near the decommissioned
smelter. Multiple depositional dust samples were taken from 8 homes and two buildings in Kern
Place, leading to 28 composite samples and from 2 homes in Government Hill leading to 19
composite samples, and analyzed using Inductively coupled plasma-optical emission
spectrometry (ICP-OES). The highest dust Pb concentrations were found in Kern Place, with
values ranging between 289 and 3817 ppm, while in Government Hill the values ranged between
148 and 909 ppm (Van Pelt, Shekhter, Barnes, Duke, Gill, & Pannell, 2020).
These findings demonstrated that children living near the decommissioned smelter site in
a U.S.-Mexico border community are at a higher risk for Pb exposure and are continuously
exposed. Yet, the current way for identifying children living in high risk zip codes for Texas is
based on the proportion (exceeding 3%) of children with elevated BLLs (>5 µg/dL) among
children ages 1-2 years tested in 2016 and the proportion (exceeding 27%) of homes built before
1950 and not by whether children lives near known community lead source (Texas Health and
Human Services, 2020). Therefore, it is important to screen children to determine the proportion
of children with BLLs exceeding the current CDC blood lead reference level and experiencing
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chronic exposure to inform decisions regarding exposure control and prevention of community
sources. At the same time, a health screening is needed to identify possible health effects
including, height, weight, body mass index, and blood pressure, and a home environment
assessment to determine sources of Pb. It is also important to determine the stability of BLLs in
children with chronic low-level exposure and describe sources of Pb at these levels.
1.10 Goals of Study
Changes in current policy must be evidence-based. The over-arching goal of this study
was to test current assumptions that one blood lead level test is sufficient to rule out child Pb
exposure, and that Pb exposure and risk of lead exposure, reliably diminishes over time. The
hypotheses also tested other possible factors that may influence children’s BLLs, accounting for
time.
Specifically, this study aimed to describe and/or test :
1) the BLLs of children living in high-risk neighborhoods of El Paso County;
2) the numbers of children with blood lead levels exceeding the current CDC reference
level of 5 µg/dL;
3) whether blood lead levels changed predictably with time, during a period of
approximately 18 months (across three time points);
4) whether factors other than time that predicted children’s low blood lead levels (< 10
µg/dL).
1.11 Hypotheses
Goals 1 and 2 will be addressed with descriptive statistical analyses. Goal 3 (H1 and
H2) will be tested using two types of models including ANOVA and Individual Growth Curve
(linear mixed) models.
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H1: There will be significant differences in child BLLs across three time points. To test
this hypothesis, median child BLLs at Time 1, Time 2, and Time 3 will be statistically compared
(ANOVA). This hypothesis is a “first-level” test of whether significant differences occurred
simply due to children aging up, and/or effects of repeated testing. If for example, children’s
BLLs decreased significantly from Time 1 to Time 3, it might suggest that as children aged,
BLLs decreased.
H2: Time as a random effect will predict changes in child BLLs across three time points.
To test this hypothesis, an individual growth curve model will be used to determine whether
child BLLs changed in a consistent direction with time; for example, if the variable Time is a
significant predictor, similar to the above “first-level” test, it would suggest that children’s BLLs
either increased or decreased due to “time.”
Goal 4 was tested using linear mixed models, one for each predictor variable tested (H3,
H4, and H5).
H3: Living below the U.S. 2020 poverty threshold will predict child BLLs controlling for
time (repeated measure), sex, and age.
H4: Living in an older home (built before 1986) will predict child BLLs controlling for
time (repeated measure), sex, age.
H5: Whether a child lived near industry will predict child BLLs controlling for time
(repeated measure), sex, and age.
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1.12 Aims and Objectives
There were six outreach objectives with this study. These were to: 1) educate the public
Pb health exposures in children’s development; 2) provide a service to the community by providing
free blood Pb testing for potentially vulnerable children; 3) determine the BLLs of children living
in high-risk neighborhoods of El Paso County; 4) determine the numbers of children with BLLs
exceeding the current CDC “elevated” reference level of 5 µg/dL; 5) determine whether blood lead
levels change predictably with time, during a period of approximately 18 months (across three
time points); and 6) determine factors other than time that predicted children’s low blood lead
levels (< 10 µg/dL).
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2. Methods and Materials
2.1 Research Design
The methods here described were part of a larger study aimed to reduce child blood Pb
levels and mitigate home lead hazard sources. This was a prospective longitudinal study of child
blood Pb levels conducted approximately over 2 years. The children were a convenience sample.
Each child was going to be tested a minimum of 4 times over the course of 2 years. The number
of BLL tests per child was dependent on the availability and compliance of the parents and most
were highly compliant. At some data collection points, parents delayed responding to requests
for follow-up testing, thus delaying the collection of a sample for a given time point. As of
March of 2020, follow-up BLL testing was suspended because of the COVID-19 pandemic.
2.2 Demographics of Community Sampled
El Paso is an urban community located in far west Texas and situated on the U.S.-Mexico
border. With approximately 834,825 residents and 289,883 households, the community is
predominantly of Hispanic or Latinx descent (82.2%). There are approximately 259,955
children ages 0-19 years. The study targeted neighborhoods with homes built before the 1980s
and located within a 2-mile radius from a shuttered smelter site. In El Paso County, there are
approximately 263,200 occupied housing units of which 195,759 (74.4%) are built before the
1980s (U.S. Census Bureau, 2017). When mapped, neighborhoods with the highest density of
occupied homes built before 1980 are located in Zip Codes 79901, 79902, 79904, 79930, 79907,
and 79915. Neighborhoods with the highest density of children aged <5 years reside in Zip
Codes 79901, 79902, 79904, 79930, 79907, 79935, and 79936.
2.3 Sample Size
The recruitment aimed to enroll as many children as possible living in high risk zip
codes. Initial recruitment in elementary schools in the high risk zip codes recruited children
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living outside the areas of interest because of the open-enrollment policy in the local school
districts. Therefore, recruitment was done in local events which reached more children living in
the areas of interest. Children living in the high risk zip codes were given priority followed by
children living outside these areas. We aimed for a minimum of 200 children from local zip
codes designated by the state and federal agencies as high-risk for child lead exposure in the late
1990’s.
2.4 Participant Recruitment
Several methods were used to recruit child participants for this study. Participants were
identified through parent outreach in elementary schools from one independent school district,
during community events, community health fairs, by door-to-door invitation, and by “word of
mouth.” Permission to recruit parents during parent events was obtained through meetings with
school principals and the school board. Permission to recruit through community events and
health fairs was obtained by emailing or meeting with managers organizing the events. First
time and follow-up testing occurred in the community during scheduled home visits. Scheduling
and appointment reminders for all enrolled children were done by a phone call or text depending
on the parents’ preferences.
The study was divided into two participation phases. Phase I included child blood Pb
screening and follow-up monitoring every 3 – 4 months, for a minimum of 4 visits. Phase II,
part of the larger study, consisted of offering children found to have BLLs ≥ 2.5 µg/dL home
environmental testing to identify home lead hazard sources, home mitigation as needed, and
ongoing child and home follow-up monitoring. All families were included in Phase I (as of
March 2020, 17 families with children having blood Pb levels of ≥ 2.5 µg/dL were participating
in Phase II). Families were compensated for their participation in Phase I with a $20 gift card to
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a retail store upon completion of forms and 4 child screenings. All study forms and materials
were available in Spanish and English versions. Researchers in this study were bilingual and
throughout the study interacted with participants in their preferred language.
2.5 Blood Sampling
Blood samples were collected between June 2018 and March 2020. The sampling
procedure followed a strict protocol to avoid sample contamination. Children’s hands were first
washed thoroughly with antibacterial soap and water and dried with paper towels. Children’s
hands were then carefully wiped with industry-standard D-Wipe TM (Esca Tech, Inc., Milwaukee,
WI), wet cloths that were developed to remove metals from skin.
One finger stick whole blood sample of 50-microliters (µL) from each child was
collected into a sterile EDTA (Safe-T-Fill®) or Heparinized (Safe-T-Fill®) capillary blood
collection 125-milliliter tube. Samples remained for about 1-3 hours and were later stored at 4
C° until they were transported on icepacks to the laboratory for analysis. The samples were
tested for Pb by inductively coupled plasma mass spectrometry (ICP-MS, Agilent 7500cx)
(Bazzi, Nriagu, and Linder, 2008). All ICP-MS anslyses were conducted by the Department of
Agronomy at Kansas State University (Dr. Ganga Hettiarachchi, Ph.D., laboratory head). Pb
blood concentrations were recorded in micrograms per deciliter (µg/dL).
2.6 Health Assessment Data
A brief health assessment survey of child participants was completed by the parent/legal
guardian (Appendix A) at the time of recruitment following informed consent. This form asked
basic demographic, socio-economic, playing behaviors including favorite toy, brief medical
behavior history of the child, and questions regarding behavioral, learning disabilities, and health
conditions. The questionnaire consisted of 26 questions and was administered with the
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assistance of a member of the research team who answered parents’ possible questions regarding
the form.
2.7 Family Demographics and Home Characteristics Data
A brief family and home characteristics survey for each family was completed by the
parent/legal guardian (Appendix B) at the time of recruitment after informed consent. This form
asked family members history of smoking and heavy metal testing, food storage, use of
homeopathic remedies, consumption of Mexican candies and rice, homeownership status, built
year of home, length of residence in the current home, recent home renovations, history of heavy
metal testing in the home, concerns of surrounding activities, pet ownership, and gardening. The
questionnaire consisted of 21 questions and was administered with the assistance of a member of
the research team to answer’s questions regarding the form.
2.8 Protection of Research Participants
Institutional Review Board (IRB) approval was obtained prior to any data collection (IRB
protocol # 1309985-10). Informed consent to participate was obtained from parents prior to the
study; assent from each child were obtained immediately prior to testing. All individuals
working on or volunteering to help in this study completed required human subjects training for
handling blood samples, conducting parent interviews, de-identifying health information, and
maintaining participant confidentiality and anonymity.
2.9 Data Analysis Plan
Before statistical analysis, all data and data distributions were examined. Information
regarding data distributions was used to guide choices of statistical models. Individual growth
curve (linear mixed) models were used in the main analyses to examine child BLLs across time
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controlling for time as a random effect; and for analyzing additional predictors controlling for
age and sex.
2.10 Data Management, Collection, and Entry
At the start of the study and before any data were collected, forms for data collection
were created and carefully reviewed by all members of the research team to understand the type
of data that were being collected and how they would be entered into a database. Levels of all
categorical variables were determined and coded. The database and a complete codebook
referencing the data codes were created in Microsoft Excel. The study here reported included 19
variables per child. (The complete study database included a total of 119 variables, with 48
variables per family and 71 variables per child.) All data were entered as the study was
conducted, by one trained staff member. Data were de-identified and coded as they were entered
into the database. As defined in our IRB and grant protocol for data safety management,
throughout the process, only one data file that linked participant names with child and survey
data was kept.
The database and related electronic files were stored in a password-protected computer in
a secured research office with restricted access. Hard copy data were carefully organized and
stored in specially designated locked file cabinets in the same secured research office. Deidentified BLLs results were emailed by Kansas State University to the principal investigator and
reviewed before being forwarded to the program manager and staff member for database entry.
The database was checked weekly for accuracy against hard copy and raw data by the program
manager and principal investigator, and initial descriptive analyses were conducted regularly to
check progress and detect early systemic errors in data coding.
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The database for the study here described was imported into SPSS software for analysis
(IBM SPSS Statistics for Windows, v26, Armonk, NY). For the current study, a reduced version
of the entire database was created to include only data related to children’s demographics,
anthropometrics, and serially collected BLLs (19 variables, 6 of which were repeated measures).
2.10.1 Database for Longitudinal Analyses
For longitudinal analyses examining the stability of child BLLs over time, a second
dataset was created in which data were transposed to create one row for each testing time point
for each child. (For example, a child participant who completed 3 BLL screenings, would have 3
rows in the database.) Binary variables were recoded with -1 and 1 values instead of 0 and 1.
Sex of child was coded -1 = male and 1= female, while for home renovation, peeling paint in the
home, living near industry, and whether a child eats non-food items variables were coded -1= no
and 1= yes. Coding binary variables this way allows to interpret coefficients as the differences
between group means and interpret the p-value as a significant interaction of the variable (GraceMartin, n.d.-a).
For continuous and predictor variables, grand mean centering was done by taking the
mean of the variable and subtracting it from each variable value. Centering was done for Age,
BMI, Waist-to-hip ratio, Systolic, and Diastolic blood pressures, and income variables.
Centering values in any type of regression analyses lessens the correlation between two variables
in an interaction term and facilitates interpretation of the parameter estimates (Grace-Martin,
n.d.-b). This organization followed recommendations for SPSS analysis of mixed effect models
with random effects described by Golub & Sobin (2019), individual growth curves (IGC)
described by Shek & Ma (2011), and mixed-effect models described by SPSS (2002).
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A third database was created from the transposed version for missing data analysis and
multiple imputation of missing values. A total of 242 rows were added to this database to
represent 3 testing time points per children for 193 children, totaling 579 rows. Missing values
for time-invariant variables, variables that do not change with tests, were entered manually by
copying and pasting the same value reported at Time 1 test. The time-invariant variables
included sex of the child, Zip Code, built year of home, living in a home before 1986, living in a
home with recent renovations, living in a home with peeling paint, living near industry, living
below U.S. 2020 poverty guideline, mother’s education level, and whether a child eats non-food
items. Values for living near industry were initially entered based on family response but were
recoded manually to reflect children living in a Zip Code where there are known nearby
industries. Values reported by families who did not live in a Zip Code with known industries
were not changed from what the families reported.
Two new variables were created to represent the length in days from the initial test
(LENGTH), and testing wave (TIME). Missing values for the variable LENGTH were imputed
with a 0 value for Time 1, and LENGTH median values for Time 2 and Time 3. The median
length in days between Time 1 and Time 2 was 166 and between Time 1 and Time 3 was 304.
Missing values for TIME were inputted manually to represent 1= Time 1, 2= Time 2, and 3=
Time 3. Missing values for age were calculated and entered by multiplying age in years by 365
to obtain age in days, then adding the length of time in days between test times and dividing total
days by 365 to get age in years.
“Living below the 2020 poverty guideline” was calculated based on zip code and family
size. All of the families that chose not to share income information (N = 36) in fact lived in
lower-income zip codes and had a family size between 3 and 8. For all 36 children with missing
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values, a 1 was entered for “yes” living below the 2020 US poverty guideline based on the
median income for a given zip code and their reported family sizes. Four children with a family
size of 3 lived in 79902 Zip Code, eleven children with a family size of 4 lived in 79902, four
children with a family size 6 lived in 79902, five children with a family size of 4 lived in 79915,
two children with a family size of 5 lived in 79905, six children with a family size of 8 lived in
79936, two children with a family size of 4 lived in 79924, one child with a family size of 4 lived
in 79925, and one child with a family size of 6 lived in 79935.
2.10.2 Using Multiple Imputation for Missing Data
Missing values for time-variant variables, that is variables that were expected to change
at each screening, were imputed for children who did not complete Time 2 or Time 3 screenings
(IBM SPSS multiple imputation function). All variables were first analyzed for patterns of
missing data to determine the best method for addressing and estimating missing values. Any
variable with at least 0.01% percent of missing values was displayed. The overall summary of
missing values indicated that 6/19 (31.6%) variables had at least one missing value, 348/579
(60.1%) of the cases had at least one missing value, and there was 1530/9843 (13.9%) missing
values in this database (see Figure 1). There were 271 missing values for BLLs, 290 for diastolic
pressure, 290 for systolic pressure, 280 for waist-to-hip ratio, 279 for BMI, and 120 for annual
income.
Missing data can be classified as missing completely at random, missing at random, and
missing not at random (Mack, Su, & Westreich, 2018; Sterne, White, Carlin, Spratt, Royston,
Kenward, et al., 2009). Missing completely at random (MCAR) is when there are no systematic
differences between missing values and the observed data. Missing at random (MAR) is when
there are systematic differences between missing values and the observed values and differences
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Figure 1
Overall Summary of Missing Values Before Multiple Imputations, N = 193

can be explained by differences in observed data. Missing not at random (MNAR) means when
there are systematic differences between the missing values and the observed values and these
differences are related to the unobserved data.
One way to address missing data is by analyzing only cases with complete data. This
method is appropriate when missing data are MCAR. For missing data that are MAR or MNAR,
the factors for missing data must be carefully evaluated to determine if analyzing complete cases
may introduce bias. If missing values are due to loss of follow-up or by an event independent
from the outcome variable, then analyzing cases with complete data may or may not be biased.
For missing data that are MAR, multiple imputation can generally produce unbiased results and
produce different values imputed for each missing variable per data set. The multiple imputation
values are derived from the probability distributions of the missing values based on the values of
other variables that will be used in a model or may influence the outcome variable (Sterne et al.,
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2009). Also, multiple imputation can guarantee to give unbiased results if the missingness
depends on observed variables outside the multilevel model (van Ginkel & Kroonenberg, 2014).
Even when there is a large proportion of missingness in a dataset (more than 40%), multiple
imputation for MAR data can reduce bias (Madley-Dowd, Hughes, Tilling, & Heron, 2019).
In this study, missing values for income were MAR because all of the families that did
not provide income information in fact lived in neighborhoods in which the median income was
below the poverty line. Missing values for BLLs, BMI, Waist-to-hip ratio, and Diastolic and
Systolic pressures were MAR because the participants were lost due to follow-up (n = 39),
voluntarily opted out of future tests (n = 17), moved away (n = 3), or the study was not able to
follow-up due to COVID-19 safety restrictions (n = 104). These factors were independent of the
study’s main outcome (child BLL). Based on the definitions of missing data and factors for
missing data, the missing values in this study are MAR and multiple imputation was deemed
appropriate.
Before conducting multiple imputation, patterns of the missing data were evaluated to
determine the best method for estimating missing values. Missingness patterns can either be
monotone or non-monotone. For missing data with a monotone pattern, patterns of missing data
are concentrated in either corner of the missing value patterns graph. Sometimes re-arranging
the variables can help detect monotonicity. For missing data with a non-monotone pattern,
patterns of missing data are isolated. For the income variable, the pattern of missingness was
non-monotone (see Figure 2). For BLL, BMI, Waist-to-hip ratio, and systolic and diastolic
pressures, the patterns of missingness were monotone (see Figure 2). Based on the patterns of
missingness, multiple imputation was conducted using fully conditional specification methods
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(FCS), a method good for monotone and non-monotone patterns of missing data. Also, linear
regression models were used to predict continuous variables for BLLs and predictors.
In SPSS, the database was set to generate random numbers using the Mersenne Twister
method and active generator initialization with a fixed value of 200000, a method recommended
by SPSS before multiple imputation (IBM Corporation, 2012). Continuous variables that were
included as predictors in later models were transformed before running multiple imputation.
These variables were centered by subtracting the mean of the variable from each case.
Transforming variables before multiple imputation are recommended by Von Hippel (2009) and
Enders, Baraldi, & Cham (2014) to get good regression estimates and to avoid biased regression
estimates when transforming variables with imputed values.

Figure 2
Missing Value Patterns of Database Before Multiple Imputations, N =193
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The number of datasets with imputed estimated values created from the multiple
imputation are called iterations. The number of iterations determines the parameter estimates
(e.g. coefficients and standard errors) for statistical models. These estimates are produced for
each iteration and then they are averaged to give an overall estimate (pooled estimate), known as
relative efficiency of imputation, and it is based on Rubin’s Rules for (point) estimate (Seaman
& Hughes, 2018; Rubin, 1996). At least 95% relative efficiency is preferred in analyses
involving multiple imputation, and for datasets with a high amount of missing information, more
iterations are needed to achieve adequate efficiency for parameter estimates (UCLA, 2016).
There are different recommendations to calculate the number of iterations. The most
recent recommendation is by Alison (2012), Graham, Olchowski & Gilreath (2007), and Bodner
(2008) who suggest that in order to achieve sound statistical inference, the number of iterations
should be similar to the percentage of cases that have missing values. Approximately 60% of
cases were incomplete, therefore 60 iterations were requested for the multiple imputation of
missing data. For 60 iterations, the relative efficiency of the imputations was 99% in the first
model of linear mixed model analyses. The number of iterations was reduced from 60 to 20 to
reduce the time for the SPSS program to run statistical analyses. At 20 iterations, the relative
efficiency was 98% in the first model of linear mixed model analyses. Linear mixed models
were conducted using the multiple imputation dataset with 20 iterations.
All individual growth curve (linear mixed) models were conducted with the original
children with three time points (N = 29), and with multiple imputation dataset that yield three
time points for 193 children (the original 29 children were included in the 193 children). Before
running analyses in the multiple imputation dataset, the file was split by the IMPUTATION_
variable to activate pooling procedures.
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2.11 Data Limitations
This study was significantly impacted by the COVID-19 shutdowns that began in March
2020, which resulted in 13.9% of missing values and 35 children with complete three testing
time points. While our goal was to complete four testing time points for approximately 200
children, the reality is that we were able to obtain three time points for only a small number of
children. The final number of children who completed three time points was N =29 after
excluding with BLLs > 10 µg/dL. This sample size was not large enough to meet basic
statistical power expectations for longitudinal analyses. To make maximal use of data that were
collected prior to the COVID shutdowns, we used multiple imputation methods to complete
missing values. The relative efficiency achieved with this approach was high (98%), increased
the number of cases with three testing time points to N =193, and increased power for the
longitudinal analyses. While clearly not ideal, the multiple imputation method was an adequate
and allowed us to conduct analyses with only limited bias introduced. Had continuing to collect
data been possible after March 2020, we would have made every effort to continue repeated
tests of BLLs to meet the initial goal of the study.
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3. Results
3.1 Sample
A total of 110 families were recruited yielding 221 children between the ages of 6 months
and 16 years. Children were recruited from 5 community events, 1 elementary school, and 3
community organizations, and were also referred by word of mouth, by participating families or
community health workers. Of the children recruited, 9 children did not assent, 1 child was too
young to participate (4.5 months), 2 children were over the age of 16 years of age, and 3 children
were not available during the home visit. Thus, a total of 206 children from 109 families
completed Time 1 testing.
As mentioned previously, this study was significantly impacted by the COVID-19
shutdowns that began in March 2020. The original goal of the study was for all 206 children to
complete 4 testing time points. In mid-March of 2020, all testing and home visits were stopped
due to the COVID-19 pandemic shutdowns. As of March 2020, 20/109 families (18.3%) and
39/206 children (18.9%) had been lost to follow-up; 9/109 (8.3%) families and 17/206 (8.3%)
children voluntarily opted out of the study, 3/109 (2.8%) families and 3/206 (1.5%) children
were lost to moving away to another county, and 1/206 (0.5%) child was lost due to immigration
issues. With regard to data collection, by March 2020, 99/206 (48.1%) of children had
completed Time 2 testing, 49/206 (23.8%) children had completed Time 3 testing, 23/206
(11.2%) children had completed Time 4 testing, and 5/206 (2.4%) children had completed Time
5. A total of 68/109 (62.4%) families and 132/206 (64.1%) children were available for follow-up
testing and the 1 child that was too young to participate before during Time 1 recruitment was
available to participate.
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As the pandemic shutdowns continued, the team looked for windows of opportunity to
collect additional blood samples from downtown families. A detailed safety plan for resuming
operations was developed but as it turned out, cases surged again to their worst levels beginning
in October and no additional samples for this study could be collected.
For this study, BLLs included in these analyses were from children whose homes had not
undergone mitigation, and/or BLLs taken pre-mitigation and up to Time 3 testing. While the
goal had been to conduct BLL screenings every 3 – 4 months, the reality of parents’ schedules
resulted in BLL screenings every three to six months from each child. Twelve BLLs that were
less than two months apart were excluded because, given the half-life of lead in whole blood
(between 30 and 45 days in children), samples spanning less than 60 days would not be expected
to yield change in BLL even if exposure sources had shifted. Three children with two values
were excluded, and nine children with three values were kept in the analysis, retaining the two
BLL values farthest from each other.
BLL values below the ICP-MS detection limit of < 0.05µg/dL were manually imputed
using values from an online random number generator application that produced random
numbers with two decimal places between the values of 0 and 0.05. A total of 9/393 (2.3%)
BLLs were imputed in this manner. (For obvious reasons, any child BLL values determined
after a home mitigation action was undertaken were not included in these analyses.)
Since the focus of this study was to analyze BLLs of children with lower-level lead
absorption, only BLL values below 10 µg/dL were included in the main analysis. There were
13/206 (6.31%) children with BLLs above 10 µg/dL, considered extreme values for the purposes
of this study. Descriptive analyses with and without extreme BLLs (> 10 µg/dL) were conducted
to inform the decision regarding extreme BLLs. The data sample including BLLs > 10 µg/dL
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resulted in N = 206 children with BLLs from one time point (Time 1), N = 95 children with
BLLs from two time points (Time 2), and N = 35 children with BLLs from three time points.
The sample of data without extreme BLLs included N = 193 children with BLLs from one time
point (Time 1), N = 86 children with BLLs from two time points (Time 2), and N = 29 children
with BLLs from three time points (Time 3). Missing data for the main analysis were handled
through multiple imputation. For all statistical tests, an alpha level of .05 was used.
3.2 Demographic and Clinical Characteristics of the Sample
Data distribution analyses were conducted for all variables. Demographic and clinical
analyses for data that included children with BLL above 10 µg/dL are described in Tables 1
through 3. Table 1 shows the demographic characteristics of the Time 1 sample (N = 206).
There was approximately equal representation of male and female children with 97/206
(47.1%) males, and 109/206 (52.9%) females. A one-sample binomial test determined that there
was no significant difference between the percentage of males (41.1%) and the percentage of
females (52.9%) (p = .444). The children’s mean age was 7.94 years (SD = 4.08), and was
similar for males and females, (males mean age of 7.73 years, SD = 4.29 and females mean age
8.12 years, SD = 3.90). An independent samples t-test determined that there was no statistically
significant difference between the mean age of males (M = 7.73, SD = 4.29) and females (M =
8.12, SD = 3.90), t(204) = 0.681, p = .497, d= .095. When children were categorized by 5-year
age groups, the numbers were approximately equivalent, categories 0 – 4 years, 60/206 (29.1%);
5 - 9 years, 81/206 (39.3%); and ≥ 10 years, 65/206 (31.6%). A Pearson chi-square test of
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Table 1
Clinical and Demographic Characteristics of Children at Time 1, N = 206
Variable

Time 1
M (n = 97) (47.1%)

Age (SD)
a

Weight lbs. (SD)
a

Height in. (SD)
a

W/H Ratio (SD)

F (n = 109) (52.9%)

T (n = 206)

7.73 (± 4.29)

8.12 (± 3.90)

7.94 (± 4.08)

71.67 (± 49.36) (94/97)

71.69 (± 42.00) (107/109)

71.68 (± 45.47) (201/206)

49.29 (±11.12) (93/97)

50.14 (± 10.16) (108/109)

49.75 (± 10.60) (201/206)

0.91(±0.10) (92/97)

0.88 (±0.07) (107/109)

0.90 (± 0.09) (199/206)

BMIb (SD)

18.94 (± 7.05) (93/97)

18.30 (± 4.83) (106/109)

18.60 (± 6.00) (199/206)

SYSc (SD)

108.97 ( ± 18.08) (88/97)

108.36 (± 11.80) (106/109)

108.63 (±14.94) (194/206)

62.20 (± 12.44) (88/97)

64.76 (± 9.13) (106/109)

63.60 (± 10.80) (194/206)

2.13 (± 4.25) (97/97)

2.65 (± 4.72) (109/109)

2.40 (± 4.50) (206/206)

0.05
38.70
0.80
1.20
2.20

0.00
27.30
0.55
1.20
2.15

0.00
38.70
0.70
1.20
2.20

(97/97)

(109/109)

(206/206)

50/97 (51.5%)
9/97 (9.3%)
4/97 (4.1%)
6/97 (6.2%)
6/97 (6.2%)
2/97 (2.1%)
0/97 (0.0%)
20/97 (20.6%)

49/109 (45.0%)
10/109 (9.2%)
10/109 (9.2%)
11/109 (10.1%)
5/109 (4.6%)
0/109 (0.0%)
1/109 (0.9%)
23/109 (21.1%)

99/206 (48.1%)
19/206 (9.2%)
14/206 (6.8%)
17/206 (8.3%)
11/206 (5.3%)
2/206 (1.0%)
1/206 (0.5%)
43/206 (20.9%)

(96/97)

(109/109)

(205/206)

48/96 (50.0%)
9/96 (9.4%)
15/96 (15.6%)
3/96 (3.1%)
9/96 (9.4%)
0/96 (0.0%)
12/96 (12.5%)

45/109 (41.3%)
9/109 (8.3%)
30/109 (27.5%)
7/109 (6.4%)
8/109 (7.3%)
1/109 (0.9%)
9/109 (8.3%)

93/205 (45.4%)
18/205 (8.8%)
45/205 (22.0%)
10/205 (4.9%)
17/205 (8.3%)
1/205 (0.5%)
21/205 (10.2%)

(96/97)

(109/109)

(205/206)

25/96 (26.0%)

36/109 (33.0%)

61/205 (29.8%)

21/96 (21.9%)
25/96 (26.0%)

18/109 (16.5%)
20/109 (18.3%)

39/205 (19.0%)
45/205 (22.0%)

14/96 (14.6%)
11/96 (11.5%)

17/109 (15.6%)
18/109 (16.5%)

31/205 (15.1%)
29/205 (14.1%)

c

DIA (SD)
Pb BL (µg/dL) (SD)
Min.
Max.
25 percentile
Median
75 percentile
Children's Ethnicity
Hispanic
Latino
Mexican
Mexican American
White
African American
Black
Two or more ethnicities
Mother's Ethnicity
Hispanic
Latino
Mexican
Mexican American
White
Black
Two or more ethnicities
Mother's Education Level
Less than High School
Diploma
High School Diploma
Completed some college or
technical training
Bachelor's Degree
More than Bachelor's Degree
Family Size (SD)
Household Annual Income
(SD)

5.07 (± 1.72) (97/97)

4.92 (± 1.67) (109/109)

4.99 (± 1.69) (206/206)

$40,854 (± 44,652) (77/97)

$44,725 (± 51,945) (86/109)

$42,897 (± $48,528) (163/206)

a

b
Children did not want to be measured or they had a physical disability that prevented proper measurement. Children were too
c
young for BMI interpretation. Children did not stay still for accurate blood pressure readings.
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Table 2
Clinical and Demographic Characteristics of Children at Time 2, N = 95
Variable

Time 2
M (n = 49) (52.1%)

Age (SD)
a

Weight lbs. (SD)
a

Height in. (SD)
a

W/H Ratio (SD)

F (n = 46) (47.9%)

T (n = 95)

7.97 (± 3.53)

9.02 (± 3.85)

8.48 (± 3.70)

65.50 (± 37.34) (49/49)

83.32 (± 47.33) (45/46)

74.03 (± 43.13) (94/95)

49.62 (± 8.58) (49/49)

52.70 (± 10.12) (45/46)

51.09 (± 9.43) (94/95)

0.92 (± 0.08) (49/49)

0.92 (± 0.08) (45/46)

0.92 (± 0.08) (94/95)

BMIb (SD)

17.43 (± 3.67) (49/49)

19.53 (± 5.74) (45/46)

18.43 (± 4.86) (94/95)

SYSc (SD)

109.44 (±11.04) (45/49)

111.74 (± 12.79) (43/46)

110.57 (± 11.91) (88/95)

65.22 (± 8.65) (45/49)
4.26 (± 8.06) (49/49)

67.30 (± 10.41) (43/46)
1.77 (± 1.96) (46/46)

66.24 (± 9.55) (88/95)
3.06 (± 6.05) (95/95)

Min.
Max.
25 percentile
Median
75 percentile
Children's Ethnicity
Hispanic
Latino
Mexican
Mexican American
White
African American
Two or more ethnicities

0.30
36.40
1.20
1.60
3.10
(49/49)
20/49 (40.8%)
8/49 (16.3%)
2/49 (4.1%)
4/49 (8.2%)
4/49 (8.2%)
1/49 (2.0%)
10/49 (20.4%)

0.30
9.80
0.80
1.20
1.80
(46/46)
16/46 (34.8%)
6/46 (13.0%)
5/46 (10.9%)
8/46 (17.4%)
3/46 (6.5%)
0/46 (0.0%)
8/46 (17.4%)

0.30
36.40
1.00
1.30
2.60
(95/95)
36/95 (37.9%)
14/95 (14.7%)
7/95 (7.4%)
12/95 (12.6%)
7/95 (7.4%)
1/95 (1.1%)
18/95 (18.9%)

Mother's Ethnicity

(49/49)
22/49 (44.9%)
8/49 (16.3%)
5/49 (10.2%)
0/49 (0.0%)
7/49 (14.3%)
7/49 (14.3%)

(46/46)
16/46 (34.8%)
5/46 (10.9%)
15/46 (32.6%)
1/46 (2.2%)
6/46 (13.0%)
3/46 (6.5%)

(95/95)
36/95 (40.0%)
13/95 (13.7%)
20/95 (21.1%)
1/95 (1.1%)
13/95 (13.7%)
10/95 (10.5%)

(49/49)
13/49 (26.5%)

(46/46)
19/46 (41.3%)

(95/95)
32/95 (33.7%)

8/49 (16.3%)
13/49 (26.5%)

4/46 (8.7%)
8/46 (17.4%)

12/95 (12.6%)
21/95 (22.1%)

8/49 (16.3%)
7/49 (14.3%)

7/46 (15.2%)
8/46 (17.4%)

15/95 (15.8%)
15/95 (15.8%)

5.10 (± 1.54) (49/49)

4.72 (± 1.57) (46/46)

4.92 (± 1.56) (95/95)

$46,733 (± 57,9756) (39/49)

$ 43,687 (± 48,686) (39/46)

c

DIA (SD)
Pb BL (µg/dL) (SD)

Hispanic
Latino
Mexican
Mexican American
White
Two or more ethnicities
Mother's Education Level
Less than High School
Diploma
High School Diploma
Completed some college or
technical training
Bachelor's Degree
More than Bachelor's Degree
Family Size (SD)
Household Annual Income
(SD)
a

$45,210 (± 53,206) (78/95)

b
Children did not want to be measured or they had a physical disability that prevented proper measurement. Children were too
c
young for BMI interpretation. Children did not stay still for accurate blood pressure readings.
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Table 3
Clinical and Demographic Characteristics of Children at Time 3, N = 35
Variable

Time 3
M (n =17) (48.6%)

Age (SD)
a

Weight lbs. (SD)
a

Height in. (SD)
a

W/H Ratio (SD)

F (n =18) (51.4%)

T (n =35)

8.51 (± 2.76)

9.16 (± 3.58)

8.85 (± 3.18)

68.89 (± 38.18) (17/17)

88.23 (± 52.32) (17/18)

78.57 (± 46.16) (34/35)

51.29 (± 7.19) (17/17)

52.66 (± 8.91) (17/18)

51.97 (± 8.00) (34/35)

0.89 (± 0.06) (17/17)

0.88 (± 0.06) (17/18)

0.88 (± 0.06) (34/35)

BMIb (SD)

17.34 (± 4.17) (17/17)

20.46 (± 6.18) (17/18)

18.90 (± 5.90) (34/35)

SYSc (SD)

110.13 (± 15.74) (16/17)

110.59 (± 16.94) (17/18)

110.36 (± 16.11) (33/35)

64.63 (± 8.40) (16/17)

66.71 (± 17.87) (17/18)

65.70 (± 13.93) (33/35)

c

DIA (SD)
Pb BL (µg/dL) (SD)

1.01 (± 1.07) (17/17)

1.26 (± 1.43) (18/18)

1.13 (± 1.26) (35/35)

Min.
Max.
25 percentile
Median
75 percentile
Children's Ethnicity

0.02
4.10
0.20
0.60
1.40
(17/17)

0.03
6.30
0.38
1.00
1.43
(18/18)

0.02
6.30
0.33
0.90
1.40
(35/35)

Hispanic
Latino
Mexican
Mexican American
African American
Two or more ethnicities

5/17 (29.4%)
3/17 (17.6%)
2/17 (11.8%)
2/17 (11.8%)
1/17 (5.9%)
4/17 (23.5%)

7/18 (38.9%)
2/18 (11.1%)
4/18 (22.2%)
3/18 (16.7%)
0/18 (0.0%)
2/18 (11.1%)

12/35 (34.3%)
5/35 (14.3%)
6/35 (17.1%)
5/35 (14.3%)
1/35 (2.9%)
6/35 (17.1%)

(17/17)
6/17 (35.3%)
3/17 (17.6%)
4/17 (23.5%)
0/17 (0.0%)
1/17 (5.9%)
3/17 (17.6%)

(18/18)
7/18 (38.9%)
2/18 (11.1%)
6/18 (33.3%)
1/18 (5.6%)
2/18 (11.1%)
0/18 (0.0%)

(35/35)
13/35 (37.1%)
5/35 (14.3%)
10/35 (28.6%)
1/35 (2.9%)
3/35 (8.6%)
3/35 (8.6%)

(17/17)
6/17 (35.3%)
1/17 (5.9%)
5/17 (29.4%)

(18/18)
11/18 (61.1%)
2/18 (11.1%)
4/18 (22.2%)

(35/35)
17/35 (48.6%)
3/35 (8.6%)
9/35 (25.7%)

4/17 (23.5%)
1/17 (5.9%)

1/18 (5.6%)
0/18 (0.0%)

5/35 (14.3%)
1/35 (2.9%)

4.71 (±1.26) (17/17)

4.44 (±1.23) (18/18)

4.57 (± 1.24) (35/35)

$37,774 (± 42,016) (14/17)

$20,534 (± 19,591) (17/18)

$28,320 (± 32,338) (31/35)

Mother's Ethnicity
Hispanic
Latino
Mexican
Mexican American
White
Two or more ethnicities
Mother's Education Level
Less than High School Diploma
High School Diploma
Completed some college or
technical training
Bachelor's Degree
More than Bachelor's Degree
Family Size (SD)
Household Annual Income
(SD)
a

b
Children did not want to be measured or they had a physical disability that prevented proper measurement. Children were too
c
young for BMI interpretation. Children did not stay still for accurate blood pressure readings.
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goodness-of-fit determined that there was an equal distribution of children by 5-year age groups,
X2 (2, N = 206)= 3.51, p = .173.
There were 163/206 (79.1%) children that identified with one ethnicity, and 43/206
(20.9%) that identified with more than one ethnicity category. Among children with one
ethnicity, 99/206 (48.1%) were identified as Hispanic, 19/206 (9.2%) Latino, 14/206 (6.8%)
Mexican, 17/206 (8.3%) Mexican American, 11/206 (5.3%) White, 2/206 (1.0%) African
American, and 1/206 (20.9%) Black. Among children with more than one ethnicity, 10/206
(4.9%) were identified as Hispanic and White, 5/206 (2.4%) Black and Hispanic, 4/206 (1.9%)
Mexican and White, 3/206 (1.5%) Hispanic, Latino, Mexican American, and White, 3/206
(1.5%) Mexican and Mexican American, 2/206 (1.0%) Asian and Black, 2/206 (1.0%) Hispanic,
Latino, and Mexican American, 2/206 (1.0%) Latino and Mexican American, 2/206 (1.0%)
Asian, Hispanic, and White, 2/206 (1.0%) Black and Mexican, 2/206 (1.0%) African American
and Mexican American, 2/206 (1.0%) Hispanic and Mexican American, 2/206 (1.0%) Mexican
American and White, 1/206 (0.5%) Hispanic and Mexican, and 1/206 (0.5%) American Indian
and Mexican.
There were 205/206 (99.5%) responses to mother’s ethnicity, with 184/205 (89.8%)
respond to one ethnicity category and 21/205 (10.2%) responding with more than one ethnicity
category. Among mothers with one response in ethnicity category, approximately, half of the
mothers 93/184 (50.5%) were identified as Hispanic; 18/184 (9.8%) identified as Latino, 45/184
(24.5%) Mexican, 10/184 (5.43%) Mexican American, 12/184 (6.52%) White, and 1/184
(0.54%) American Indian. Among mothers with more than one response in the ethnicity
category, 2/21(9.5%) identified as Asian, Hispanic, and Mexican, 1/21 (4.8%) Hispanic, Latino,
and Mexican, 1/21 (4.8%) Hispanic, Latino, and Mexican American, 1/21 (4.8%) American
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Indian and Mexican, 2/21 (9.5%) Asian and Black, 1/21 (4.8%) Black and Hispanic, 1/21 (4.8%)
Hispanic and Mexican, 5/21 (23.8%) Hispanic and White, 1/21 (4.8%) Latino and White, 2/21
(9.5%) Latino and Mexican American, 4/21 (19.0%) Mexican and White. For mother’s
education level, 61/205 (29.6%) had an education level less than high school, 39/205 (19/0%)
had a high school diploma, 45/205 (22.0%) had completed some college or technical training,
31/205 (15.1%) had a bachelor’s degree, and 29/205 (14/1%) had an education level more than a
Bachelor’s degree.
Information regarding fathers’ demographic characteristics were less complete than for
mothers, with ethnicity information provided for only 169/206 (82.0%) and level of education
for 149/206 (72.3%). There were 154/169 (91.1%) responses with one ethnicity category and
15/169 (8.87%) responses with more than one ethnicity categories for father’s ethnicity. Among
fathers with one response in ethnicity category, 81/169 (47.9%) identified as Hispanic, 35/169
(20.7%) Mexican, 15/169 (8.9%) White, 13/169 (7.7%) Latino, 10/169 (5.9%) Mexican
American, 6/169 (3.6%) Black, 4/169 (2.4%) African American, 4/169 (2.4%) Asian, and 1/169
(0.6%) American Indian. Among fathers with more than one response in ethnicity categories,
3/15 (20.0%) identified as Hispanic, Mexican, Mexican American, and White, 1/15 (6.67%)
Hispanic, Latino, and Mexican, 7/15 (46.7%) Hispanic and White, 2/15 (13.3%) Asian and
White, and 2/15 (13.3%) Latino and Mexican. For father’s level of education, 42/149 (28.2%)
had an education level less than high school, 31/149 (20.8%) had a high school diploma, 28/149
(18.8%) completed some college or technical training, 23/149 (15/4%) had a bachelor’s degree,
and 25/149 (16.8%) had an education level more than a Bachelor’s degree.
The families in this study had a mean family size of 4.99 (SD = 1.69). Annual income
information was collected from 87/109 (79.8%) families reflecting income levels for 164/206
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(79.6%) children. The mean annual household income was $42,896.81 (SD = $48,527.55) with a
range between $5,200 and $234,000 and a median of $24,000 (one outlier value of $624,000 was
not included in the mean calculation). The U.S. federal poverty guidelines for 2020 was $30,680
for a family of five. In this sample, 43/87 (49.4%) of families reflecting 91/164 (55.5%) children
in the study fell below the poverty threshold (U.S. Department of Health and Human Services,
2020). The median household income for El Paso in 2018 was $44,597. In this sample, 56/87
(64.4%) of families reflecting 116/164 (71.2%) of children were living in a home with an income
below the El Paso median household income.
Body Mass Index (BMI) was calculated according to the standard algorithm, which is
based on a child’s weight, height, gender, and age for children ages 2 to 20 years. The BMI was
then interpreted using the standard screening weight categories of “underweight,” “normal,”
“overweight,” and “obese.” For this sample, the mean BMI for males (M = 18.9, SD = 7.05) at
the mean age of 7.7 years (SD = 4.29) (rounded to 8) met the criteria for “overweight,” falling
between the eighty-fifth percentile of 17.4 and the ninety-fifth percentile of 19.1. For a male
child, age 8, a “normal” or healthy weight should fall between the fifth percentile (13.8) and
eighty-fifth percentile (17.9) of the U.S. range. For this sample, the mean BMI for females (M =
18.3, SD = 4.83) at the mean age of 8.12 years (SD = 3.90) (also rounded to 8) met the criteria
for “normal.” For a female child, age 8, a “normal” or healthy weight should fall between the
fifth percentile (13.6) and eighty-fifth percentile (18.4) of the U.S. range. There is no BMI
standard set for children under the age of 2 years, therefore, children in this study below the age
were not given a BMI classification.
The height of children was measured in centimeters and converted into inches, and
weight was collected in pounds. Then height and weight were compared to U.S. ranges for boys
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and females by age. There are no “normal” or healthy ranges for height and weight because BMI
is the preferred metric to clinically assess weight and height for children ages between 2 and 20
years (CDC, 2017). For this study, the male mean height of 49.3 inches (SD = 11.1) was
between the twenty-fifth (48.9) and fiftieth percentile (50.4); the mean weight of 71.7 pounds
(SD = 49.4) was between the ninetieth percentile (71.7) and ninety-fifth percentile (77.8) of the
U.S. national average for an eight-year-old male (CDC, 2017). The female mean height of 50.1
inches (SD = 10.2) was between the twenty-fifth percentile (48.9) and fiftieth percentile (50.4);
the mean weight of 71.7 pounds (SD = 42.0) was between the ninetieth percentile (73.2) and
ninety-fifth percentile (79.7) of the national average for an eight-year-old female (CDC, 2017).
Blood pressure was obtained for 194/206 (94.2%) of child participants; 12/206 (5.83%)
of children, all under the age of 4 years, could not hold still long enough to obtain a reading.
Blood pressure was determined in millimeters of mercury (mmHg) and recorded values were
compared to U.S. averages for males and females based on age, weight, and height summarized
by the University of Iowa Health Care (UIHC, 2020).
Normal child ranges for systolic and diastolic blood pressure are between the fiftieth and
ninetieth percentile for males and females between the ages of 1 month and 19 years. Blood
pressure above the ninetieth percentile is considered elevated and requiring further clinical
assessment for determining the stage of hypertension. Blood pressure below the fiftieth
percentile is considered abnormal requiring clinical assessment and monitoring for a health
condition.
The mean systolic and diastolic pressures for males (M = 109.0, SD = 18.1, and M = 62.2,
SD = 12.4, respectively) were within the normal U.S. range. (The fiftieth and ninetieth percentile
for systolic blood pressure for an 8-year-old male, with a height between 47.24 and 55.12 inches,
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and weight between 44.10 and 88.18 pounds should be between 93 and 113 mmHg (UIHC,
2020). The fiftieth and ninetieth percentile for the diastolic blood pressure of the same male
should be between 60 and75 mmHg.) The mean systolic and diastolic pressures for females (M
= 108.4, SD = 11.8, and M = 64.8, SD = 9.1, respectively) were also within the normal U.S.
range. (The fiftieth and ninetieth percentile for the systolic pressure of an 8-year-old female,
with a height between 47.24 and 55.12 inches and weight of 44.10 to 88.18 pounds should be
between 94 and112 mmHg (UIHC, 2020). The fiftieth and ninetieth percentile for the diastolic
blood pressure of the same female should be between 60 and 75 mmHg.)
In summary, the sample included approximately equal numbers of male and female
children, spread relatively evenly across the age range of 0.5 to 16 years. The vast majority of
mothers identified as Hispanic, and a majority of families (64.4 %) were living below the median
income level in El Paso. Approximately 91/164 (55.5%) of families were living at or below the
poverty level. Males but not females were overweight, and both males and females blood
pressures were within the normal U.S. range for children of the same age and sex.
Demographic and clinical analysis of data without BLL values over 10 µg/dL are
described in Tables 4 through 6. Table 8 shows the demographic characteristics of the Time 1
sample (N = 193). Removing these 13 children with BLLs > 10 µg/dL did not change the overall
demographic and clinical characteristics of the sample. As compared to the dataset with BLL
values over 10 µg/dL (N = 206), the dataset data without BLL values over 10 µg/dL (N = 193),
also included approximately equal numbers of male and female children and spread relatively
evenly across the same age range of 0.5 to 16 years. The vast majority of mothers still identified
as Hispanic, and the majority, 110/154 (71.4%), of children were living below the median
income of El Paso. Approximately, the same 85/154 (55.2%) of children were living below or at
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Table 4
Clinical and Demographic Characteristics of Children at Time 1, N = 193
Variable

Time 1
M (n = 91) (47.2%)

Age (SD)
a

Weight lbs. (SD)
a

Height in. (SD)
a

W/H Ratio (SD)

F (n = 102) (52.8%)

T (n = 193)

7.77 (± 4.29)

8.19 (± 3.87)

7.99 (± 4.07)

71.88 (± 48.70) (88/91)

71.16 (± 40.19) (100/102)

71.50 (± 44.26) (188/193)

49.38 (±11.05) (87//91)

50.32 (± 10.13) (101/102)

49.88 (± 10.54) (188/193)

0.91(± 0.10) (86/91)

0.88 (± 0.07) (100/102)

0.90 (± 0.09) (186/193)

BMIb (SD)

19.02 (± 7.17) (87/91)

18.09 (± 4.53) (100/102)

18.52 (± 5.91) (187/193)

SYSb (SD)

108.48 ( ± 17.46) (83/91)

108.20 (± 12.04) (99/102)

108.33 (±14.72) (182/193)

61.59 (± 11.52) (83/91)

64.77 (± 9.23) (99/102)

63.32 (± 10.43) (182/193)

1.58 (± 1.45) (91/91)

1.52 (± 1.47) (102/102)

1.55 (± 1.45) (193/193)

0.05
8.20
0.80
1.20
1.90

0.00
8.70
0.50
1.15
1.90

0.00
8.70
0.70
1.20
1.90

(91/91)

(102/102)

(193/193)

47/91 (51.6%)
9/91 (9.0%)
4/91 (4.4%)
4/91 (4.4%)
5/91 (5.5%)
2/91 (2.2%)
0/91 (0.0%)
20/91 (22.0%)

46/102 (45.1%)
10/102 (9.8%)
10/102 (9.8%)
9/102 (8.8%)
5/102 (4.9%)
0/102 (0.0%)
1/102 (1.0%)
21/109 (20.6%)

93/193 (48.2%)
19/193 (9.8%)
14/193 (7.3%)
13/193 (6.7%)
10/193 (5.2%)
2/193 (1.0%)
1/193 (0.5%)
41/193 (21.2%)

(91/91)

(102/102)

(193/193)

46/91 (50.5%)
9/91 (9.9%)
13/91 (14.3%)
3/91 (3.3%)
8/91 (8.8%)
0/91 (0.0%)
12/91 (13.2%)

42/102 (41.2%)
9/102 (8.8%)
26/102 (25.5%)
7/102 (6.9%)
8/102 (7.8%)
1/102 (1.0%)
9/102 (8.8%)

88/193 (45.6%)
18/193 (9.3%)
39/193 (20.2%)
10/193(5.2%)
16/193 (8.3%)
1/193 (0.5%)
21/193 (10.9%)

(91/91)

(102/102)

(193/193)

23/91 (25.3%)

32/102 (31.4%)

55/193 (28.5%)

20/91 (22.0%)
24/91 (26.4%)

18/102 (17.6%)
20/102 (19.6%)

38/193 (19.7%)
44/193 (22.8%)

13/91 (14.3%)
11/91 (12.1%)

15/102 (14.7%)
17/102 (16.7%)

28/193 (14.5%)
28/193 (14.5%)

c

DIA (SD)
Pb BL (µg/dL) (SD)
Min.
Max.
25 percentile
Median
75 percentile
Children's Ethnicity
Hispanic
Latino
Mexican
Mexican American
White
African American
Black
Two or more ethnicities
Mother's Ethnicity
Hispanic
Latino
Mexican
Mexican American
White
Black
Two or more ethnicities
Mother's Education Level
Less than High School
Diploma
High School Diploma
Completed some college or
technical training
Bachelor's Degree
More than Bachelor's Degree
Family Size (SD)
Household Annual Income
(SD)

5.12 (± 1.74) (91/91)

4.91 (± 1.69) (102/102)

5.01 (± 1.71) (193/193)

$40,854 (± 44,652) (73/91)

$45,122 (± 53,445) (80/102)

$43,287 (± $49,757) (153/193)

a

b
Children did not want to be measured or they had a physical disability that prevented proper measurement. Children were too
c
young for BMI interpretation. Children did not stay still for accurate blood pressure readings.
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Table 5
Clinical and Demographic Characteristics of Children at Time 2, N = 86
Variable

Time 2
M (n = 44) (51.2%)

Age (SD)

F (n = 42) (48.8%)

T (n = 86)

8.14 (± 3.54)

8.90 (± 3.85)

8.52 (± 3.69)

67.24 (± 38.61) (44/44)

79.63 (± 44.75) (41/42)

73.21 (± 41.90) (85/86)

Height in. (SD)
W/H Ratioa (SD)

50.12 (± 8.57) (44/44)
0.91 (± 0.08) (44/44)

52.09 (± 9.99) (41/42)
0.92 (± 0.08) (41/42)

51.07 (± 9.28) (85/86)
0.92 (± 0.08) (85/86)

BMIb (SD)

a

Weight lbs. (SD)
a

17.51 (± 3.83) (44/44)

19.12 (± 5.43) (41/42)

18.29 (± 4.72) (85/86)

c

109.78 (±11.41) (40/44)

106.53 (± 12.76) (39/42)

110.22 (± 1156) (79/86)

c

65.13 (± 8.36) (40/44)

67.36 (± 10.73) (39/42)

66.22 (± 9.60) (79/86)

1.98 (± 1.40) (44/44)

1.88 (± 2.02) (42/42)

1.93 (± 1.72) (86/86)

Min.
Max.
25 percentile
Median
75 percentile
Children's Ethnicity
Hispanic
Latino
Mexican
Mexican American
White
African American
Two or more ethnicities

0.30
5.5
1.13
1.55
2.60
(44/44)
18/44 (40.9%)
8/44 (18.2%)
2/44 (4.5%)
2/44 (4.5%)
3/44 (6.8%)
1/44 (2.3%)
10/44 (22.7%)

0.30
9.80
0.90
1.20
1.83
(42/42)
14/42 (33.3%)
6/42 (14.3%)
5/42 (11.9%)
6/42 (14.3%)
3/42 (7.1%)
0/42 (0.0%)
8/42 (19.0%)

0.30
9.80
1.00
1.30
2.23
(86/86)
32/86 (37.2%)
14/86 (16.3%)
7/86 (8.1%)
8/86 (9.3%)
6/86 (7.0%)
1/86 (1.2%)
18/86 (20.9%)

Mother's Ethnicity

(44/44)
20/44 (45.5%)
8/44 (18.2%)
3/44 (6.8%)
0/44 (0.0%)
6/44 (13.6%)
7/44 (15.9%)

(42/42)
14/42 (33.3%)
5/42 (11.9%)
13/42 (31.0%)
1/42 (2.4%)
6/42 (14.3%)
3/42 (7.1%)

(86/86)
34/86 (39.5%)
13/86 (15.1%)
16/86 (18.6%)
1/86 (1.2%)
12/86 (14.0%)
10/86 (11.6%)

(44/44)
11/44 (25.0%)

(42/42)
15/42 (35.7%)

(86/86)
26/86 (30.2%)

7/44 (15.9%)
12/44 (27.3%)

4/42 (9.5%)
8/42 (19.0%)

11/86 (12.8%)
20/86 (23.3%)

7/44 (15.9%)
7/44 (15.9%)

7/42 (16.7%)
8/42 (19.0%)

14/86 (16.3%)
15/86 (17.4%)

5.18 (± 1.57) (44/44)

4.67 (± 1.57) (42/42)

4.93 (± 1.59) (86/86)

SYS (SD)
DIA (SD)
Pb BL (µg/dL) (SD)

Hispanic
Latino
Mexican
Mexican American
White
Two or more ethnicities
Mother's Education Level
Less than High School
Diploma
High School Diploma
Completed some college or
technical training
Bachelor's Degree
More than Bachelor's Degree
Family Size (SD)
Household Annual Income
(SD)

$48,678 (± 59,980) (36/44)

a

$ 45,337 (± 50,545) (35/42)

$47,031 (± 55,159) (71/86)

b
Children did not want to be measured or they had a physical disability that prevented proper measurement. Children were too
c
young for BMI interpretation. Children did not stay still for accurate blood pressure readings.
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Table 6
Clinical and Demographic Characteristics of Children at Time 3, N = 29
Variable

Time 3
M (n = 14) (48.3%)

Age (SD)
a

Weight lbs. (SD)
a

Height in. (SD)
a

W/H Ratio (SD)

F (n = 15) (51.7%)

T (n = 29)

8.86 (± 2.61)

9.21 (± 3.77)

9.04 (± 3.21)

73.06 (± 40.23) (14/14)

86.13 (± 55.94) (14/15)

79.59 (± 48.27) (28/29)

52.43 (± 6.71) (14/14)

52.29 (± 9.44) (14/15)

52.36 (± 8.04) (28/29)

0.88 (± 0.05) (14/14)

0.88 (± 0.06) (14/15)

0.88 (± 0.05) (28/29)

BMIb (SD)

17.66 (± 4.54) (14/14)

19.93 (± 6.47) (14/15)

18.79 (± 5.60) (28/29)

SYSc (SD)

111.21 (± 16.59) (14/14)

107.86 (± 15.92) (14/15)

109.54 (± 16.05) (28/29)

65.00 (± 8.64) (14/14)

62.64 (± 10.92) (14/15)

63.82 (± 9.73) (28/29)

c

DIA (SD)
Pb BL (µg/dL) (SD)

1.14 (± 1.13) (14/14)

1.37 (± 1.55) (15/15)

1.26 (± 1.26) (29/29)

Min.
Max.
25 percentile
Median
75 percentile
Children's Ethnicity

0.02
4.10
0.85
1.00
1.58
(14/14)

0.03
6.30
0.40
1.00
1.50
(15/15)

0.02
6.30
0.33
1.00
1.45
(29/29)

Hispanic
Latino
Mexican
Mexican American
African American
Two or more ethnicities

4/14 (28.6%)
3/14 (2.4%)
2/14 (14.3%)
0/14 (0.0%)
1/14 (7.1%)
4/14 (28.6%)

5/15 (33.3%)
2/15 (13.3%)
4/15 (26.7%)
2/15 (13.3%)
0/15 (0.0%)
2/15 (13.3%)

9/29 (31.0%)
5/29 (17.2%)
6/29 (20.7%)
2/29 (6.9%)
1/29 (3.4%)
6/29 (20.7%)

(14/14)
5/14 (35.7%)
3/14 (24.4%)
2/14 (14.3%)
0/14 (0.0%)
1/14 (7.1%)
3/14 (21.4%)

(15/15)
5/15 (33.3%)
2/15 (13.3%)
5/15 (33.3%)
1/15 (6.7%)
2/15 (13.3%)
0/15 (0.0%)

(29/29)
10/29 (34.5%)
5/29 (17.2%)
7/29 (24.1%)
1/29 (3.4%)
3/29 (10.3%)
3/29 (10.3%)

(14/14)
4/14 (28.6%)
1/14 (7.1%)
4/14 (28.6%)

(15/15)
8/15 (53.3%)
2/15 (13.3%)
4/15 (26.7%)

(29/29)
12/29 (41.4%)
3/29 (10.3%)
8/29 (27.6%)

4/14 (28.6%)
1/14 (7.1%)

1/15 (6.7%)
0/15 (0.0%)

5/29 (17.2%)
1/29 (3.4%)

4.71 (±1.34) (14/14)

4.43 (±1.11) (15/15)

4.52 (± 1.21) (29/29)

$41,695 (± 47,032) (14/17)

$21,591 (± 21,501) (17/18)

$30,436 (± 32,338) (25/29)

Mother's Ethnicity
Hispanic
Latino
Mexican
Mexican American
White
Two or more ethnicities
Mother's Education Level
Less than High School Diploma
High School Diploma
Completed some college or
technical training
Bachelor's Degree
More than Bachelor's Degree
Family Size (SD)
Household Annual Income
(SD)
a

b
Children did not want to be measured or they had a physical disability that prevented proper measurement. Children were too
c
young for BMI interpretation. Children did not stay still for accurate blood pressure readings.
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poverty level. Males but females remained overweight, and males and females blood pressures
remained within in normal ranges. In summary, there were no major changes in the
demographic and clinical characteristics of the dataset including N =206 as compared to the
dataset including N =193, and the dataset with N = 193 was used for all subsequent analyses.
In the N= 193 dataset, a large percentage of children, 71/193 (36.8%), lived in the 79902
and 79905 zip codes (see Table 7). The median built year of homes where children resided was
1969, ranging between 1900 and 2016 (also see Table 7). Homes built before 1986 may still
contain lead-based paint even though the selling of lead-based paint in the U.S. was banned in
1978 because lead-based paint if stored correctly, could last up to 10 years. A total of 136/193
(70.5%) of children lived in a home built before 1986. Also, living near industries may influence
child BLLs. In this sample, 121/193 (62.7%) children lived near an industry.
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Table 7
Home Characteristics of Children, N = 193
Variable

M (n = 91)

F (n = 102)

Total

Home Built Year
Min.
Max.
25th percentile
Median
75th percentile

1900
2016
1937
1962
1998

1900
2016
1950
1971
1998

1900
2016
1947
1969
1998

Home Built Before 1986

66/91 (72.5%)

70/102 (68.6%)

136/193 (70.5%)

Living Near Industry

60/91 (65.9%)

61/102 (59.8%)

121/193 (62.7%)

79836
79849
79901
79902
79903
79904
79905
79907

0/91 (0.0%)
4/91 (4.4%)
4/91 (4.4%)
20/91 (22.0%)
4/91 (4.4%)
1/91 (1.1%)
24/91 (26.4%)
6/91 (6.6%)

3/102 (2.9%)
1/102 (1.1%)
6/102 (5.9%)
22/102 (21.6%)
1/102 (1.1%)
1/102 (1.1%)
25/102 (24.5%)
11/102 (10.8%)

3/193 (1.6%)
5/193 (2.6%)
10/193 (5.2%)
42/193 (21.8%)
5/193 (2.6%)
2/193 (1.0%)
49/193 (25.4%)
17/193 (8.8%)

79912
79915
79924
79925

3/91 (3.3%)
3/91 (3.3%)
10/91 (11.0%)
1/91 (1.1%)

3/102 (2.9%)
2/102 (2.0%)
7/102 (6.9%)
4/102 (3.9%)

6/193 (3.1%)
5/193 (2.6%)
17/193 (8.8%)
5/193 (2.6%)

79928
79930

3/91 (3.3%)
1/91 (1.1%)

0/102 (0.0%)
2/102 (2.0%)

3/193 (1.6%)
3/193 (1.6%)

79932
79934
79935
79936
79938
88063

1/91 (1.1%)
1/91 (1.1%)
0/91 (0.0%)
3/91 (3.3%)
1/91 (1.1%)
1/91 (1.1%)

1/102 (1.1%)
0/102 (0.0%)
1/102 (1.1%)
5/102 (4.9%)
6/102 (5.9%)
1/102 (1.1%)

2/193 (1.0%)
1/193 (0.5%)
1/193 (0.5%)
8/193 (4.1%)
7/193 (3.6%)
2/193 (1.0%)

Zip Code

3.3 Characterization of Child BLLs
Children’s BLLs are generally non-normally distributed and display a positive skew.
Based on the histogram shape and the skewness metric (4.94) children’s BLLs at Time 1 test
(N=206) were not normally distributed. Non-parametric statistical analyses of demographic
variables were conducted from this point forward. The median BLL for all children was 1.2
µg/dL and was the same in males and females (see Table 1). A Mann-Whitney rank-sum test
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determined that there was no statistical significant difference in medians of BLLs between males
(n=97) and females (n = 109), z = .214, p = .830, r = .015 (see Table 1). For both male and
female children the mean BLL of 2.13 µg/dL (SD = 4.25) and 2.65 (SD = 4.72) respectively,
were below the CDC elevated level of ≥ 5 µg/dL (Advisory Committee on Childhood Lead
Poisoning Prevention, 2012). A total of 18/206 (8.73%) children had elevated BLLs at Time 1.
A one-sample binomial test determined that the percentage of children with BLLs exceeding the
CDC elevate level at Time 1 (8.73%) was higher than the expected national percentage of 2.5%
children ages 1 to 5 with elevated BLLs, p < .001.
The percentage of children with BLLs ≥ 5 µg/dL was notably greater at Time 2 with
10/95 (10.5%) as compared to Time 1, 18/206 ( 8.7%), and Time 3, 1/35 (2.9%). Among
children who completed Time 1 and Time 2 tests (n = 95), the percentage of children with low
dangerous BLLs ≥ 5 µg/dL were 11/95 (11.6%) and 10/95 (10.5 %) respectively. One-sample
binomial tests determined that both percentages of children with BLLs ≥ 5µg/dL at Time 1 and
Time 2 among children with two time points exceeded the expected national percentage of 2.5%
with elevated BLLs, at Time 1, p < .001 and Time 2, p < .001.
Among children who completed Time 1, Time 2, and Time 3 tests (n = 35), the
percentage of children with BLLs ≥ 5 µg/dL were 3/35 (8.6%), 5/35 (14.3%), and 1/35, (2.9%)
respectively. Again, two out of three of these proportions far exceeded the expected national
percentage of 2.5% of children ages 1 to 5 with elevated BLLs.
Among children with two time points (N = 95), the median difference of BLLs for all
children and male and female children was 1.15 µg/dL. A Mann-Whitney rank-sum test
determined that there was no statistically significant difference in the median difference of BLLs
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by male children (Mdndiff = 1.15) and female children (Mdndiff = 1.15), U = 1105, p = .870 , r =
.017 (see Table 10).
Among children with three time points, the mean difference of BLLs of all children
decreased over time from 5.10 to 3.70 to 2.6 µg/dL between Time 1 and Time 2, Time 2 and
Time 3, and Time 1 and Time 3 respectively (see Tables 11 and 12). The median difference of
BLLs between Time 1 and Time 2 was 1.10 µg/dL, between Time 2 and Time 3 was 0.90 µg/dL,
and between Time 1 and Time 3 was 0.90 µg/dL.
In summary, children in our study had higher percentages of elevated BLLs compared to
the expected national percentage of 2.5% for children ages 1 to 5 years at all three time test
points. Whether BLLs differed predictably by Time was tested in subsequent analyses.
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Table 8
Cumulative Frequencies of Children’s BLLs at Time 1, Time 2, and Time 3, N = 206
Pb intervals
(µg/dL)

0.000-0.499
0.500-0.999
1.000-1.499
1.500-1.999
2.000-2.499
2.500-2.999
3.000-3.499
3.500-3.999
4.000-4.499
4.500-4.999
5.000-5.499a
5.500-5.999
6.000-6.499
8.000-8.499
8.500-8.999
9.000-9.499
9.500-9.999
10.000-10.499b
12.000-12.499
13.500-13.999
15.000-15.499
15.500-15.999
16.500-16.999
17.000-17.499
20.000-20.499
20.500-20.999
21.000-21.499
22.000-22.499
26.500-26.999
27.000-27.499
27.500-27.999
33.500-33.999
34.000-34.499
35.500-35.999
36.000-36.499
38.000-38.499
Total
a
b

Freq
33
47
46
24
17
5
6
3
4
3
2
4
1
1
1
0
0
0
2
0
1
0
0
1
1
0
1
1
0
1
0
0
1
0
0
0
206

Time 1 (n=206)
Freq
C.
%
Freq
16.0
22.8
22.3
11.7
8.3
2.4
2.9
1.5
1.9
1.5
1.0
1.9
0.5
0.5
0.5
0.0
0.0
0.0
1.0
0.0
0.5
0.0
0.0
0.5
0.5
0.0
0.5
0.5
0.0
0.5
0.0
0.0
0.5
0.0
0.0
0.0
100.0

33
80
126
150
167
172
178
181
185
188
190
194
195
196
197
197
197
197
199
199
200
200
200
201
202
202
203
204
204
205
205
205
206
206
206
206
206

C.
Freq
%
16.0
38.8
61.2
72.8
81.1
83.5
86.4
87.9
89.8
91.3
92.2
94.2
94.7
95.1
95.6
95.6
95.6
95.6
96.6
96.6
97.1
97.1
97.1
97.6
98.1
98.1
98.5
99.0
99.0
99.5
99.5
99.5
100.0
100.0
100.0
100.0
100.0

Freq
8
15
30
15
2
6
3
3
1
2
3
1
0
0
0
1
1
0
0
0
0
0
0
0
0
0
1
0
0
0
1
0
1
0
1
0
95

≥ 5.0 µg/dL CDC BLL guideline for intervention
BLLs outside the study focus (> 10 µg/dL)
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Time 2 (n=95)
Freq
C.
%
Freq
8.4
15.8
31.6
15.8
2.1
6.3
3.2
3.2
1.1
2.1
3.2
1.1
0.0
0.0
0.0
1.1
1.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
1.1
0.0
0.0
0.0
1.1
0.0
1.1
0.0
1.1
0.0
100.0

8
23
53
68
70
76
79
82
83
85
88
89
89
89
89
90
91
91
91
91
91
91
91
91
91
91
92
92
92
92
93
93
94
94
95
95
95

C.
Freq
%
8.4
24.2
55.8
71.6
73.7
80.0
83.2
86.3
87.4
89.5
92.6
93.7
93.7
93.7
93.7
94.7
95.8
95.8
95.8
95.8
95.8
95.8
95.8
95.8
95.8
95.8
96.8
96.8
96.8
96.8
97.9
97.9
98.9
98.9
100.0
100.0
100.0

Freq
12
6
10
1
3
1
0
0
1
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
35

Time 3 (n=35)
Freq
C.
%
Freq
34.3
17.1
28.6
2.9
8.6
2.9
0.0
0.0
2.9
0.0
0.0
0.0
2.9
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
100.0

12
18
28
29
32
33
33
33
34
34
34
34
35
35
35
35
35
35
35
35
35
35
35
35
35
35
35
35
35
35
35
35
35
35
35
35
35

C.
Freq
%
34.3
51.4
80.0
82.9
91.4
94.3
94.3
94.3
97.1
97.1
97.1
97.1
100.0
100.0
100.0
100.0
100.0
100.0
100.0
100.0
100.0
100.0
100.0
100.0
100.0
100.0
100.0
100.0
100.0
100.0
100.0
100.0
100.0
100.0
100.0
100.0
100.0

Table 9
Characteristics of BLLs for Children with Two Test Points, N = 95
Variable
Males
(49/95)

Time 1
Females
(46/95)

Total

Males

Time 2
Females

Total

M

2.40

3.14

2.75

4.26

1.70

3.06

SD
Min.

± 5.85
0.05

± 5.18
0.00

± 5.32
0.00

± 8.06
0.30

± 1.96
0.30

± 6.05
0.30

Max.

38.70

22.60

38.70

36.40

9.80

36.40

25 percentile

0.80

0.40

0.70

1.20

0.80

1.00

Median

1.20

1.25

1.20

1.60

1.20

1.30

75th percentile

2.20

2.80

2.30

3.10

1.80

2.60

th

Table 10
Characteristics of BLLs Change for Children with Two Time Points, N = 95
Between Time 1 and Time 2
Variable

Male

n

Female

Total

49/95

46/95

95/95

4.43

2.99

3.73

± 8.96

± 4.97

± 7.31

Min. diff

0.10

0.00

0.00

Max .diff

37.40

21.60

37.40

25 percentile

0.60

0.70

0.70

Median diff.

1.15

1.15

1.15

3.05

3.45

3.10

0%

0/49 (0.0%)

1/46 (2.2%)

1/95 (1.1%)

< 50 %

11/49 (22.4%)

12/46 (26.1%)

23/95 (25.2%)

≥ 50 %

38/45 (77.5%)

33/46 (71.7%)

71/95 (74.7%)

Mdiff
SDdiff

th

th

75 percentile
% Change
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Table 11
Characteristics of BLLs for Children with Three Test Points, N = 35
Variable

Time 1

Time 2

Females
(18/35)

M

Males
(17/35
)
1.54

4.69

3.16

6.53

1.87

SD

± 0.84

± 7.28

± 5.42

± 10.97

Min.

0.10

0.30

0.10

Max.

3.40

22.60

25 percentile

0.95

Median
75 percentile

th

th

Total

Males

Females

Time 3
Total

Male
s

Females

Total

4.13

1.01

1.23

1.13

± 2.26

± 8.05

± 1.43

± 1.26

0.40

0.30

0.30

±
1.07
0.02

0.03

0.02

22.50

36.40

9.80

36.40

4.10

6.30

6.30

0.93

1.00

0.95

0.68

0.80

0.20

0.38

0.30

1.30

1.75

1.60

1.70

1.20

1.30

0.60

1.00

0.90

2.25

2.90

2.30

4.35

2.03

2.70

1.40

1.43

1.40

Table 12
Characteristics of BLLs Change for Children with Three Time Points, N = 35
Variable

Time 1 and Time 2

Time 2 and Time 3

Time 1 and Time 3

Male
17/17

Female
18/18

Total
35/35

Male
17/17

Female
18/18

Total
35/35

Male
17/17

Female
18/18

Total
35/35

5.55

4.67

5.10

6.10

1.43

3.70

1.11

4.30

2.76

± 10.35

± 7.18

± 8.74

± 11.00

± 2.06

± 8.04

± 0.95

± 7.16

± 5.36

Min. diff

0.10

0.10

0.10

0.00

0.00

0.00

0.06

0.10

0.06

Max. diff

34.20

21.60

34.20

36.00

8.30

36.00

3.10

22.30

22.30

25 percentile

0.50

0.68

0.60

0.45

0.45

0.50

0.95

0.93

0.40

Median

0.90

1.25

1.10

1.20

0.70

0.90

1.30

1.75

0.90

3.05

4.90

3.80

4.10

1.38

2.10

2.25

2.90

2.17

0/17
(0.0%)
6/17
(35.3%)

0/17
(0.0%)
5/18
(27.8%)

0/35
(0.0%)
11/35
(31.4%)

1/17
(5.9%)
5/17
(29.4%)

1/18
(5.6%)
5/18
(27.8%)

2/35
(5.7%)
10/35
(28.6%)

0/17
(0.0%)
5/17
(29.4%)

0/18
(0.0%)
3/18
(16.7%)

0/35
(0.0%)
8/35
(22.9%)

11/17
(64.7%)

13/18
(72.2%)

24/35
(68.6%)

11/17
(64.7%)

12/18
(66.7%)

23/35
(65.7%)

12/17
(70.6%)

15/18
(83.3%)

27/35
(77.1%)

n
Mdiff
SDdiff

th

th

75 percentile
% Change
0%
< 50 %
≥ 50 %
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The primary goal of this study was to examine the stability (variability) of child BLLs in
the lower ranges of exposure, that is, below 10 µg/dL in the dataset including N = 193.
Histograms and the skewness metric (2.18) showed that children’s BLLs at Time 1 test (N = 193)
were not normally distributed. The median BLL for all children of 1.2 µg/dL in this sample (N =
193) was the same as the sample that included BLL values greater than 10 µg/dL. The median
BLL for males was 1.20 and for females was 1.15 (see Tables 1 and 4). A Mann-Whitney ranksum test determined that there was no statistically significant difference in medians of BLLs
between males (n = 44) and females (n = 42), U = 753, p = .140, r = .106 (see Table 4). For both
male and female children, the mean BLL of 1.58 µg/dL (SD = 1.45) and 1.52 (SD = 1.47)
respectively, were below the CDC elevated level of ≥ 5 µg/dL (Advisory Committee on
Childhood Lead Poisoning Prevention, 2012). A total of 9/193 (4.7%) children had elevated
BLLs (≥ 5 µg/dL) at Time1. A one-sample binomial test determined that the percentage of
children with BLLs exceeding the CDC elevate level at Time 1 (4.7%) was higher than the
expected national percentage of 2.5% children ages 1 to 5 with elevated BLLs, p < .001.
The percentage of children with BLLs ≥ 5 µg/dL was greater at Time 2 with 6/86 (7.0%)
as compared to Time 1, 9/193 (4.7%), and Time 3, 1/29 (3.4%). Among children who completed
Time 1 and Time 2 tests (n = 86), the percentage of children with BLLs ≥ 5 µg/dL was 7/86
(8.1%) and 6/86 (7.0 %) respectively. One-sample binomial tests determined that both
percentages of children with BLLs ≥5 µg/dL at Time 1 and Time 2 among children with two
time points exceeded the expected national percentage of 2.5% with elevated BLLs, at Time 1, p
< .001 and Time 2, p < .001.
Among children who completed Time 1, Time 2, and Time 3 tests (n = 29), the
percentage of children with BLLs ≥ 5 µg/dL was 0/29 (0.0%), 2/29 (6.9%), and 1/29, (3.4%)
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respectively. Again, two out of three of these proportions far exceeded the expected national
percentage of 2.5% of children ages 1 to 5 with elevated BLLs. One-sample binomial tests
determined that both percentages of children with BLLs ≥ 5µg/dL at Time 2 and Time 3 among
children with three time points exceeded the expected national percentage of children with
elevated BLLs, at Time 1, p < .001 and Time 2, p < .001.
Among children with two time points (N = 86), the median difference of BLLs for all
children was 1.05, for males was 1.00 and for females was 1.10. A Mann-Whitney rank-sum test
determined that there was no statistical significant difference in the median difference of BLLs
by male children (Mdndiff = 1.00) and female children (Mdndiff = 1.10), U = 920, p = .978, r =
.038 (See Table 14).
Among children with three time points, the mean difference of BLLs of all children
decreased over time from 1.40 to 1.30 to 1.00 µg/dL between Time 1 and Time 2, Time 2 and
Time 3, and Time 1 and Time 3 respectively (see Tables 15 and 16). Section 3.5 will test the
change of BLLs over time of this sample (N = 29) and a sample with multiple imputations to
equal a sample of N = 193 children with three time points using individual growth curve
modeling.
In summary, among N = 193 children, consistently higher percentages of children with
elevated BLLs as compared to the national expected percentage of 2.5% were found. Also, there
were no significant differences in mean differences overtime for all children and between males
and females.
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3.4. Change in Children’s BLLs Over Time
The average time length between Time 1 and Time 2 for children with two BLL time
points (N = 86) was 6.3 months (SD = 3.46). The average time length between Time 1 and Time
2 for children with three BLL time points (N = 29) was 3.0 months (SD = 1.31). The average
time length between Time 1 and Time 3 for the same children (N=29) was 10.14 months (SD =
3.11).
In order to consider the changes in BLL from a descriptive (not inferential) perspective,
for each child, the percentage of change in BLLs between test points was calculated by dividing
the absolute BLL difference of two time points over the initial compared BLL value and then by
multiplying the result by 100. The percentages were then categorized into three categories no
change, less than 50% change, and equal to or greater than 50% change, and proportions for each
category were calculated (see Tables 13 and 15).
Among children with two test points (N = 86), only two children had no change in BLLs
between Time 1 and Time 2, 23/86 (26.7%) had BLLs with less than 50% change, and 62/86
(72.1%) had BLLs with 50% or more change. There were slight differences in the proportions of
BLL change between male and female children. A total of 33/44 (75.0%) of males and 29/42
(69.0%) of females had a BLL with 50% or more change between Time 1 and Time 2 (see Table
14). A Fisher Exact test determined that there were no differences in proportions of BLL change
between males and females, X2 (2, N = 86) = 1.73, p = .710.
Among children with three test points (N = 29), 11/29 (37.9%) had BLLs with less than
50% change and 18/29 (62.1%) had BLLs with 50% or more change between Time 1 and Time
2. For the same children, 2/29 (6.9%) had no change in BLLs, 10/29 (34.5%) had BLLs with
less than 50% change, and 17/29 (58.6%) had BLLs with 50% or more change between Time 2
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and Time 3. Between Time 1 and Time 3, 8/29 (27.6%) had BLLs with less than 50% change,
and 21/29 (72.4%) had BLLs with 50% or more change (see Table 16). A Likelihood Ratio test
determined that there were no differences in the proportions of BLL change between Time 1 and
Time 2 and between Time 2 and Time 3, X2 (2, N = 29) = 2.207, p = .332. Another Likelihood
Ratio test determined that there were no differences in proportions of BLL change between Time
1 and Time 3 by sex, X2 (1, N = 29) = .901, p = .343.
Figures 3 and 4 are linear graphs showing BLLs overtime for children with two time
points (N = 86), and children with three time points (N = 29). In both graphs, the majority of
BLLs change between time points but there is no clear direction of constant increases or
decreases of BLLs overtime (see Figures 3 and 4).
Table 13
Characteristics of BLLs for Children with Two Test Points, N = 86
Variable
Males
(44/86)

Time 1
Females
(42/86)

Total

Males

Time 2
Females

Total

M

1.59

1.69

1.64

1.98

1.88

1.93

SD
Min.

± 1.48
0.05

± 1.85
0.00

± 1.66
0.00

± 1.40
0.30

± 2.02
0.30

± 1.72
0.30

Max.

6.30

8.70

8.70

5.50

9.80

9.80

25 percentile

0.80

0.38

0.60

1.13

0.90

1.00

Median

1.05

1.15

1.10

1.55

1.20

1.30

75th percentile

2.08

1.98

1.98

2.60

1.83

2.23

th
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Table 14
Characteristics of BLLs Change for Children with Two Time Points, N = 86
Between Time 1 and Time 2
Variable

Male

n

Female

Total

44/44

42/42

86/86

1.55

1.59

1.57

± 1.40

± 1.63

± 1.51

Min. diff

0.10

0.00

0.00

Max .diff

5.60

8.20

8.20

25 percentile

0.60

0.70

0.60

Median

1.00

1.10

1.05

75 percentile

1.93

1.65

1.78

0%

0/44 (0.0%)

1/42 (2.4%)

1/86 (1.2%)

< 50 %

11/44 (25.0%)

12/42 (28.6%)

23/86 (26.7%)

≥ 50 %

33/44 (75.0%)

29/42 (69.0%)

62/86 (72.1%)

Mdiff
SDdiff

% Change

Table 15
Characteristics of BLLs for Children with Three Test Points, N = 29
Variable

Time 1

Time 2

Females
(15/29)

M

1.39

1.58

1.49

1.77

2.11

1.95

1.14

1.37

1.26

SD

± 0.72

± 0.95

± 0.84

± 1.29

± 2.41

± 1.93

± 1.14

± 1.55

± 1.35

Min.

0.10

0.30

0.10

0.40

0.30

0.30

0.02

0.03

0.02

Max.

2.50

4.10

4.10

5.40

9.80

9.80

4.10

6.30

6.30

25 percentile

0.90

0.70

0.90

0.88

0.80

0.85

0.09

0.40

0.30

Median

1.25

1.60

1.40

1.50

1.20

1.30

1.00

1.00

1.00

75 percentile

2.23

1.90

2.05

2.00

2.70

2.20

1.58

1.50

1.45

th

th

Total

Males

Females

Time 3

Males
(14/29)

90

Total

Males

Females

Total

Table 16
Characteristics of BLLs Change for Children with Three Time Points, N = 29
Variable

Time 1 and Time 2

Time 2 and Time 3

Time 1 and Time 3

Male
14/14

Female
15/15

Total
29/29

Male
14/14

Female
15/15

Total
29/29

Male
14/14

Female
15/15

Total
29/29

1.05

1.68

1.38

1.33

1.61

1.48

0.95

1.26

1.11

± 1.07

± 2.05

± 1.65

± 1.32

± 2.22

± 1.81

± 0.85

± 1.16

± 1.02

Min. diff

0.10

0.10

0.10

0.00

0.00

0.00

0.06

0.10

0.06

Max. diff

4.40

8.20

8.20

4.50

8.30

8.30

2.90

4.10

4.10

25 percentile

0.40

0.60

0.55

0.38

0.50

0.45

0.20

0.40

0.35

Median

0.75

1.10

0.90

0.93

0.80

0.90

0.80

0.90

0.80

75 percentile

1.33

1.30

1.30

1.86

1.70

1.74

1.49

1.87

1.59

0/14
(0.0%)
6/14
(42.9%)

0/15
(0.0%)
5/15
(33.3%)

0/29
(0.0%)
11/29
(37.9%)

1/14
(7.1%)
5/14
(35.7%)

1/15
(6.7%)
5/15
(33.3%)

2/29
(6.9%)
10/29
(34.5%)

0/14
(0.0%)
5/14
(35.7%)

0/15
(0.0%)
3/15
(20.0%)

0/29
(0.0%)
8/29
(27.6%)

8/14
(57.1%)

10/15
(66.7%)

18/29
(62.1%)

8/14
(57.1%)

9/15
(60.0%)

17/29
(58.6%)

9/14
(64.3%)

12/15
(80.0%)

21/29
(72.4%)

n
Mdiff
SDdiff

% Change
0%
< 50 %
≥ 50 %
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Figure 3
BLLs Overtime for Children with Two Time Points, N = 86
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Figure 4
BLLs Overtime for Children with Three Time Points, N = 29
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3.5 Linear Mixed Models
Given the non-normal distribution of child BLLs, Individual Growth Curve models were
used because they do not assume normally distributed variables. The main analyses to assess
BLL change over time followed steps recommended by Shek and Ma (2011) in conducting
longitudinal data analyses using Individual Growth Curve models in SPSS. The steps included
running at least two base models (Level 1 and Level 2 models) before running additional models
with higher-order change trajectories with TIME, and before adding predictors to the model with
TIME. Level 1 model is an unconditional mean model, also called the intraindividual change
model of repeated measures over time and uses no predictors. This model was used to assess the
amount of change in BLL within children (intraindividual differences) from all timepoints.
Using the results from the Level 1 model, the Intraclass Correlation Coefficient (ICC) was then
calculated to estimate the amount of variability across children (interindividual differences). If
the intraclass correlation coefficient is less than 0.25, the variability is overwhelming due to
intraindividual differences and it is assumed that the Individual Growth Curve models are not
likely to perform better than a traditional ANOVA.
Level 2 model is a baseline growth curve model and assesses significant variations in
individual trajectory changes of BLLs by time. If there is no significant interindividual
difference in change over time then it is recommended to not do further higher-order change
trajectories with TIME. Level 1 and Level 2 models were conducted on the database with
children with three time points (N = 29) and the database with imputed missing values (N = 193).
Estimated parameters of multiple imputation datasets in SPSS exclude F statistics and overall pvalue. Pooled estimates of fixed effects were given in SPSS for N =193 dataset.
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Level 1 model analysis for the original children with three time points (N = 29) showed
that the variability within children was statistically significant, F (1, 29) = 95.69, p < .001. The
mean BLL was 1.57 µg/dL (t = 9.78, p < .001, 95% CI for the difference was 1.24 to 1.89). The
calculated Intraclass Correlation Coefficient was extremely low (0.03) and estimated that only
3% of all total variation in BLLs was due to between-child (interindividual) differences. In other
words, 97% of all total variation in BLLs was attributable to within child (intraindividual)
differences. As explained by Shek & Ma (2010), an Individual Growth Curve for this sample
will not perform better than a traditional ANOVA and, it was also noted that the sample size
(N=29) was likely too small to calculate a valid Individual Growth Curve model. For these
reasons, the Level 1 model was re-run using the imputed dataset (N = 193). The results are
shown in Table 17.
Level 1 model analysis for the multiple imputation dataset (N = 193) for three time points
showed that the variability within children was (again) statistically significant, p < .001 (only the
intercept is tested for significance as shown in Table 17). The calculated Intraclass Correlation
Coefficient increased to 0.32 as compared to the Level 1 model of the previous dataset (0.03, N=
29). Thus, approximately 32% of all total variation in BLLs was due to between-child
(interindividual) differences and approximately 68% of all total variation in BLLs was
attributable to within child (intraindividual) differences. Thus, the Intraclass Correlation
Coefficient using the imputed dataset met the 0.25 threshold criteria suggested by Shek and Ma
(2010), and a Level 2 Individual Growth Curve model with TIME was calculated.
3.5.1. Managing Lack of Model Convergence
Level 2 model with TIME as the only predictor produced the model did not converge.
(“Iteration was terminated…” error, SPSS). Before proceeding to interpret the results of this
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model, possible coding and/or data issues were considered and ruled out including: 1) the
number of imputations used; or 2) broadly differing parameter ranges preventing model
convergence; 3) the covariance structure specified did not fit the data; or 4) the model could not
fit both random intercepts and random slopes (requiring that the model be calculated only with
random slopes).
Before creating a new imputed dataset with more iterations (to rule out the first reason for
the output error), two additional models with TIME coded as a scaled variable instead of a
nominal variable, (with levels re-codded to 5, 10, and 15) were run. These two test models failed
to correct convergence error. Then the original model was run with the restricted maximum
likelihood (REML) method to estimate the covariance matrix instead of the maximum likelihood
(LM) method, but this model also failed to correct the convergence error.
If covariance structure error is not corrected after trying different covariance structure
methods, it can be assumed that the predictor variable, in this case, TIME, does not fit the
covariance structure between the intercept and slope, and the relationship of TIME with BLLs
cannot be examined from this model (Heck, Thomas, & Tabata, 2011). (Simply stated, TIME is
not a predictor of BLL.)
Another model was tested that excluded random intercepts for TIME. With this
adjustment, the model converged. Thus, the converged model using TIME as the predictor and
testing only random slopes (and not random intercepts) was interpreted and showed that TIME
was not a significant predictor in the dataset with N =29, and in the dataset multiple imputation
dataset of N= 193 (the results are shown in Table 17). In other words, TIME as a random effect
did not predict increases or decreases in children’s BLLs. Based on these findings, TIME was
not included as a random effect in subsequent Individual Growth Curve models.
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Given that TIME was not a significant predictor of child BLLs, other logical explanations
of variability over time were: 1) BLLs of children were varying due to factors other than TIME;
and 2) children do not become less vulnerable to lead exposure as they get older. Three factors
that may explain the BLL variability within children were whether the child was living below the
2020 poverty guideline (POVERTY), lived in a home built before 1986 (OLDER_HOME), or
lived near an industry (INDUSTRY). All three predictor variables were binary variables and
coded -1 = no, 1 = yes.
Additional linear mixed models analyzed each of these factors looking at the interaction
of each factor, controlling for AGE and SEX as fixed effects. The models, as recommended by
Shek and Ma (2010), Heck, Thomas, & Tabata (2011), and SPSS (2002), followed mixed-effects
models for longitudinal data with SUBJECTS option to model each subject’s set of random
parameters for the repeated effect of TIME and with COVTYPE (UN) option to specify
unstructured covariance matrix of the random parameters within one subject, (see syntax for all
models in Appendix C). The variable TIME was added in the mixed-effect models as a repeated
measure to model the possible correlation of the residual errors (the difference between the
observed value and the estimated value) with each child.
Table 17 summarizes estimates of fixed effects for the models predicting the influence of
TIME, AGE, and SEX, on child BLLs. The Level 2 model with AGE and SEX as main effects
for N = 29 and N = 193 datasets were not significant predictors of child BLLs. The interaction of
AGE and SEX for N = 29 dataset was not significant (Est. = -0.027, SE = 0.041, t = -0.66, and p
= .514) but for the N = 193 multiple imputation dataset, the interaction was significant (Est. =
0.056, SE = 0.023, t = 2.59, p = .010). Since the AGE and SEX interaction predicted child
BLLs, these predictors were included in models with a third predictor.
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The significant AGE and SEX interaction that was observed in the multiple imputation
dataset (N =193), was graphed grouping cases by sex. Each iteration (n =20) was graphed, and
in every graph, we see that females had higher mean BLLs during pre- and adolescent years than
males during the same ages. Graph of the 20th iteration is shown on Figure 5.

Note: All interactions showed same line patterns. This graph is based on the 20th iteration of the multiple
imputation set.

Figure 5
Line Graph of the Interaction of Age by Sex in Multiple Dataset, N = 193
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Table 18 summarizes estimates of fixed effects for the models predicting the influence of
living below the 2020 poverty threshold (POVERTY) on child BLLs, controlling for AGE and
SEX. In both datasets, POVERTY, as a main effect, was not a significant predictor of child
BLLs. The AGE and SEX interaction remained significant of child BLLs in the multiple
imputation dataset (N = 193).
Table 19 summarized estimates of fixed effects for the model predicting the influence of
living in home built before 1986 (OLDER_HOME) on child BLLs, controlling for AGE and
SEX. In both datasets, OLDER_HOME, as a main effect, was not a significant predictor of child
BLLs. Like the previous models AGE and SEX interaction remained significant in the multiple
imputation dataset (N = 193).
Table 20 summarized estimates of fixed effects for the model predicting the influence of
living near industry (INDUSTRY) on child BLLs, controlling for AGE and SEX. In the N = 29
dataset, INDUSTRY, as a main effect was not a predictor of child BLLs (Est. = 0.16, SE = 0.12,
t = 1.31, p = .200) but it was a significant predictor of child BLLs in the multiple imputation
dataset N = 193 (Est. = 0.22, SE = 0.093, t = 2.41, p = .026). The estimate suggested that child
BLLs increased on average 0.22 µg/dL when living near an industry. The 95% Confidence
Interval (CI) for INDUSTRY was between 0.041 and 0.41 suggesting that, while significant, this
estimate was not very specific. The AGE and SEX interaction remained significant in the
multiple imputation dataset. The interaction between AGE, SEX, and INDUSTRY was not a
significant predictor for child BLLs.
In summary, individual growth curve models were appropriate to use for the imputed
dataset (N = 193). The interaction between sex and age was significant in all models, but neither
sex nor age alone predicted child BLLs. The age and sex interaction was seen in pre- and
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adolescent female children. Of the variables tested, living near industry significantly predicted
child BLLs.
Table 17
Estimates of Fixed Effects for Child BLLs, Time, Age, and Sex.
Estimates of Fixed Effects
Est.

SE

t

Sig.

95% CI
Lower
Upper
bound
bound

RF%

Level 1 Model (N = 29)
Intercept

1.57

0.16

9.78

< .001

1.24

1.89

-

Intercept

1.81

0.11

16.98

< .001

1.60

2.02

0.98

Intercept

1.80

0.39

4.60

< .001

1.32

2.58

-

TIME

-0.12

0.18

-0.62

.535

0.003

0.25

-

Intercept

1.64

0.17

9.38

< .001

1.29

1.98

0.99

TIME

0.087

0.10

0.85

.400

-0.12

0.29

0.98

Intercept

1.50

0.12

12.22

< .001

1.25

1.75

-

AGE

0.057

0.041

1.37

.181

-0.028

0.14

-

SEX

0.097

0.123

0.79

.439

-0.16

0.35

-

SEX*AGE

-0.027

0.041

-0.66

.514

-0.11

0.057

-

Intercept

1.75

0.11

16.03

< .001

1.53

1.97

0.98

AGE

0.006

0.023

0.282

.778

-0.034

0.051

0.99

SEX

-0.12

0.08

-0.14

.890

-0.18

0.15

0.99

SEX *AGE

0.056

0.023

2.59

.010

0.014

0.10

0.99

Level 1 Model (N = 193)

Level 1 Model with TIME (N = 29)

Level 1 Model with TIME (N = 193)

Level 2 Model with SEX & AGE (N = 29)

Level 2 Model with SEX& AGE (N = 193)

Note. Significant p-value at alpha level .05 is highlighted in red.
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Table 18
Estimates of Fixed Effects for Child BLLs and Living Under Poverty Threshold. Controlling for
Sex, and Age.
Estimates of Fixed Effects
Est.

SE

t

Sig.

95% CI
Lower
Upper
bound
bound

RF%

Level 2 Model with AGE, SEX, & POVERTY
(N = 29)
Intercept

1.27

0.29

4.42

< .001

0.68

1.85

-

AGE

0.065

0.091

0.72

.478

-0.12

0.25

-

SEX

0.31

0.29

1.089

.285

-0.27

0.90

-

POVERTY

0.35

0.32

1.10

.282

-0.30

1.00

-

AGE*SEX

0.006

0.091

0.068

.946

-0.18

0.19

-

AGE*POVERTY

-0.035

0.11

-0.33

.741

-0.25

0.18

-

SEX*POVERTY

-0.03

0.32

-0.92

.366

-0.94

0.36

-

AGE*SEX*POVERTY
Level 2 Model with AGE, SEX, & POVERTY
(N = 193)

-0.011

0.11

-0.11

.917

-0.23

0.21

-

Intercept

1.76

0.12

14.89

< .001

1.52

1.99

0.98

AGE

0.011

0.025

0.42

.675

-0.039

0.06

0.98

SEX

0.023

0.093

0.31

.757

-0.15

0.21

0.99

POVERTY

0.034

0.10

0.34

.735

-0.16

0.24

0.99

AGE*SEX

0.065

0.023

2.79

.006

0.019

0.11

0.99

AGE*POVERTY

-0.022

0.024

-0.94

.349

-0.069

0.024

0.99

SEX*POVERTY

-0.05

0.10

-0.5

.619

-0.24

0.14

0.99

AGE*SEX*POVERTY

-0.022

0.024

-0.91

.362

-0.07

0.026

0.99

Note. Significant p-value at alpha level .05 is highlighted in red.
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Table 19
Estimates of Fixed Effects for Child BLLs, and Living in a Home Built Before 1986. Controlling
for Sex, and Age.
Estimates of Fixed Effects
Est.

SE

t

Sig.

95% CI
Lower
Upper
bound
bound

RF%

Level 2 Model with AGE, SEX, &
OLDER_HOME (N = 29)
Intercept

1.57

0.13

11.66

< .001

1.29

1.84

-

AGE

0.040

0.049

0.83

.412

-0.058

0.14

-

SEX

0.079

0.13

0.59

.563

-0.20

0.35

-

OLDER_HOME

-0.12

0.13

-0.92

.367

-0.40

0.15

-

AGE*SEX

0.022

0.049

0.47

.641

-0.076

0.12

-

AGE*OLDER_HOME

0.009

0.049

0.21

.839

-0.89

0.11

-

SEX*OLDER_HOME

0.074

0.13

0.55

.587

-0.2

0.35

-

AGE*SEX*OLDER_HOME
Level 2 Model with AGE, SEX, &
OLDER_HOME (N = 193)

-0.084

0.048

-1.74

.091

-0.18

0.014

-

Intercept

1.74

0.12

14.92

< .001

1.51

1.97

0.08

AGE

0.012

0.027

0.46

.644

-0.04

0.065

0.98

SEX

0.017

0.093

0.19

.853

-0.17

0.20

0.99

OLDER_HOME

0.030

0.097

0.30

.761

-0.16

0.22

0.99

AGE*SEX

0.053

0.024

2.19

.029

0.006

0.10

0.99

AGE*OLDER_HOME

-0.011

0.024

-0.46

.645

-0.059

0.036

0.99

SEX*OLDER_HOME

-0.07

0.093

-0.76

.447

-0.25

0.11

0.99

AGE*SEX*OLDER_HOME

0.008

0.025

0.31

.754

-0.042

0.057

0.99

Note. Significant p-value at alpha level .05 is highlighted in red.
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Table 20
Estimates of Fixed Effects for Child BLLs, and Living Near Industry. Controlling for Sex, and
Age.
Estimates of Fixed Effects
Est.

SE

t

Sig.

95% CI
Lower
Upper
bound
bound

RF%

Level 2 Model with AGE, SEX, & INDUSTRY
(N = 29)
Intercept

1.50

0.12

12.12

< .001

1.25

1.76

-

AGE

0.059

0.04

1.38

.178

-0.03

0.15

-

SEX

0.10

0.12

0.81

.425

-0.15

0.35

-

INDUSTRY

0.16

0.12

1.31

.200

-0.09

0.42

-

AGE*SEX

-0.040

0.04

-0.94

.353

-0.12

0.047

-

AGE*INDUSTRY

-0.024

0.04

-0.56

.583

-0.011

0.064

-

SEX*INDUSTRY

0.079

0.12

0.63

.532

-0.18

0.33

-

AGE*SEX*INDUSTRY
Level 2 Model with AGE, SEX, & INDUSTRY
(N = 193)

-0.021

0.04

-0.49

.629

-0.11

0.066

-

Intercept

1.68

0.11

15.49

< .001

1.47

1.90

0.98

AGE

0.005

0.023

0.19

.847

-0.041

0.050

0.98

SEX

0.008

0.085

0.092

.927

-0.16

0.17

0.99

INDUSTRY

0.22

0.093

2.41

.017

0.041

0.41

0.99

AGE*SEX

0.048

0.021

2.23

.026

0.006

0.090

0.99

AGE*INDUSTRY

-0.017

0.021

-0.78

.435

-0.058

0.025

0.99

SEX*INDUSTRY

-0.045

0.087

-0.058

.602

-0.21

0.12

0.99

AGE*SEX*INDUSTRY

0.028

0.022

1.28

.202

-0.015

0.070

0.99

Note. Significant p-value at alpha level .05 is highlighted in red.
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4. Discussion
4.1 Brief Summary of Study Rationale
Generally speaking, state and federal policies that pertain to testing children for lead
exposure guide clinicians to test children for lead exposure at least once before the age of 24
months, and again, usually once, only if and when specific factors suggest a highly increased risk
of lead exposure. Recent studies have suggested that hundreds of thousands of children each
year continue to be exposed to lead in the U.S., and that our current screening guidelines entirely
miss detection of a majority of lead-exposed children. These studies, in turn, suggested that our
current practices are completely inadequate for detecting lead-exposed children. One critical
factor may be reliance on one-time-only testing and a focus on only children below the age of 5
years. Our clinical observations and previous studies of the distributions of child BLLs in
downtown El Paso have suggested that individual children's BLLs are highly variable and that
children up to the age of 15 years suffer the effects of ongoing exposure to environmental lead.
Following on a thorough review of the literature (see Introduction), it was concluded that
variability of BLL rather than stability should be assumed given the multiple physiological
factors that influence lead absorption, distribution, and accumulation in children's bodies.
This study aimed to test the stability (variability) of child BLLs among children living in highrisk neighborhoods along the U.S.-Mexico border. The study first attempted to determine
whether child BLLs were predicted by time. Once those results were determined, we wanted to
also know if age, sex, home built year, living below the 2020 poverty threshold, and living near
industry would predict BLLs in children with chronic low-level lead absorption across time.
The children in this study were from neighborhoods with legacy contamination from
operations of different industries (including a decommissioned copper and lead smelter, oil
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refinery, railroad loading stations, and international bridges), and with a large percentage of older
housing (approximately 70.5% of children in this study lived in a home built before 1986).
Families in these neighborhoods were mainly of Hispanic/Mexican/ Latino/ Mexican American
origin, and 55.5% of children were living below the U.S. poverty threshold. Our goal was to test
child BLLs four times over the course of two and a half years, but our study was placed on hold
in mid-March of 2020 due to the COVID-19 pandemic shutdowns. For this study, we analyzed
children with three BLL time points (N = 29) and used multiple imputation to impute data for
164 children (yielding N = 193).
4.2 Summary of Major Findings
A total of 221 children were initially recruited, 206 children were tested, and data from
193 were included in these analyses.
In the initial examination of the descriptive data, child BLLs were non-normally
distributed and displayed a positive skew. For this reason, non-parametric analyses of
demographic variables and of BLLs change over time were conducted in the dataset with N = 29
and multiple imputation N = 193. Initially, Individual Growth Curve models were used to test
BLL change without and with regard to time, as recommended by Shek and Ma (2001), before
introducing predictors into the model. The Individual Growth Curve model without regard to
time demonstrated significant BLL changes (intraindividual differences) within children across
three time points in both datasets. These findings suggested that children's BLLs do not remain
stable or decrease over time at these lower-levels of Pb absorption and contradict current clinical
guidelines and assumptions that children's BLLs will constantly remain low throughout
childhood.
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The Individual Growth Curve model recommended by Shek and Ma (2001) to test
whether time was a significant predictor did not converge for either dataset because the model
could not fit time as a proposed covariance between intercept and slope. A second model with
time and only random slopes was performed. This model determined that time was not a
significant predictor of child BLLs in either dataset. This finding refutes the study's hypotheses
that children's BLLs will remain steady over time and were not predicted by time. Our study
determined that time does not predict increases or decreases in child BLLs suggesting that BLLs
in children vary due to factors other than time, and children do not become less vulnerable to
lead exposure as they get older.
From this point forward, linear mixed models with time as a repeated measure were
calculated, testing age and sex, and then “living under U.S. 2020 poverty threshold,” “living in
an older home (built before 1986)”, and “living near industry,” controlling for age and sex. All
models with predictors were not significant in the N = 29 dataset. For the models using
the N =193 dataset, age and sex interaction was a significant predictor of child BLLs in all
models, but sex and age on their own were not significant predictors.
Of the models that analyzed other predictors controlling for age and sex, only living near
industry was a significant predictor of child BLLs, and the interaction between age, sex, and
industry was not significant. Children living below the U.S. poverty threshold or in a home
before 1986 (with a higher probability to have lead-based paint) were not at more risk for
increases in BLLs over time. Children living near an industry were at more risk for increases in
BLLs over time, with an average increase of 0.22 µg/dL. These findings suggested that
assumptions regarding the greater risk of exposure in younger children are not warranted and not
correct, and the risk of exposure may depend on sources of lead in the environment rather than
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the age of a child, age of home, and socioeconomic status for this community. Also, for children
with chronic low-level lead absorption, living near an industry is a significant contributor to
child BLLs over time. This study identified nine key findings, explained below.
4.3 Child BLLs Vary Across Time
Studies examining the stability of BLLs over time in children with chronic low-level lead
absorption have rarely been conducted. Our study demonstrated that for children with chronic
low-level lead absorption (BLLs < 10 µg/dL), BLLs fluctuated significantly over time, over a
period of 1.5 to 2 years. These findings were significant in both of our datasets analyzed.
Our findings contradicted current federal and state recommendations to screen children for blood
Pb once under the age of 5, based on the assumption that children's BLLs with lower Pb
absorption levels will decrease over time and with age.
The variability of BLLs observed in our study support the strong influence on variability
that would be expected from multiple shifting environmental (refer to section 1.5, pages 9-15),
physiological, and behavioral factors (see sections 1.6, 1.7, and 1.8, pages 16-43), that together
in complex ways, influence lead exposure, absorption, distribution, and accumulation in children.
In addition to these factors, children in our study lived in neighborhoods identified as high risk to
Pb exposure, a risk-based on families with lower socioeconomic statuses, the concentration of
older homes, and history of environmental contamination from a decommissioned Pb smelter site
and proximity to major highways. Thus, the likelihood that one child BLL screen, as suggested
in state and federal guidelines, is completely inadequate to identify children who are exposed to
Pb, particularly in highest-risk neighborhoods.
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4.4 Time and Child BLLs
Time was not a significant predictor of child BLLs in our study. When we introduced
time as the only predictor in the individual growth curve models, time did not predict increases
or decreases in child BLLs. Instead, BLLs within children differed significantly across time
points tested. Since time was not a predictor of the significant within-child variability of BLLs,
this suggested that 1) BLLs of children are varying due to factors other than time; and 2) children
do not become less vulnerable to lead exposure as they get older.
These findings suggested that assumptions regarding the greater risk of younger
children's exposure are not warranted and not correct. In most U.S. states, guidelines for
childhood lead screening include children up to the age of 2 years and in some up to the age of 6
years of age. The guidelines assume that only children below the age of 6 years adopt risky
behaviors that expose them greater to Pb and that beyond this age, their bodies are matured
enough to reduce Pb absorption and get rid of Pb faster. While behaviors like crawling, teething,
placing non-food items in the mouth, and playing soil do place younger children at greater risk to
Pb exposure and may decrease or stop by the age of 6, there is not enough evidence to suggest
that child BLLs will continue to decline after this age. Partially, because 1) there are no studies
that monitor child BLLs beyond the age of 6 and the same children over a long period of time
(more than two years), 2) there are few studies that identify ongoing exposures in children with
chronic low-level Pb absorption (BLLs < 10 µg/dL), and 3) we need more studies to understand
how Pb is absorbed and distributed in a growing child. The CDC Lead Prevention Task Force
also recognizes the lack of evidence to support screening guidelines for children beyond the age
of 6 years and acknowledges the importance of identifying behaviors and factors that may
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predict BLLs for older children and children with chronic low-level lead absorption (Advisory
Committee on Childhood Lead Poisoning Prevention, 2012).
It is important to consider that time was not a significant predictor for children ages 6
months to 16 years with low-level lead absorption, perhaps because of the relatively short time
period that was monitored. At the same time, the significant variability demonstrated is critical
to consider.
The effect of time on child BLLs has been suggested in large cross-sectional studies in
young children, including elevated BLLs (≥ 10 µg/dL). For example, one study included BLLs
of children screened within two weeks of their first or second birthdays (N = 267,687) born
between 1994 and 1997 and analyzed BLL variation with regard to time, age, and season (Haley
& Talbot, 2004). Each month's geometric means ranged between 3.75 and 4.40 µg/dL, and the
percentage of children with elevated BLLs (≥ 10 µg/dL) ranged between 3.7% and 6.4%. With
regard to time, child BLLs demonstrated a "long-term decreasing trend" in both age groups, even
when there was a higher proportion of children with elevated BLLs at age 2 and seasonal
variations in both age groups. However, these findings suggested that the effects of time on
BLLs may have been from reduced Pb sources in the 1990s (banned of leaded gasoline and lead
paint remediation).
Another study analyzed BLLs of children during the first two years of life and measured
Pb concentrations and isotope ratios in blood, urine, household dust, and duplicate diet samples
(bottle-fed vs. breastfed) for children with BLLs ≤ 10 µg/dL (Manton et al., 2000). Information
was collected from two groups of children. The first group included 22 children that were
followed every four months from birth to between 1 and 2 years of age, and the second group
included 20 children of ages 2 to 4 years that were followed for one year. The geometric mean
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of BLLs from birth and at 4 months remained unchanged with levels 0.92 and 0.99 µg/dL,
respectively. After 4 months, the BLLs remained near-constant or gently raised, depending on
whether children were exposed to lead during home renovations for one brief or prolonged
exposure and if bottle or breastfed. Two children experienced BLLs > 10 µg/dL after being
exposed to Pb due to construction in their home. One child had a constant BLL of 0.63 µg/dL
after 24 months from birth. Another two children at 4 months had peaks above 6 µg/dL, but no
Pb source was identified. Children who had a prolonged exposure over the first 2 years of life
took longer to reach half-life of blood lead compared to children with brief exposure during the
same time. The half-life of the briefly exposed children was 8 to 11 months, while for the group
that had prolonged exposure was between 20 and 38 months. Pb sources for children birth to 4
months of age were dietary, and for children aged 5 months to 2 years were hand wipes (most
likely from household dust).
In summary, BLL changes over time in children with chronic low-level lead absorption
were not predicted by time and maybe better predicted by sources of Pb and child behaviors.
More studies are needed to characterize if BLLs change with regard to time (i.e., more test points
over 5 years) and to identify sources that explain chronic low-level Pb exposure.
4.5 Contribution of Sex and Age Differences to Child BLLs
Our study also determined that age and sex were not contributing factors to child BLLs,
but the interaction between age and sex was a significant predictor. The findings regarding sex
are contrary to some sex differences we have seen in Pb exposed children, where boys have
higher BLLs than girls because boys have higher red blood cells count (Sobin et al., 2009, 2011,
2015; Liu, Huo, Lin, & Zhang, 2015).
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The findings regarding age are also contrary to age differences claimed in Pb exposed
children, where younger children have higher BLLs than older children because younger
children adopt behaviors that expose them more to environmental Pb, and their bodies cannot get
rid of Pb fast enough. While these two arguments are valid for expecting younger children to
have a higher risk of Pb exposure, there are no studies that support these assumptions. As more
research is done in children beyond the age of 2, we are finding that children older than 2 may be
experiencing higher percentages of elevated BLLs than the national expectance (like in our
study), constant or gently increases of BLLs (Manton et al., 2000 and are at higher risk to Pb
effects.
Some of the studies have found that the most significant susceptibility to both cognitive
and behavioral development is between ages 5 and 7, having stronger negative associations on
IQ (Hornung, Lanphear, & Dietrich, 2009; Chen, Dietrich, Ware, Radcliffe, & Rogan, 2005), and
adolescent criminal behavior (Hornung, Lanphear, & Dietrich, 2009) compared to BLLs
measured at age 2. Also, neurobehavioral function, including fine motor dexterity, working
memory, visual attention, and short-term memory, have been documented in children ages 5 to
11 years (Sobin et al., 2015) and cognitive deficits in adolescents (Lanphear et al., 2000).
The interaction of age and sex on child BLLs in our study was contrary to what is usually
expected from males and younger children. When we graphed the interaction, females between
the ages of pre-and adolescent had higher BLLs than males of the same age. To our knowledge,
no study has demonstrated that female adolescents may be experiencing higher BLLs compared
to males, and it is uncertain for now what may have caused this finding. We do know that BLLs
in pre-and adolescent girls can affect puberty, where higher BLLs (ranging between 0.7 and 21.7
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µg/dL) are associated with delayed attainment of menarche and pubic hair (N = 1,235) (Wu,
Buck, & Mendola, 2003).
A possible explanation for the interaction observed could be that females in our study
were experiencing nutritional deficiencies, and specifically iron deficiency, caused by heavy
menstrual bleeding and unhealthy diets, and/or disordered eating habits that can become more
common beginning in adolescence. As explained in the Introduction (Section 1.6.3., pages 2528), nutritional deficiencies of iron, calcium, zinc, and protein can facilitate the absorption of
ingested Pb into organs and blood. In heavy menstrual bleeding, iron found in red blood cells is
lost in larger quantities than women without this condition. If iron is not replenished through
iron-rich diets or treatments, the deficiency can lead to iron deficiency anemia (Mansour,
Hofmann, & Gemzell-Danielsson, 2021). In both iron deficiency and associated anemia, Pb can
be absorbed more quickly and in greater quantities in the body, increasing BLLs. Iron deficiency
anemia also has been associated with mean BLLs of 8.6 µg/dL in children with malaria infection
(Mukisa, Kasozi, Aguttu, Vuzi, & Kyambadde, 2020); and in children living near a lead
producing industry (Rondó, Conde, Souza, & Sakuma, 2011). Whether lower BLLs can rise
during heavy menstrual bleeding still needs to be investigated. Iron deficient diets are
commonly reported in adolescents (and among vegans) (Mansour et al., 2021), and in
combination with heavy menstrual bleeding, could amplify Pb absorption in female adolescents.
Also, some adolescents of reproductive age with iron deficiency anemia can develop pica
(behavior for eating non-food items), increasing opportunities to ingest Pb (Introduction, Section
1.2, page 4 and Section 1.6.3 page 24). In one study, 11/34 (32.4%) women of reproductive age
with iron deficiency anemia reported past history of pica during menstruation, and during the
study, pica changes were related to age at menarche (Median age at menarche = 13 years)
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(Fernandez-Jimenez, Moreno, Wright, Shih, Vaquero, & Remacha 2020). In addition to iron
deficiency anemia, this behavior can increase BLLs in Pb exposed children and may explain the
increased BLLs we saw in our study. However, additional studies are needed to understand the
association between iron deficiency anemia, heavy menstrual bleeding, pica, and BLLs.
Adolescents can also adopt unhealthy diets and disordered eating habits for weight
control that increase absorption of ingested Pb. The most common disordered eating habits in
adolescents include skipping meals, extreme dieting, diet pills, and bulimia (Neumark-Sztainer,
Wall, Larson, Eisenberg, & Loth, 2011), and girls are more frequent dieters than boys (Field et
al., 2003). These eating habits can result in nutritional deficiencies as well as more frequent
empty stomachs, which can allow for ingested Pb to be absorbed in greater amounts and at
greater rates (Introduction, Section 1.6.3., pages 25-28). It is possible that our study captured Pb
absorption in pre-and adolescent females due to one or a combination of heavy blood flow
menstruation, iron deficiency, iron deficiency anemia, pica, and unhealthy eating behaviors. For
now, it is uncertain if any of these factors and/or other unknown and known physiological and
behavioral factors, contributed to increases of BLLs in pre-and adolescent females; additional
research is needed to explain this observation.
4.6 Living Below Poverty Threshold and Child BLLs
In our study, living with a family below the U.S. 2020 poverty threshold did not predict
child BLLs. This finding also is contrary to some differences seen in many studies with Pb
absorption, where children living in a family below the poverty line were more likely to have
higher BLLs because they experience food insecurity, may live near industries, in an older home,
in a home with chipping paint, and were less educated to identify Pb hazards and had fewer
resources to mitigate Pb sources.
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While all these factors may explain the differences in BLLs often seen in children living
with families below the poverty line, it is uncertain if, in our study, some protective factors may
explain our finding. Perhaps, there are Pb sources in this community regardless of family
income that predicts child BLLs, or the families in our study increased their knowledge on
identifying Pb risk in their homes and implemented low-cost strategies to mitigate risks. Some
of the low-cost strategies included wet wiping windowsills and mopping floors at least once a
week, washing hands before eating, replace toys recalled by the U.S. Consumer Protection
Agency cover contaminated soil, and paint over deteriorating areas with lead encapsulating paint.
Also, it is uncertain if living below the poverty line is a factor that is significant in children with
higher BLLs (> 10 µg/dL) but not in children with BLLs less than 10 µg/dL. While many
factors that contribute to child BLLs have been identified, there are likely many others that are
not yet understood, particularly with factors that associated with BLLs below 10 µg/dL.
Even though living with a family income below the U.S. 2020 poverty level did not
predict child BLLs in our study, we cannot ignore the mechanisms of Pb absorption that are
influenced by food intake and routes of exposure in children living with lower socioeconomic
families and in areas with legacy soil Pb contamination. The majority of our children (71.2%)
lived with a family below the median household income and in areas where there is historical Pb
contamination or nearby industries (62.7%). Children living with families of lowersocioeconomic statuses can experience food insecurity, leading to circumstances where a child
absorbs more Pb because of an empty stomach or experiences nutritional deficiencies that allow
Pb to be absorbed and distributed differently in children's bodies. The instability of food intake
can lead to Pb absorption instability, explaining the higher variability of BLLs we see in these
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children living with lower socioeconomic families (refer to Pb absorption mechanism on section
1.6.3, pages 23-29).
Together with food insecurity, living in areas with legacy soil Pb contamination or nearby
industries allow for higher variability of BLLs because Pb sources and routes of exposure are not
constant, and the bioavailability of these sources is still unknown. There can be outdoor (air and
soil) and indoor sources of Pb (leaded dust, deteriorating lead-based paint, and consumer
products) that may explain the variability of BLLs. As mentioned in section 1.6, pages 16- 40,
Pb absorption is mainly through inhalation or ingestion, and in children, physiological and
behavioral factors can vary BLLs. Physiological and behavioral factors can include higher
respiratory rates, immature Pb distribution mechanisms in the lungs and GI tract, consuming
higher amounts of Pb contaminated foods, eating contaminated non-food items, unstable food
intake, and nutritional deficiencies. Sources of Pb and the stability or instability of these sources
need to be fully characterized for these children to mitigate sources appropriately.
4.7 Living in an Older Home and Child BLLs
Living in an older home did not predict child BLLs in our study. Homes built before
1986 were categorized as living in an older home because we accounted for when lead-based
paint production was banned (in 1978) and allowed for some years for stored lead-based paint to
phase out, and also accounted for when lead soldering in household plumbing was banned (in
1986). Our cut point for older homes was higher than the cut point used by U.S. EPA (before
1978). According to the U.S. EPA, homes built between 1960-1977 are 24% more likely to
contain lead-based paint, while homes built between 1940-1959 are 69%, and homes built before
1940 are 87% (U.S. EPA, 2020). While home built year may be a good indicator of lead-based
paint, the risk to lead-based paint is higher when there is chipping, peeling, or deteriorating paint,
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and when wet wiping and wet mopping cleaning techniques are not frequently used in
windowsills and floors.
Perhaps one reason that explains no effect of an older home in child BLLs is that the
families in our study, due to their participation, gained knowledge on identifying Pb risks at
home and implemented low-cost mitigation strategies to reduce lead-based paint risks. Another
reason could be that all our homes were not at risk to Pb through household water because the
families were connected to the municipal water system, free of leaded main lines, and delivered
water with an anti-corrosive treatment preventing Pb from leaching in the household plumbing.
Also, it is uncertain if living in an older home is a factor that significantly predicts lead exposure
in children with higher BLLs (> 10 µg/dL) but not in children with BLLs less than 10 µg/dL.
Further studies are needed to examine these possible predictors among children with lower-range
BLLs.
4.8 Living Near an Industry Predicts Higher Child BLLs Overtime
Living near an industry was the only significant predictor of child BLLs. This finding is
somewhat expected given that living near an industry has historically been a predictor of
elevated BLLs. Our study demonstrated that living near an industry can still be a significant
source of Pb exposure in children with low-level chronic absorption, increasing an average of
0.22 µg/dL overtime. This finding highlights the importance of regulating industries that
contaminate air quality and nearby soils of neighborhoods with children. While there can be
other Pb sources in the homes of our participating families, engineering controls to reduce
emissions and stricter air quality standards may need to be implemented before we can address
chronic low-lead absorption in these children. In addition to engineering controls, families living
near industries can reduce contamination and bioavailability of Pb found in soil by covering open
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soil with grass, gravel, mulch, or cement; household dust can be substantially reduced by wet
wiping windowsills and wet mopping floors at least once a week. More studies are needed to
characterize how living near an industry can contribute to child BLLs over a more extended
period of time (5-10 years).
4.9 Multiple Imputation and the Prediction of Child BLLs
The Intraclass Correlation Coefficient (ICC) result for the full imputed sample, N =193,
was still on the low side but greater than the 0.25 threshold suggested by Shek & Ma (2001) to
continue with individual growth curve models. While the N =29 dataset results were below the
recommended Intraclass Correlation Coefficient value, we proceeded with the individual growth
curve models because the data, as expected for child BLLs, were highly skewed. Perhaps, the
full imputed sample introduced much more interindividual variability because a large portion of
the data were imputed, allowing us to detect differences in BLLs by our predictor variables
overtime. The method allowed us to detect significant effects of INDUSTRY and AGE by SEX
interaction, addressing a Type II error we got on the original dataset of N =29.
Also, our study suggested that multiple imputation worked well for simulating missing
BLL values. Increasing our sample size from N =29 to N =193 allowed us to increase statistical
power and reduce the probability of committing a Type II error. Simultaneously, multiple
imputation is never an ideal approach, and ongoing studies over more extended periods with a
larger number of children are needed to fully understand how children's BLLs of children living
in high-risk communities might be expected to fluctuate over time. Increasing the number of
data waves can also introduce more interindividual variability allowing for better detection of
differences in BLLs over time.
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4.10 Children in One U.S./Mexico Border Community Still at Risk for Lead Exposure
El Paso, TX, is a city with a legacy of environmental contamination. Most of the
contamination can be attributed to the copper, lead, cadmium, and zinc smelter operations by the
American Smelting and Refining Company (ASARCO), which operated during 1887-1999.
For many years, ASARCO provided jobs, housing, health clinics, grade school education, good
pay, and benefits for generations of families and created a close-knit community near the smelter
plant for the workers and their families. Simultaneously, ASARCO emitted sulfur dioxide, Pb,
zinc, cadmium, and arsenic through their smokestacks, contaminating nearby air, soil, and bodies
of water. Most of the contamination was done without the community's knowledge and not
knowing how the emissions would affect the health of residents. A collection of community
complaints about a yellow and smelly smog that covered the evenings led to environmental and
health investigations in 1971. These investigations started a legal battle (possibly ongoing)
between the city and ASARCO to clean the nearby areas and address workers' and residents'
health.
Before the Clean Air Act in 1970, ASARCO operated without regulating and disclosing
its emissions. In 1971, city and state air quality boards, involving the Texas Commission on
Environmental Quality (TECQ) and local EPA office, studied the emissions released between
1969 and 1971 and discovered that ASARCO emitted 1012 metric tons of Pb, 508 metric tons of
Zn, 11 metric tons of cadmium, and 1 metric ton of arsenic (Landrigan et al., 1975). The amount
of Pb that was emitted concerned Dr. Bernard Rosenblum, who served as the director of the El
Paso City-County Health Department at that time and estimated that 2,700 persons between the
ages of 1 and 19 would have elevated BLLs ≥ 40 µg/dL (safety standard for BLLs at the time)
and affecting residents within a four-mile radius of the smelter. Dr. Rosenblum collected air and
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soil samples and contacted the CDC for help in testing residents' BLLs. The CDC sent Dr. Philip
Landrigan and his research team, which analyzed the air and soil samples collected by the city's
health department and conducted additional studies on soil, household dust, water, pottery, and
BLLs (Bernstein, 2004).
The City-County Health Department in El Paso conducted two series of tests to
determine annual mean Pb concentrations in ambient air. Twenty-four-hour air samples were
collected through 1971 and between June 1972 and June 1973. A total of 39 air samples were
taken in the upwind and downwind direction of the smelter property and analyzed for Pb and
zinc using atomic absorption spectrophotometry. These tests showed high mean concentrations
of metallic waste in the air immediately downwind of the smelter. For 1971, the annual mean Pb
concentration was 92 µg/m3, and for 1972-1973 it was 43 µg/m3. Both mean Pb concentrations
exceeded the then EPA safety standard for airborne Pb content of 2.0 µg/m3. For comparison, air
samples from the other 15 industrial establishments in El Paso were analyzed, but none had
metallic emissions. Dustfall Pb concentrations at the smelter site were 204 mg/m2 per month
(based on data from 10 months) and decreased with the smelter's distance. Also, size fraction
analysis determined that particles below 1µM showed the highest Pb concentrations, and the
mean Pb/bromine ratio decreased rapidly with distance from the smelter.
The local health department analyzed soil samples at selected sites between June and
December 1972. These findings showed that Pb and other metals' highest concentrations were at
the soil surface within 0.2 miles from the smelter site (Bernstein, 2004). Additional soil samples
were taken by Dr. Landrigan's team at the surface, 2.5 inches, and 5.0-inch depths from 99 sites
from March 1972 through 1973 and were analyzed for Pb content using a mixture of x-ray
fluorescence and atomic absorption spectrophotometry techniques. The highest levels of Pb
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were found within 200 meters of the smelter with a mean concentration of 3,457 ppm (n = 54
samples), and mean concentration decreased with distance from the smelter with concentrations
above background levels as far as 10 km away from the smelter site (background levels not
disclosed). Monthly household dust samples from 51 homes between July 1972 and June 1973
were also analyzed. The geometric mean Pb content in 53 household dust samples was 22,191
ppm (there were no EPA standards for household dust at the time, these standards were effective
in 2001), and levels also decreased with distance (Landrigan et al., 1975). The health department
also analyzed Pb in drinking water, milk, and food from homes in El Paso between January and
March of 1972 but found it free of Pb (Bernstein, 2004).
These findings confirmed that the smelter was responsible for Pb contamination in air,
soil, and dust and justified testing residents living near the smelter. An initial study was
conducted by Dr. Landrigan's team between January and March of 1972 to analyze BLLs of
adults and children in neighborhoods located approximately one mile from ASARCO's
smokestacks. This study demonstrated that 43% of persons in all age groups and 62% of the
children through the age of 10 years had BLLs above 40 µg/dL (sample size not available)
(CDC, 1997). This study alarmed the research team because it was the first time many children
within the city limits had exceeded the threshold of 40µg/dL.
A second study was conducted in August 1972 to analyze the BLLs of residents of all
ages within 4.1 miles of the smelter. This time, the target area was divided along census tract
lines into three subareas using concentric circles at one mile (Area I), 2.5 miles (Area II), and 4
miles (Area III) from the smelter. All households in Area I were visited, while for areas II and
III, the homes were selected at random representing approximately 2% of the households. A
total of 672/833 (80.7%) occupied households were interviewed. Venous blood samples were
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obtained and analyzed by atomic absorption spectrophotometry (AAS) from all persons up to the
age of 20 years and from every other person above that age in each household interviewed. A
total of 1,369 persons participated in the study. In addition to BLLs, household soil, dust, paint,
and pottery for cooking were tested for Pb (Landrigan et al., 1975).
The highest percentage of persons having BLLs ≥ 40 µg/dL were from families living
nearest to the smelter. The study also revealed that children living in all areas were being
exposed to Pb from the smelter. About 27% of children living in all three areas between the ages
of 5 to 9 years and 14% between the ages of 10 to 14 years had BLLs ≥ 40 µg/dL. Children
closest to the smelter and between the ages of 1 to 4 years had the highest BLLs, with 69% (n =
49) of children having BLLs ≥40 µg/dL compared to children of the same age range and living in
Areas II and III, with 27% (n = 83). The highest level was a two-year-old girl living in
Smeltertown with a BLL of 83 µg/dL.
A total of 1,600 paint samples from 541 homes were analyzed for Pb content. (Paint was
considered positive if the Pb content by dry weight of paint ≥ 1.0%). The study found at least
one positive paint sample in 30% of the homes in Area I (n = 95), 35% in Area II, and 25% in
Area III (n for Areas II and III = 446). Peeling paint was observed in 92% of households in Area
I and 54% from Areas II and III. When comparing children living in homes with and without
lead-based paint, there was no difference in the prevalence of BLLs ≥ 40 µg/dL, with prevalence
rates of 32% and 39%. These findings revealed that lead-based paint was not the only source of
Pb exposure in children living in all three study areas.
Another source for Pb for this community was from pottery vessels used for food storage
and preparation. Out of the 670 homes visited, 37 of them used such pottery. Lead release in the
pottery vessels was high in 12 vessels from all areas with levels ≥ 100 ppm and detected in 7
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vessels from areas II and III, with levels between 7 and 99 ppm. There was a positive correlation
between children's BLLs of ages 1 to 19 years (n =27) and Pb released from pottery. Also, the
proportion of children with BLLs ≥ 40 µg/dL was higher in children with pottery exposure levels
≥ 100 ppm (6 out of 13 children) compared to children with pottery exposure levels < 100 ppm
(1 out of 14 children). The mean BLLs of the children in the higher pottery exposure were 37
µg/dL, and for children in the lower pottery exposure was 29 µg/dL.
Elevated Pb concentrations were also found in the soil of the three areas, with Area I
having a significantly higher concentration compared to the other two areas. With a total of 466
surface soil samples analyzed, the geometric means for Area I was 1,791 ppm, Area II, 684 ppm,
and for Area III, 370 ppm. Only in Area I was found that there was a significant positive
relationship between soil Pb content and children BLLs ages 1 to 19 years (p < 0.05). Children
that had BLLs ≥ 40 µg/dL lived in homes with a geometric mean soil content of 2,587 ppm.
Household dust samples were also the highest in Area I. With a total of 594 household
samples, the geometric mean for Area I was 4,022 ppm (n = 106), while for Area II was 922 ppm
(n = 234), and 816 ppm for Area III (n = 254). Like for soil samples, there was a significant
positive relationship between household dust Pb concentrations and BLLs of children ages 1 to
19 years (p < 0.0001). Children who had BLLs ≥ 40 µg/dL lived in homes with a geometric
mean Pb concentration of 6,447 ppm (Landrigan et al., 1975). Also, these findings showed that
person ages 1 through 19 years with BLLs ≥ 40 µg/dL were exposed to significantly higher mean
Pb concentrations of soil and dust (3,264 ppm for soil and 3,522 ppm for dust, p < 0.001)
compared to persons with BLLs < 40 µg/dL (1,032 ppm for soil and 1,279 ppm for dust).
In summary, these findings suggested that Pb emitted by the smelter and deposited in soil
and dust were probable sources of Pb in persons living within 4.1 miles of the smelter. Together
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all these findings suggested that ASARCO emissions were responsible for children's elevated
BLLs. The findings were argued by ASARCO, stating that Pb exposure came from lead-based
paint and gasoline emissions from a nearby major interstate. Also, during this time, there was a
lack of evidence to demonstrate the harmful effects of Pb in children with BLLs <40 µg/dL. Pb
emissions in a residential area were not viewed as a public health threat back then, with support
from the National Academy of Sciences stating, "lead attributable to emissions and dispersion
into the general ambient environment has no known harmful effects" (Committee on Biological
Effects of Atmospheric Pollutants, 1972). Also, parents of exposed children did not understand
the urgency to address Pb exposure because none of the children appeared sick, and the adults
living there had come from generations where they saw no health problems (Perales, 2008).
Another study conducted shortly after contradicted Dr. Landrigan's findings. The study
was carried by Dr. James McNeil, an El Paso pediatrician and former ASARCO physician, and
Dr. Potasnick, a psychologist from the El Paso School District. While the findings were not
published in a peer-reviewed journal, according to archived interviews, this study concluded that
BLLs between 40 and 80 µg/dL were safe in children provided that the child received good
nutrition and supported ASARCO's claim that Pb exposure was from other sources such as leadbased paint (Bernstein, 2004). El Paso Pediatrics Society even went to the extent of announcing
in March of 1972, that "From the statistical data available to us there is no evidence that there is
lead intoxication problem outside of Smeltertown." The El Paso Board of Health decided to
accept McNeil's study as well. These findings were are still questioned because the study was
funded by the International Lead Zinc Research Association, a group connected with the metal
industry.
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Two months later, in 1972, Dr. Landrigan and his research team got more funding for
additional studies to demonstrate that even at lower levels (< 40 µg/dL), early Pb exposure could
harm the nervous system and brain function in children. At the same time, Dr. McNeil, along
with Dr. Rosenblum, Dr. Jorge Magaña, Dr. Jose Alva, and Dr. Jose Roman, formed the Lead
Surveillance Committee of the El Paso County Medical Society and stopped further studies by
Dr. Landrigan, adopting findings by Dr. McNeil's study instead (Bernstein, 2004). Wanting to
stop further testing beyond Smetlertown, they rejected a $50,000 grant from the CDC for Dr.
Landrigan to continue the studies. Dr. Landrigan protested to The Office of the Texas Attorney
General, where the city and committee's decision was overruled, allowing Dr. Landrigan to
conduct his studies (Bernstein, 2004; CDC, 1997).
In 1973, Dr. Landrigan administered tests to measure impairment in non-verbal cognitive
and perceptual-motor skills measured by Wechsler IQ tests and subclinical impairment in fine
motor skills measured by the finger-tapping test of physical reflexes in 124 exposed children
ages 3-15 years (Landrigan et al., 1975; Whitworth, Rosenblum, Dickerson, & Baloh, 1974). A
venous blood sample for Pb analysis using Delve's cup atomic-absorption spectrophotometry
was taken from each child at the time of the neuropsychological testing.
Two groups of children matched by primary language, ethnic background, socioeconomic
index, duration of residence, and living within 6.6 km from the smelter were compared. One
group had venous sampled BLLs of ≥40 µg/dL (n = 46 with BLLs ranging between 40 and 68
µg/dL, and mean BLLs of 48 µg/dL) and the other group had BLLs < 40 µg/dL (n = 78, BLLs,
with mean BLL concentration of 27 µg/dL). The study showed that children with higher BLLs
had significantly lower IQ scores and slower reaction times as compared to children with lower
BLLs (mean scores, W.I.S.C. plus W.P.P.S.I., 95 vs. 103). The differences were maintained
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after scores were age-adjusted and stratified by sex. According to historical reports, for the first
time in Pb research, this study demonstrated health effects in children from the exposure that did
not result in physiologically observable clinical symptoms (CDC, 1997).
Also, this study compared BLLs of children whose BLLs were taken in the 1972 study.
In 80 children whose BLLs had been < 40 µg/dL, 78 remained stable below this level in 1973
(mean BLLs 26.9 vs. 26.9). The two children whose BLLs raised above 40 µg/dL were excluded
from further analysis. Of the children whose BLLs had been ≥ 40 µg/dL in 1972, BLLs tended
to be lower in 1973 (mean BLLs 48.3 vs. 40.5). About half (22/46 children) of the children in
this group had BLLs below 40 µg/dL in 1973. Suggested causes for the BLL decrease in this
group were that many children "moved away from the immediate vicinity of the smelter, smelter
emissions had decreased, and the population had aged." Two subgroups were formed from the
group with BLLs ≥ 40 µg/dL to distinguish which children had BLLs that did not remain above
this level in 1973. After comparing various characteristics and scores on tests, there were no
significant differences between them, and data from the subgroups were combined.
Findings from this study suggested that BLLs can fluctuate in either direction in a span of one
year.
Another study conducted by Dr. McNeil and funded by ASARCO contradicted once
again Dr. Landrigan's findings. This study was also not published in a peer-reviewed journal,
and according to achieved interviews, McNeil found no evidence of adverse effects in IQ in
children (Bernstein, 2004). This study was different in its study design, and children with high
lead absorption were defined geographically by proximity to the smelter rather than by BLLs,
allowing for children with BLLs < 40 µg/dL to be in the exposed group. Also, the characteristics
of the groups were not matched by socioeconomic status. Dr. Landrigan's work was published in
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the international medical journal, The Lancet, while Dr. McNeil's research was published in a
local journal with no peer review. Dr. McNeil would continue to contradict Dr. Landrigan's
studies and scientific integrity for some years before vanishing. The findings from Dr.
Landrigan's studies provided enough evidence for the city to sue ASARCO for Pb contamination
and forced ASARCO to install emission controls. There was a court settlement in 1972 between
the city and ASARCO, which fined ASARCO and asked for new emissions control equipment
and funding for medical care for children with elevated BLLs. ASARCO installed emission
control equipment 5 years after the court settlement.
A follow-up study was conducted by Dr. Morse, Dr. Landrigan, and Dr. Rosenblum in
1977 to compare children's BLLs after the smelter plant made engineering improvements. This
study demonstrated a reduction in children's BLLs aged 1 to 18 who lived in Areas I and II. The
mean BLL in children living within 0.8 km of the plant decreased from 41.1 to 17.7 µg/dL
(approximately 50%), and for children living at 0.8 and 1.6 km from the plant decreased from
31.2 to 20.2 µg/dL (Morse, Landrigan, Rosenblum, Hubert, & Housworth, 1979). While the
engineering controls to reduce Pb emission reduced children's BLLs, according to Dr. Landrigan
in an interview for The New York Times, "El Paso still had one of the highest airborne Pb levels
in the country…about the fifth-highest" ("El Paso Smelter Still Poses Lead‐Poisoning. Peril to
Children in Juarez," 1977).
ASARCO closed its zinc plant in 1982, followed by the closure of the Pb plant in 1985,
and demolished the cadmium plant in 1986. ASARCO expanded the copper plant in 1989, but
the decline of copper value resulted in its closure in 1999. In 1998, the EPA discovered that
ASARCO had been incinerating illegally hazardous waste from the U.S. Department of Defense
for 8 years, waste that may have included copper and other metals. In the same year, ASARCO

126

and EPA signed two consent decrees to resolve ASARCO's operations and comply with federal
regulations. No testing was done for workers and community members or in soil, air, and water
for contaminants in the Department of Defense waste (Bernstein, 2004).
In 1996, another study was conducted by the Texas Department of Health to investigate
an apparent cluster of multiple sclerosis (MS) cases in neighborhoods around the smelter,
including the Kern Place-Mission Hills area of El Paso. The study attempted to determine the
number of people who had been diagnosed with MS among persons who lived in these
neighborhoods and Smeltertown during the 1940s, 1950s, and 1960s. Former students who
attended Mesita or E.B. Jones Elementary schools were contacted by mailing address and mailed
demographic and medical information questionnaire. In the case of MS diagnosis, a copy of the
medical records stating diagnosis was requested. Out of the total of 5,272 former students
identified, 260 returned the survey (174 from Mesita and 86 from E. B. Jones). Prevalence
estimates were calculated for the cohorts of former students from each school, combined cohorts
of both schools, and compared them to national estimates. The study found 14 cases of MS from
Mesita students and none from E.B. Jones. The prevalence using the number of cases and the
total number of former students identified was 266 cases per 100,000 population, and its
prevalence among just Mesita students was 360 per 100,000. Both crude prevalence estimates
were higher than previously published U.S. prevalence estimates for MS, ranging from 87 to 160
per 100,000. The crude prevalence estimate for former Mesita students was twice as high as
expected (THHS, 2011). However, the study did not suggest causes for the excess MS, and
according to residents, there was little public disclosure of the study (Bernstein, 2004).
Between the years 1993 and 1994, four master's level students from UTEP analyzed the
top ½ inch soil in and outside the smelter site for Pb and As (Barnes, 1993; Devanahalli, 1994;

127

Ndame, 1993; Srinivas, 1994). The highest Pb concentrations were found at the smelter site with
5,194 ppm by Barnes and 1,500 ppm by Ndame. The Pb concentrations found in other El Paso
areas ranged between 17 and 560 ppm, with mean concentrations of 93 ppm by Barnes, 50 ppm
by Srinivas, and 103 ppm by Devanahalli. A health consultation by the Texas Health
Department and ATSDR used the four studies to compared Pb and As concentrations in soil.
This report found that concentrations of Pb and As at the smelter site were significantly higher
compared to concentrations found in areas near but excluding the smelter site (p < 0.05)
(Villanacci, Lyke, Pettigrew, & Yarbrough, 2001).
In 1999, an environmental task force formed by then-mayor Ray Caballero asked a UTEP
professor to organize historical documents relating to ASARCO. These documents revealed that
ASARCO had been accused of contaminating more than 40 sites across the nation. In the same
year, ASARCO was sold to Grupo Industrial Minera Mexico (Grupo), a formally part of
ASARCO in the past. After the acquisition, the price of copper dropped, and the company was
in a lot of debt and obligation to clean up sites. The Justice Department entered negotiations
with the Grupo in 2001 to establish a trust fund to pay for remediation. They settled in August
2002 with a $100 million trust fund. This amount was not enough to remediate all sites, as it
estimated that it would take $1 billion.
Later in 1999, an environmental chemist from New Mexico State University discovered
elevated levels of heavy metals on The University of Texas at El Paso (UTEP) campus. Soil lead
levels exceeded 2,200 ppm. Ambient air monitors located near the UTEP campus failed to pick
up the increase of heavy metals. No health risks were identified by the University officials, as
students were unlikely to put soil in their mouths. Since then, the UTEP campus has gone
through many architectural and landscaping transformations, most likely eliminating campus
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risks. ASARCO stated that the contamination found on UTEP soil was most likely from brick
plants in Juarez and car emissions. Later it was tracked to a company that bought and crushed
the slag that resulted from ASARCO's ore processing (Bernstein, 2004).
These findings convinced then-Mayor Caballero and state senator Eliot Shapleigh to
bring the EPA to conduct more environmental tests. By September 2004, the EPA had tested
more than 3,638 residential properties, where 1,082 of them had shown contamination. These
properties identified for remediation rank up costs as much as $30,000 per property. The EPA
received $2 million from ASARCO and spent a million dollars more tax-payer dollars to
remediate properties but was not enough to do a complete cleanup. Declaring the areas as a
Superfund site would help finance the remediation, but homeowner groups and ASARCO
believed that the designation would decrease property values, stop economic development, and
take a long time to remediate. ASARCO believed that the EPA was overestimating remediation
costs and suggested increasing the 500 ppm soil Pb standard that the EPA was using to identify
for remediation. It is important to note that remediation decision was already based on the
average concentrations found in residential yards, diluting higher concentrations found in the
yards. The City of El Paso and the governor also did not recommend the Superfund designation.
While the debate for Superfund designation continued, ASARCO's 10-year operating
permit by the Texas Commission on Environmental Quality (TCEQ) was up for renewal. The
new permit would have allowed emitting 6,672 tons of sulfur dioxide and 7.69 tons of Pb. After
a contested hearing, city council voting, and citizen march to city hall, the permit was not
renewed. ASARCO closed its operations in 1999 and tried to re-open in 2002, but the
community of El Paso, activist groups including student-led protests and The Get the Lead Out

129

Coalition, school districts, and governmental agencies denied the re-opening, and in 2008 the
company declared bankruptcy. The ASARCO smokes stacks were demolished in 2013.
Demolition, removal of the buildings and structures, remediation, and restoration of the side
were done by ARCADIS company, assuring that methods used eliminated windblown
contaminants and surface water and groundwater contamination.
Our study, 20 years after the smelter plant closed indefinitely and 8 years since the CDC
adopted 5 µg/dL as the reference value to identify children with elevated BLLs, demonstrated
that children in El Paso, TX are still at high risk to lead exposure. Out of the 206 children that
were tested (including BLLs > 10 µg/dL), the mean BLL was 2.40 µg/dL (SD = 4.50), and the
median BLL was 1.20 µg/dL. A total of 18/206 (8.73%) children had elevated BLLs at Time 1
and was significantly higher than the expected national percentage of 2.5%. The percentage of
children with elevated BLLs (≥ 5 µg/dL) was notably greater at Time 2, 10/95 (10.5%), and
slightly higher at Time 3, 1/35 (2.9%). Among children with two BLL time points, the
percentage of children with elevated BLLs was 11/95 (11.6%) at Time 1 and 10/95 (10.5%) at
Time 2.
Our main analyses that included 193 children with BLLs < 10 µg/dL demonstrated that
living near industry was a significant predictor of child BLLs change over time. This finding
prompts for future research to identify which industries are near children and understand how
children are being exposed to these industries, whether it be through air, soil, or household dust.
4.11 Improved Child BLL Surveillance Programs are Needed
Monitoring child BLLs is essential for helping public health officials and scientists to
understand risk patterns, develop interventions, and eventually eliminate the problem of
childhood Pb poisoning. Nationally, BLLs is a notifiable condition, meaning that when a child is
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tested in a clinical setting, the BLL, regardless of the level, must be reported to local or state
health department so that the CDC can gather the data and place it in The Tracking Network for
childhood Pb poisoning. While this sounds like a straightforward data reporting system, it is not
perfect because conditions for screening, reporting, and clinical case management are based on
state and local health department conditions which are dependent on unequal financial and
staffing resources.
For example, there is no comprehensive surveillance program in place in Texas, and
testing child BLLs is not standard clinical practice by pediatricians. Standard testing is done
only in children who participate in the Special Supplemental Nutrition Program for Women,
Infants, and Children (WIC) and Medicaid programs. WIC and Medicaid require that children
get tested at ages 12 and 24 months, and any child between 24 and 72 months with no previous
record of child Pb testing. For children outside of these programs, parents are responsible for
requesting testing, or a physician may request testing based on symptoms, a child living in a
targeted zip code, or risk factors identified through a screening questionnaire. It is uncertain how
many children outside these programs get tested, but based on former and current child Pb
studies conducted by Dr. Christina Sobin laboratory at the University of Texas at El Paso, many
parents (of approximately 1,000 child participants between 2006 through 2020) anecdotally
stated that they were unaware of child Pb exposure and health effects, and testing methods before
participating in their child Pb studies (Sobin, personal communication, 2020). Also, testing
conditions may vary further by city. For example, in Houston, the same conditions apply to
Medicaid children, but for non-Medicaid children, testing must be considered at 6, 12, 24
months, and 3 and 4 years of age (Houston Health Department, 2020).
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More inclusive testing conditions are practiced in some states, including children enrolled
in childcare, preschool up to first grade, and non-Medicaid children. For example, in ten states
and the District of Columbia (DC), they implement "universal" testing for children ages 1 and 2
years and further testing at ages 3 and 4 years if they live in a high-risk area. In eight states,
targeting testing beyond the Medicaid population is implemented, including children living in
housing built before 1950, living near a Pb smelter, and participating in the WIC program. Then
there are some states with less inclusive testing conditions. For example, in twenty-seven states,
including Texas, testing populations outside the Medicaid populations are only a
recommendation and in five states testing recommendations are unclear or unwritten.
While testing conditions are more inclusive for some states, all states disregard testing
children older than 6 years of age. This is a problem because current testing conditions neglect
the health effects of Pb exposure in older children. As reviewed in an earlier section (see page 6,
for health effects), Pb can still be harmful in children of all ages and may disrupt development
even through puberty. Even though Pb exposure is less likely to occur in older children, older
children can still get exposed through different playing behaviors and have access to more
environments than younger children. According to the CDC, while more research is needed to
characterize Pb exposure risks in older children to provide adequate testing recommendations,
prevention strategies to protect all children should be implemented. Testing recommendations
should include non-Medicaid children and children older than 6 years living to reduce adverse
health effects in older children (Advisory Committee on Childhood Lead Poisoning Prevention,
2012).
Reporting child BLLs also varies by state. Most states (40 states and the District of
Columbia) report all BLLs of children under the age of 6 years tested using laboratory
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procedures or point-of-care devices. Other states like Pennsylvania require reporting all BLLs
by laboratory procedures and BLLs from point-of-care devices if they are >5 µg/dL. Some states
only require reporting BLLs that are greater than a threshold level set by the state, like at
>5µg/dL, 10 µg/dL, or 2.3 µg/dL (Safer Chemicals, Safer Families, 2017). In Texas, it is
recommended to report all BLLs (elevated and non-elevated) of children below 15 years of age
from all laboratory and point-of-care devices tested in healthcare facilities (Texas Health and
Human Services [THHS], 2019). These reporting inconsistencies, combined with testing
inconsistencies across all states, create a particular challenge for identifying children at risk of
childhood Pb poisoning and may explain the low rates of children with detectable BLLs.
Adopting the CDC recommended reference level for environmental Pb investigations
also differs by state. The CDC recommends environmental investigations for children with
BLLs ≥ 5µg/dL (CDC, 2019). The environmental investigation consists of preventive education
with family, home assessment to identify Pb sources, and funnel state or county resources to
mitigate Pb sources. These investigations are essential in reducing exposed child BLLs because,
up to now, the best method to reduce child BLLs is to remove or securely cover the Pb source.
Unfortunately, these investigations are limited by the "jurisdictional requirements and available
resources" of local conditions. This means that not all children with elevated BLLs get an
environmental investigation because there is not enough funding to hire staff for home
investigations and mitigate home sources. In Texas, a child must have one venous BLL of 20
µg/dL or two consecutive (12 weeks apart) venous BLL of between 10-19 µg/dL range to be
considered for case management and environmental Pb investigation (THHS, 2018). Children
with BLLs between 5-19 µg/dL are only given preventive education and may get BLL testing to
follow up at the pediatrician's discretion. What is more worrisome, it is uncertain how BLL
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follow-ups are being conducted to ensure the reduction of BLLs with children above the CDC
reference level but below the state's action threshold.
In summary, the current differences in local, state, and federal conditions for testing and
reporting children's BLLs may still leave out children who can also be at risk for Pb exposure.
The current testing conditions exclude children older than 6 years, living in homes built before
1986, living in poverty, and living near highways and industrial operations. As a reminder, only
children participating in WIC or Medicaid programs or with a physician referral get screened for
Pb exposure in Texas. This means that currently, it is unknown how many children have
detectable BLLs, and there is very little in place to manage cases of children with BLLs <10
µg/dL. Also, what is most important is that the above screening recommendations are made
without the understanding of how Pb is absorbed and distributed in the body, limiting the
interpretation for clinical management and public health risk identification.
4.12 Implementation of Ongoing Child Data Monitoring
While in this study, child data monitoring took part in participant's homes, monitoring
children's BLLs overtime may be achieved in partnerships with local schools. With the help of
school principals, nurses, physical education teachers, and parent liaisons, our team has
developed a method for collecting blood samples and anthropometric data for 30 to 50 children
per day for one week and repeat every three to four months. This method was achieved by first
building a good relationship with a school's principal to support parent recruitment, Pb
education, and repeated testing at their school. With the principal's support, school district
approval was obtained, and a couple of meetings were conducted with the school's staff to plan
logistics and scheduling for parent recruitment, testing of children, and disseminating
information to parents.
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Parent recruitment was done during parent-teacher conferences, where parents completed
informed consent, child health history, and family demographic forms. A list of children with
parent informed consent was provided to the lead research team, allowing the team to organize
children by grade level and the physical education hour schedule. The parents are notified a day
before the child test by the school's staff notification system or by sending a note home with a
participating child. On the day of the test, participating children are excused from physical
education class and escorted by parent liaison or nurse to a room with blood and anthropometric
data collection stations. A lead research team member explains to children the study, what is
required of their participation, and their right not to participate. If a child assents, a deidentifying
number is assigned to the child, and their height, weight, waist, hip, and blood pressure are
measured. Then the child is asked to wash their hands with soap and water, and a lead research
team member collects blood samples via finger-prick as explained in the Methods section (see
page 52). After a child completes a blood test, the child is rewarded with school supplies and
escorted back to physical education class. Repeated BLL tests are conducted every three to four
months around the school's academic testing schedule. Parent brochures are created with child
results, and these are reviewed with the parent during school information sessions conducted
before or after school with the help of the school nurse and parent liaison. Further
communication with parents was done through the school notification system or the study's
phone.
4.13 Future Directions
There are several follow up studies that need to be conducted to confirm findings in this
study: 1) children need to be retested over a more extended period (for at least 5 years) to see if
BLLs are consistent with study findings; 2) additional soil, air quality, and household dust need
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to be tested to identify industries responsible for Pb sources; 3) the stability and instability of
sources for lead need to be identified in children with chronic low-level lead absorption, 4)
understand how Pb from different sources are absorbed and distributed in the body in children
with low-level Pb absorption.
Age and sex will have to be considered during the retesting phase. It may be possible
that retesting children for a more extended period will strengthen the interaction between age and
sex and provide a clearer picture of how they interact with child BLLs. If we continue to see that
pre-and adolescent female children experience higher BLLs than males of the same age, then we
can assume that puberty is also playing a role in Pb absorption, and further studies will be needed
to understand the interaction.
While living below the poverty level and living in an older home did not predict child
BLLs in our study, these factors, in addition to other environmental and behavioral factors, need
to be considered during the retesting phase. Environmental factors such as interior and exterior
paint conditions, soil Pb concentrations, household dust Pb concentrations, and bioavailability of
Pb in nearby soil and household dust and behavioral factors such as eating non-food items,
child's favorite toy, outdoor and indoor activity, eating imported candy or spices, and using
imported glazed pottery for cooking, food storage, or as dishware should be considered.
Identifying Pb sources in children with chronic low-level Pb absorption will help identify target
points of interventions to prevent child Pb exposure.
While living near an industry was a significant predictor in our study, the sources are not
yet identified. There are different industries (sometimes clustered) in central El Paso that are
near our targeted families. To rule out industries, environmental (soil and air) concentrations of
Pb and isotope ratio analyses may be needed to differentiate the different industries. Isotope
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ratio analyses may also be done in children's blood to match the isotope absorbed and found in
the environment. The bioavailability and stability of these sources also are needed to understand
how these sources vary BLLs in children with low-level chronic absorption. In addition,
ongoing education to identify lead hazards and to teach parents how to implement low-cost
strategies to reduce lead hazard sources within homes, should be used in all neighborhood
located within a two to three mile radius of industrial sites with known emission issues.
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5. Conclusion
5.1 Summary
Studies have shown that current state and federal policies are completely inadequate for
identifying lead-exposed children. Our study demonstrated significant variability within children
ages 6 months to 16 years over time with regard to BLL and chronically exposed to lower levels
of lead absorption. Time was not a significant predictor in this study, however being a pre-and
adolescent female, and living near industry predicted a significant proportion of variance in child
BLLs. Puberty may be playing a role in Pb absorption for females pre-and adolescent, and
nearby living industries can be a significant Pb source over time, even in children with chronic
low-level Pb absorption. However, more studies are needed to determine industries, routes of
exposure and to understand the sex and age interaction observed in this study. The remaining
unexplained variance in the model can be attributed to the multiple environmental, physiological,
and behavioral factors that influence lead exposure, absorption, distribution, and accumulation in
children, especially for children living with lower socio-economic families and in areas with
legacy Pb soil contamination where food insecurity plays a major role in BLL instability. While
age, sex, living with a family below the U.S. poverty threshold, and living in an older home did
not predict child BLLs in this study, these factors influence BLL absorption and need to be
considered in future studies.
Child BLLs in these neighborhoods must be continuously monitored, and ongoing child
data monitoring can be achieved through local schools. Other possible sources of contamination,
such as soil, air, and household dust in homes nearby industries, must be tested to characterize
these sources' stability and instability in children. Comprehensive community education to
reduce Pb risks, reliable sources of nutritious foods, and policy changes regarding screening and
138

environmental interventions must be implemented to reduce ongoing Pb exposure in this one
U.S./Mexico border community.
5.2 Afterword
The relationships that the study team built with the communities of families participating
in these studies were initially built in elementary schools and through our active recruitment and
education efforts in community events and door-to-door campaigns. It was the privilege of the
study team to gain families’ trust. We were welcomed into their homes to do BLL screening
with their children and environmental testing inside and outside of their homes. The families
also allowed us to keep strong ties with them throughout the ongoing COVID-19 pandemic. Our
main communication during the pandemic has been through phone calling and text messaging,
and we launched a website with educational resources for parents in English and Spanish to
continue preventing Pb exposures at home. Most of our families have remained engaged and
said that they would like to continue once it is safe for the Lead Research Team and families to
interact face-to-face. We truly appreciate the communities’ trust, support, and patience.
We feel that these communities are aware of the ill effects of Pb and want to reduce Pb
risks in their homes. While BLL screening was a valuable service to these communities, we
continue to provide community education on identifying possible sources of Pb in their homes,
neighborhoods, and limiting exposure to sources of Pb, including limiting consumer products
that contain Pb and renovating homes without safe practices to contain lead-based paint.
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Appendix A
Child Health Screening Project
Department of Public Health Sciences
University of Texas at El Paso

III.

Child Health and Personal History (Fill one for each child participating from the family)

Referral Source:

_____________________

Date: _______________

Mother’s Name: ______________________________

Father’s Name: _______________________________

Child Name
________________________________________
Last
First

SEX

male

female

DOB

Study ID #

__ __
month

75 - ___ ___ ___ - ___ __
Study
Family
Child

Mother’s Education (check one):

__ __ __ __
Current Age _____________
day
year
Father’s Education (check one):

_____
_____
_____
_____
_____
_____
_____
_____
_____

_____
_____
_____
_____
_____
_____
_____
_____
_____

Completed grades 1-6
Completed some high school
Graduated high school
Completed technical training
Completed some college
Graduated college (BA, BS)
Completed some graduate school
Completed graduate degree (MA, MS)
More than graduate school education

Completed grades 1-6
Completed some high school
Graduated high school
Completed technical training
Completed some college
Graduated college (BA, BS)
Completed some graduate school
Completed graduate degree (MA, MS)
More than graduate school education

Child’s RACE/ETHNICITY:
Please circle all that apply:

Mother’s RACE/ETHNICITY:
Please circle all that apply:

Father’s RACE/ETHNICITY:
Please circle all that apply:

Alaska Native
African American
American Indian
Asian
Black
Hispanic
Latino
Mexican
Mexican American
Native Hawaiian
Pacific Islander
White

Alaska Native
African American
American Indian
Asian
Black
Hispanic
Latino
Mexican
Mexican American
Native Hawaiian
Pacific Islander
White

Alaska Native
African American
American Indian
Asian
Black
Hispanic
Latino
Mexican
Mexican American
Native Hawaiian
Pacific Islander
White

WHICH HAND DOES YOUR CHILD USE FOR
WRITING?

HANDEDNESS: left
right
equally) or I don’t know

WHAT TYPE OF SCHOOL DOES YOUR CHILD
ATTEND?

SCHOOL:

ambidextrous (both

1 public
2 private
3 special education
4 private tutor/home school
5 preschool/daycare
6 other/none ______________________
7 not in school yet
Name of school: ________________________________

IF IN SCHOOL, WHAT GRADE IS YOUR CHILD IN?

Current Grade: preK K
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1st

2nd

3rd

4th

5th

6th

Child Health Screening Project
Department of Public Health Sciences
University of Texas at El Paso

What is the parent/guardian’s occupation (living with child)? _____________________________________
What is the child’s favorite toy or object? _______________________________________________________
Where are the child’s toys kept?

_______________________________________________________

Where does the child like to play?

_______________________________________________________

Have you ever been told your child has any of the following? (circle all that apply)
Learning disability

Attention problems

Slow or delayed development

Stuttering

Intellectual and learning disabilities

Eye problems

Pica (eating dirt or other non-food items)

Hearing loss

Behavior disorder
Do you have any concerns about your child’s behavior or development? If yes, please explain:
___________________________________________________________________________________________
___________________________________________________________________________________________
___________________________________________________________________________________________
___________________________________________________________________________________________
___________________________________________________________________________________________
Is your child taking any medications currently? If so, which ones? ___________________________________
___________________________________________________________________________________________
___________________________________________________________________________________________
___________________________________________________________________________________________
History of other serious diagnoses, medical disorder(s) or hospitalization(s): __________________________
___________________________________________________________________________________________
___________________________________________________________________________________________
___________________________________________________________________________________________
___________________________________________________________________________________________
Is there anything else you would like to tell us about your child’s health and development? _____________
___________________________________________________________________________________________
___________________________________________________________________________________________
___________________________________________________________________________________________
___________________________________________________________________________________________
___________________________________________________________________________________________
Thank you for your time!
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Appendix B
Family Demographics and Child Environment Characteristics Form
Department of Public Health Sciences
University of Texas at El Paso

Study ID # 75 - ___ ___ ___
Family ID

Informant relationship to child: __________________ Date: ___________

I. Family Demographics (fill one per family)
Address: _________________________________________________ Phone #1 ________________________
City _______________________ State _________ Zip___________ Phone #2 ________________________
1. Does anyone smoke at home?

YES

NO

a. If yes, who and for how long: ____________________________________________________
2. How many family members live at home (circle one):

2

3

4

5

6

7

8

9

10+

3. Estimate the weekly income of your family?: ____________________________
4. Has anyone in your family been told that they have blood levels of lead, arsenic, or cadmium (circle all
that apply)?
YES
NO
If yes:
a. When: _______________________

What was the result? ___________________________

b. When: _______________________

What was the result? ___________________________

c. When: _______________________

What was the result? ___________________________

5. If any family member was told that they had blood levels of lead, was the source of exposure identified?
YES NO
I DON’T KNOW
a. If yes, what was it? ______________________________________________________________
6. Do you store fruit juices, tomato sauces, other foods or drinks in pottery, porcelain, pewter, leaded
crystal or cans?
7. Do you cook or store food in a bean pot or in pottery that is glazed?

YES

NO

DON’T KNOW

YES

NO

DON’T KNOW

8. Does your family use alternative, traditional, or home remedies such as Ayurvedic powders, or any
medicine powders such as Greta, Azarcon, Alarcon, Maria Luisa or pay-loo-ah?
9. Does your family eat Mexican candy?

YES

NO

DON’TKNOW

YES

NO

DON’TKNOW

a. If yes, what type?____________________________________________________________________
b. If yes, how often? ___________________________________________________________________
10. Does the family eat rice (white or brown)?

YES

NO

DON’T KNOW

a. If yes, how many times per week does the family eat rice? _______________________________
b. What brands of rice do you buy? ____________________________________________________

c. Where do you purchase your rice? ___________________________________________________
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Family Demographics and Child Environment Characteristics Form
Department of Public Health Sciences
University of Texas at El Paso

II. Home and Child Environment Characteristics (fill one per family)
11. Do you rent or own your home?

RENTING

HOMEOWNER

OTHER:______________

12. Was your home built before 1978?

YES

NO

DON’T KNOW

a. If yes, how long has the family lived at this address? ________________________________
b. What is the year that the home was built?__________________________________________
13. Have there been recent renovations or repairs to the house?

YES

NO

DON’T KNOW

14. Is there any peeling paint anywhere on the outside or inside of your home?
YES

NO

DON’T KNOW

a. Where is the peeling paint (location)?______________________________________________
b. Has the peeling paint ever been tested for lead?

YES

NO

DON’T KNOW

15. Have you ever had your outdoor soil, indoor dust, paint, or water tested for lead?
YES

NO

DON’T KNOW

a. If yes, what and when was it tested, and do you know the result? _______________________
16. Have you recently moved to this address from another residence?

YES

NO

DON’T KNOW

a. If yes, could you give us the address and zip code of the prior residence? ____________________
b. When did you move into this current residence? ______________________________________
17. Does your children spend time in any building other than your home (e.g., day care, grandparent’s house,
neighbor’s house, etc.)?

YES

NO

DON’T KNOW

a. If yes, could you give us the address and zip code of the other building?
________________________________________________________________________________
18. Is your family living near an industrial facility such as a battery recycling plant, smelter, or metal
recycling plant?

YES

NO

DON’T KNOW
a. If yes, what type of facilitiy is it: _____________________________________________________
b. Is there any other building or activity you are concerned about in you neighborhood?
YES

NO

If yes, describe:___________________________________________________________________

19. Do you have pets?

YES

NO

a. If yes, how many and what type of pets do you have?
b. _____________________________________________________________________________
c. If yes, where do the pets spend most of their time?

INDOORS

OUTDOORS

d. Where do the pets sleep? _______________________________________________________
20. Do you raise chickens for eggs?

YES

NO

21. Do you have a vegetable garden?

YES

NO

YES

NO

a. If yes, do you eat leafy green vegetables from the garden?
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Appendix C
SPSS Syntax Multiple Imputations and Longitudinal Data Analysis
Changing database into longform
VARSTOCASES /ID = Child
/MAKE DATE FROM T1_DATE T2_Date T3_DATE
/MAKE BMI FROM T1_BMI T2_BMI T3_BMI
/MAKE BMI_RSLT FROM T1_BMI_Reslt T2_BMI_Reslt T3_BMI_Reslt
/MAKE WAIST FROM T1_WAIST T2_WAIST T3_WAIST
/MAKE HIPS FROM T1_HIPS T2_HIPS T3_HIPS
/MAKE WTHRatio FROM T1_WTHRatio T2_WTHRatio T3_WTHRatio
/MAKE SYSTOLIC FROM T1_SYSTOLIC T2_SYSTOLIC T3_SYSTOLIC
/MAKE DIASTOLIC FROM T1_DIASTOLIC T2_DIASTOLIC T3_DIASTOLIC
/MAKE WEIGHT FROM T1_WEIGHT T2_WEIGHT T3_WEIGHT
/MAKE HEIGHT FROM T1_HEIGHTIN T2_HEIGHTIN T3_HEIGHTIN
/MAKE AGE_RANGE FROM AGERANGE_T1 AgeRange_T2 T3_AgeRange
/MAKE AGE FROM T1_CALC_AGE T2_CALC_AGE T3_CALC_AGE
/MAKE BLL FROM T1_BPb T2_BPb T3_BPb
/MAKE TIME FROM TIME_1 Time_2a Time_3a
/INDEX = Wave
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SPSS Syntax Multiple Imputations and Longitudinal Data Analysis
Unconditional Mean Model (Level 1 Model without TIME)
mixed BLL
/fixed intercept
/random intercept | subject(ID) covtype(un)
/print solution testcov /method ml.
Unconditional Linear Growth Curve Model (Level 1 Model with TIME)
mixed BLL with TIME
/fixed intercept TIME
/random TIME | subject(ID) covtype(un)
/print solution testcov /method ml.
Adding Predictors (Level 2 model with AGE and SEX)
mixed BLL with AGE SEX
/fixed intercept AGE SEX AGE*SEX
/repeated TIME | subject(ID) covtype(un)
/print solution testcov /method ml.
Adding Predictors (Level 2 model with AGE, SEX, and POVERTY)
mixed BLL with AGE SEX POVERTY
/fixed intercept AGE SEX POVERTY AGE*SEX POVERTY*AGE POVERTY*SEX
POVERTY*AGE*SEX
/repeated TIME | subject(ID) covtype(un)
/print solution testcov /method ml.
Adding Predictors (Level 2 model with AGE, SEX, and OLDER_HOME)
mixed BLL with AGE SEX OLDER_HOME
/fixed intercept AGE SEX OLDER_HOME AGE*SEX OLDER_HOME*AGE
OLDER_HOME*SEX OLDER_HOME*AGE*SEX
/repeated TIME | subject(ID) covtype(un)
/print solution testcov /method ml.
Adding Predictors (Level 2 model with AGE, SEX, and INDUSTRY)
mixed BLL with AGE SEX INDUSTRY
/fixed intercept AGE SEX INDUSTRY AGE*SEX INDUSTRY*AGE INDUSTRY*SEX
INDUSTRY*AGE*SEX
/repeated TIME | subject(ID) covtype(un)
/print solution testcov /method ml.
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SPSS Syntax Multiple Imputations and Longitudinal Data Analysis
Multiple Imputations (20 iterations), N=193
DATASET DECLARE imputedData4.
DATASET DECLARE IterationHistory4_MDR.
MULTIPLE IMPUTATION
Wave
SEX
BLL
TIME
AGE
BMI
WTHRatio
SYSTOLIC
DIASTOLIC
ZIPCODE
ANL_INC
HOME_YEAR
HOME_RENV
PAINT_PEAL
NEAR_INDS
MOM_EDU
PICA
/IMPUTE METHOD=FCS MAXITER= 1000 NIMPUTATIONS=20 SCALEMODEL=
LINEAR
SINGULAR=1E-012 MAXPCTMISSING=NONE MAXCASEDRAWS=10000
MAXPARAMDRAWS= 10000 MAXMODELPARAM=10000
/CONSTRAINTS
Wave (
ROLE =IND )
/CONSTRAINTS
SEX (
ROLE =IND )
/CONSTRAINTS
BLL (MIN= 0.00 MAX= 9.80 RND= 0.01 )
/CONSTRAINTS
TIME (
ROLE =IND )
/CONSTRAINTS
AGE (
ROLE =IND )
/CONSTRAINTS
BMI (MIN= -8.8 MAX= 48.9 RND= 0.1
)
/CONSTRAINTS
WTHRatio
(MIN= -0.20 MAX= 0.50 RND= 0.01 )
/CONSTRAINTS
SYSTOLIC (MIN= -47
MAX= 64
RND= 1
)
/CONSTRAINTS
DIASTOLIC (MIN= -37
MAX= 41
RND= 1
)
/CONSTRAINTS
ZIPCODE
(
ROLE =IND )
/CONSTRAINTS
ANL_INC
(MIN= -45488 MAX= 262352
RND= 1
)
/CONSTRAINTS
HOME_YEAR
(
ROLE =IND )
/CONSTRAINTS
HOME_RENV
(
ROLE =IND )
/CONSTRAINTS
PAINT_PEAL (
ROLE =IND )
/CONSTRAINTS
NEAR_INDS (
ROLE =IND )
/CONSTRAINTS
MOM_EDU (
ROLE =IND )
/CONSTRAINTS
PICA (
ROLE =IND )
/IMPUTATIONSUMMARIES MODELS DESCRIPTIVES
/OUTFILE IMPUTATIONS= imputedData4 FCSITERATIONS=IterationHistory4_MDR.
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Curriculum Vita
Michelle Del Rio was born and raised in El Paso, Texas. She is the middle child of five
siblings and was the first of her family to go to college. At the University of Texas at El Paso
(UTEP), she was a member of the Medical Professions Organization, and was one of eleven
UTEP students who successfully revived the Mariachi Los Mineros. She graduated in 2010 with
a Bachelor’s of Science degree in Biomedical Sciences and was the first in the College of
Sciences to graduate with three minors: Chemistry, Psychology, and Spanish. After graduation,
she worked at Texas Tech University Paul L. Foster School of Medicine and Biomedical
Sciences in the Histology Research core facility as the lead technician of the core. Also during
this time, Michelle was president of the Association of Women in Sciences for the El Paso
chapter, where she helped to create a mentorship program for local high school girls, and had the
honor of attending the White House event in Washington, D.C., that introduced the National
Science Foundation (NSF) work-family-friendly policy for Science Technology Engineering,
and Mathematics (STEM) sectors, and also had the honor of introducing former first lady Mrs.
Michelle Obama. After a year of working at Texas Tech, Michelle was accepted into the Masters
of Public Health degree program at UTEP. She completed her course work while working at
Texas Tech, which included a practicum at the World Health Organization-Pan American Health
Organization (WHO-PAHO) where she contributed to the completion of a major epidemiological
database of mortality rates for communities along the U.S. and Mexican border regions, and
afterwards was hired as a special consultant to analyze qualitative data for studies of
Promotoras/Community Health Workers effectiveness in the border region. In fall 2014,
Michelle accepted a position as Program Manager/Coordinator for the Center of Environmental
Resource Management (CERM) where she managed Health Impact Assessments (HIAs)
examining two projects of water quality and access and wastewater management, and one project
on public transportation system in rural communities along the U.S. Mexico border. Michelle
completed her Master’s in Public Health in 2015, and continued working at CERM for two more
years before she was accepted to the Interdisciplinary Health Sciences Ph.D. program at UTEP.
Before starting her doctoral training, Michelle developed and taught an HIA course for
undergraduate and graduate students in UTEP’s Department of Public Health Sciences for
summer 2016, and was a co-instructor in the Esri ConnectED: Integrating Spatial Thinking in
West Texas and Southern New Mexico School Districts, a program led by Dr. Stanley Mubako
at CERM. Michelle completed her coursework while working at UTEP as graduate research
assistant for the first two years of the Ph.D. program, and was later promoted to project manager
in the HUD Lead Technical Study lead by Dr. Christina Sobin, a collaboration between UTEP’s
Department of Public Health, CERM, and Kansas State University. At the same time, Michelle
helped developed and taught the Environmental Health online course for fall 2018 at UTEP’s
Department of Public Health Sciences. In spring 2021, Michelle completed her Ph.D., and
accepted a postdoctoral fellow position in the Department of Environmental and Occupational
Health, School of Public Health, Indiana University at Bloomington.
Michelle plans to combine her public health sciences and research backgrounds to
continue to address and resolve public health issues along the U.S.-Mexico border. She hopes to
one day create a special community center dedicated to health services and community health
research program where environmental health is integrated into healthcare.
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